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Summary 
Despite the remarkable ability of bone to remodel and spontaneously regenerate, the body is 
incapable of self-healing in case of a critical sized bone defect caused by severe trauma or after a 
bone tumor resection. In such a case a surgical intervention is needed. Concerns regarding 
autogeneic and allogeneic bone tissue transplantation necessitate the search for synthetic bone tissue 
engineering alternatives. Such a bone substitute or scaffold has to be biocompatible, bioactive and 
biodegradable so that the implant material can integrate with the surrounding bone matrix, promote 
bone formation and finally be replaced by newly generated bone tissue. Additionally, in order to allow 
cell in-growth, vascularization and efficient transport of nutrients, oxygen, growth factors and 
metabolites, the scaffold should be porous with a high degree of interconnectivity. 
In this thesis, two biodegradable polyesters, poly(ε-caprolactone) (PCL) and poly(D,L-lactide) 
(PDLLA), were processed by means of electrospinning and 3D plotting. As such, four potential bone 
tissue engineering scaffolds were fabricated: electrospun PCL, electrospun PDLLA, 3D plotted PCL 
and a multiscale PCL scaffold fabricated by combining electrospinning and 3D plotting.  
In order to enhance the bioactivity of these scaffolds, a surface coating with an apatite was 
applied. The apatite structure is chemically comparable to the mineral phase found in natural bone 
and acts as an excellent cell support to maintain desirable cell-substrate interactions. Moreover, as 
bone apatite has carbonate content of 3 – 13 weight percent (wt%), and several studies showed that 
the cell adhesion, proliferation and metabolic activity of bone cells was increased on apatites with a 
high carbonate content, the incorporation of carbonate in the apatite lattice of the coating was of 
interest. 
In the first part of the thesis, the electrospun PCL and PDLLA scaffolds were coated with a thin 
and homogenous primer layer of calcium deficient hydroxyapatite (CDHAp). Coating was achieved in 
two steps: activation and nucleation. During the first step, reactive groups were created on the fiber 
surface. These served as nucleation points for apatite deposition during the second step in which the 
samples were alternately dipped in calcium and phosphate rich solutions. A cell study was conducted 
to determine whether the CDHAp coating enhanced cell viability. CDHAp coated electrospun PCL and 
PDLLA demonstrated to be a good substrates for cell attachment and growth of MC3T3-E1 cells. 
In the second part of the thesis, coating of the 3D PCL scaffold with hydroxyapatite with 
various carbonate contents was achieved. Analysis of the cell viability and adhesion of MC3T3-E1 
cells showed that a hydroxyapatite coating with a carbonate content of at least 10 wt% carbonate 
improved the osteogenic cell response when compared to uncoated 3D plotted PCL scaffolds and 
scaffolds coated with a hydroxyapatite with a lower carbonate content. 
In the final part of the thesis the previously optimized protocols for the coating of electrospun 
and 3D plotted PCL were combined for the coating of the innovative multiscale scaffold with 
hydroxyapatite with a low and medium carbonate content. Seeding of MC3T3-E1 cells on these coated 
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scaffolds showed that the cells reached confluence after 1 day of culture and formed a monolayer after 
7 days of culture. Moreover, the cells were able to infiltrate and colonize the interior of the scaffold. 
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Samenvatting 
Bot is een dynamisch en actief weefsel, waardoor het in staat is om kleine defecten en 
breuken spontaan te herstellen. Grotere botdefecten, bijvoorbeeld ten gevolge van de resectie van 
een bottumor, kunnen echter niet spontaan genezen. Bij dergelijke botdefecten is chirurgische 
interventie nodig. Problemen geassocieerd met het gebruik van autogeen en allogeen bot, zoals 
schaarste van botdonors en afstoting, hebben geleid tot het onderzoek naar synthetische 
botsubstituten. Dergelijk synthetisch materiaal moet biocompatibel, bioactief en biodegradeerbaar zijn, 
zodat integratie met het omliggend weefsel mogelijk is, botvorming bevorderd wordt en het materiaal 
geleidelijk vervangen wordt door nieuw botweefsel. Om de ingroei van cellen, bloedvaten en transport 
van voedingstoffen, zuurstof en metabolieten mogelijk te maken is het bovendien noodzakelijk dat de 
structuur poreus is met een hoge graad van interconnectiviteit van de poriën. 
In deze thesis werden twee biodegradeerbare polyesters, poly(ε-caprolacton) (PCL) en 
poly(D,L-lactide) (PDLLA) verwerkt via twee fabricatietechnieken, elektrospinnen en 3D plotting. Op 
die manier werden vier poreuze constructen gefabriceerd die mogelijks gebruikt kunnen worden bij 
botweefselgeneratie toepassingen: 1) elektrogesponnen PCL, 2) elektrogesponnen PDLLA, 3) 3D 
geplot PCL en 4) een construct bestaande uit een combinatie van elektrogesponnen en 3D geplot 
PCL. 
Het voordeel van PCL en PDLLA is hun biocompatibiliteit en biodegradeerbaarheid. Door hun 
hydrofobe karakter is de bioactiviteit van deze polyesters echter beperkt. Ter verhoging van de 
bioactiviteit kunnen de stalen gecoat worden met een calcium fosfaatlaag, bij voorkeur apatiet met een 
hoog carbonaatgehalte. Dergelijke apatietstructuur is chemisch vergelijkbaar met de minerale fase van 
bot. 
In het eerste deel van deze thesis werden elektrogesponnen PCL en PDLLA gecoat met een 
dunne en homogene calcium deficiënte hydroxyapatietlaag (CDHAp) in twee stappen. De eerste stap 
bestond uit de activatie van de polyesters, waarbij reactieve groepen gecreëerd werden op het 
vezeloppervlak. In de tweede stap dienden deze reactieve groepen als aanhechtingsplaatsen voor 
calcium fosfaatkristallen tijdens een alternerende onderdompeling van de stalen in calcium- en 
fosfaatrijke oplossingen. Een celstudie met MC3T3-E1 pre-osteoblasten toonde aan dat de 
celviabiliteit verhoogd was op de gecoate stalen in vergelijking met de onbehandelde 
elektrogesponnen PCL en PDLLA stalen.  
In het tweede deel van de thesis werden 3D geplotte PCL structuren gecoat met 
hydroxyapatiet met variërende carbonaatconcentraties door incubatie in mineralisatieoplossingen met 
ion concentraties gebaseerd op deze van humaan bloedplasma. Analyse van de celviabiliteit en 
adhesie van MC3T3-E1 cellen toonde aan dat een hydroxyapatietlaag met een carbonaatinhoud van 
minstens 10 gewichtspercent (gew%) carbonaat resulteerde in een verbetering van de celrespons in 
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vergelijking met onbehandelde 3D geplotte PCL en stalen gecoat met hydroxyapatiet met een lagere 
carbonaatconcentratie.  
Tenslotte werden de coatingprocedures die geoptimaliseerd werden voor het 
elektrogesponnen en 3D geplotte PCL toegepast op de meest innovatie PCL structuur bestaande uit 
een combinatie van electrogesponnen nanovezels en 3D geplotte microvezels. Zo werd deze ‘hybride’ 
structuur gecoat met een laagje carbonaat bevattend hydroxyapatiet. Incubatie van MC3T3-E1 cellen 
op deze gecoate stalen toonde aan dat de cellen reeds na 1 dag in een confluente laag aanwezig 
waren en dat de cellen na 7 dagen een ‘monolayer’ vormden op de stalen. Histologische coupes van 
de stalen toonden bovendien aan dat de cellen in staat waren om de structuren binnen te dringen en 
te koloniseren. Bijgevolg zijn dergelijke structuren bestaande uit nano- en microvezels, gecoat met 
een laagje carbonaat bevattend hydroxyapatiet goede kandidaten voor botregeneratie toepassingen. 
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1 Bone 
A total of 213 bones make up the adult human skeleton, ranging from long bones in 
the limbs, short bones in the wrists and ankles and flat bones in the sternum and skull, to 
irregular bones such as the pelvis and vertebrae. The skeleton serves as structural support 
for the body, permits movement by providing levers for the muscles, protects vital internal 
organs and structures, provides maintenance of mineral homeostasis and acid-base balance, 
serves as a reservoir of growth factors and cytokines and provides the environment for 
hematopoiesis within the marrow spaces.1 Bone consists of several tissues, but the most 
prevalent type is osseous tissue or bone tissue. Bone tissue is arranged in either a compact 
pattern (compact or cortical bone) or a trabecular pattern (spongy or cancellous bone). The 
adult human skeleton is composed of 80% compact bone and 20% spongy bone.2 
Compact bone is dense and solid with a porosity of only 5-10%. It is found as the 
external layer or cortex of the bones and has a smooth, dense and continuous structure 
(Figure 1A). This type of bone is built up by osteons or Haversian systems, which are 
composed of lamellae that are concentrically oriented around a central Haversian canal, 
which contains blood vessels for nutrient supply and nerve fibers (Figure 1B).1-3 
Spongy bone has a high porosity (50-95%) and is found in the extremities of long 
bones and in the center of short, flat and irregular bones. As seen in figure 1A, the matrix 
structure is composed of a network of trabeculae, small bone rods and plates that form a 
three-dimensional (3D) interconnected porous network. Within this structure, nutrients are 
supplied from capillaries that surround the bone trabecula.2,3 
 The outer surface of compact bone is surrounded by the periosteum, a fibrous 
connective tissue layer, which contains blood vessels, nerves, fibroblasts and 
osteoprogenitor cells (Figure 1A). The endosteum is a thin membranous structure that covers 
the inner surfaces of bone. Although considerably thinner than the periosteum, the 
endosteum also contains fibroblasts and osteoprogenitor cells (Figure 1A).1  
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Figure 1: Structure of a typical long bone showing both compact (cortical) and spongy (cancellous) 
bone. © 2011 Pearson Education, Inc. 
1.1 Bone extracellular matrix  
Like other connective tissues, bone consists of cells embedded in an organic 
extracellular matrix (ECM). The latter is comprised of fibers and an amorphous gel-like 
ground substance, produced by the cells. A characteristic elementary unit of the bone ECM 
is the mineralized collagen fibril. These fibrils consist of an organic phase strengthened by an 
inorganic mineral phase of calcium phosphate crystals.  
1.1.1 Collagen 
Side-by-side cross-linking of collagen fibrils forms collagen fibers. According to the 
collagen fiber arrangement, two types of bone can be identified microscopically; woven bone 
and lamellar bone. The presence of the characteristic 67 nm repeat structure in the collagen 
fibers of both the ordered and disordered materials, indicates that type I collagen is the major 
component of both types.4 
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Woven bone is characterized by a disordered organization of collagen fibers and is 
mechanically weak. It is produced very quickly by osteoblasts and is a transient tissue type 
that is characteristically found in the fetus and in the callus produced during fracture repair. 
Woven bone contains blood vessels and a high portion of osteocytes.4,5 
Lamellar bone is the most common structural type found in bones and is laid down 
much more slowly than woven bone. The collagen fibers and their associated mineral show a  
plywood-like arrangement and even though the final degree of mineralization of lamellar 
bone is less than that of woven bone, lamellar bone is mechanically much stronger. It is 
formed in the fetus during the third trimester and after fracture woven bone is gradually 
replaced by lamellar bone during the process of hard callus or bony formation (see section 
1.3).5 
1.1.2 Mineral phase 
The inorganic mineral phase of mature bone is a calcium phosphate with an X-ray 
diffraction (XRD) pattern that closely resembles that of stoichiometric hydroxyapatite [HAp; 
Ca10(PO4)6(OH)2]. The apatite crystals are intimately associated with the organic matrix and 
account for 60 to 70 wt% of the bone’s dry weight. The diffraction peaks in the pattern of 
bone mineral are much broader and less resolved compared to the ones found in HAp, which 
confirms the presence of nanometer sized plate-shaped crystals.4 Chemical analysis has 
shown that bone mineral lacks hydroxyl groups but contains impurities such as F-, Cl-, Na+, 
K+, Fe2+, Zn2+, Sr2+, Mg2+, CO32- and HPO42-.2,6-8 As the impurities are incorporated in the 
apatite lattice by a substitution of the lattice ions, the properties of the apatite mineral 
change, especially the crystal size, solubility, strength and brittleness. Consequently, the 
solubility of the apatite mineral in the body can be fine-tuned by the controlled incorporation 
of impurities in the apatite lattice. As a result, the concentration of impurities depends on the 
location of the apatite in the skeleton.6,7 For example, bone mineral contains approximately 
7wt% carbonate which makes this apatite amenable to dissolution. In contrast, the carbonate 
content in the less soluble apatite of enamel approximates 3.5wt%.  
1.1.3 Non-collagenous proteins and water 
Proteoglycans and other non-collagenous proteins (NCPs) such as osteocalcin, 
osteonectin, osteopontin and bone sialoproteins are present as ground substance. These 
proteins account for approximately 5% of the total protein content of bone and are thought to 
play a crucial role in bone formation and modulation of cell adhesion, migration, proliferation 
and differentiation. However, little is known about the location and function of the NCPs.2,4 
Proteoglycans have a high water-absorbing capacity, however the water content of bone is 
lower than in other connective tissues. 
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The complex composite structure gives bone its requisite strength and high fracture 
toughness.9 The inorganic component of bone makes the tissue hard and rigid, while the 
organic component provides flexibility and resilience.3,10 Each bone constantly undergoes 
modeling during life to help it adapt to changing biomechanical forces, as well as remodeling 
to remove old and/or microdamaged bone.1 The forces that a bone needs to withstand and 
hence its composition varies depending on its place in the body. In addition, the properties of 
bone differ with species, race, gender and age.11,12 In general, the mechanical properties of 
both compact and spongy bone have been demonstrated to depend on density, porosity, 
architecture and the mineral and matrix components.2 Table 1 shows some illustrative values 
of the compact bone properties of various bones in the human body.  
 
Table 1: Average values for mechanical and physical properties of wet compact human bone.  
Bone Age Breaking load  Ultimate 
tensile 
strength 
Young's 
modulus 
Density Ref 
 
 
kg MPa/m2 GPa/m2 g/cm3 
 
Femur 20-39 - 124 17.6 - 11 
 41 71.2 100.03 14.61 1.91 12 
 71 57.2 66.69 13.34 1.85 12 
Tibia 20-39 - 174 18.4 - 11 
 41 83.0 103.95 18.53 1.96 12 
 72 70.8 82.38 15.89 1.83 12 
Fibula 33 64.9 98.07 18.83 1.91 12 
 59 57.6 78.45 14.91 1.73 12 
Humerus 20-39 - 125 17.5 - 11 
Radius 20-39 - 152 18.9 - 11 
 
1.2 Bone cells 
The calcified matrix embeds bone cells which play a crucial role in modeling and 
remodeling of the bone, both tailored by mechanical, hormonal and physiological 
parameters. The first process modulates the bone size and shape while the remodeling 
process renews old or damaged bone to maintain bone strength and homeostasis of calcium 
and phosphate. In adults, bone modeling occurs less frequent when compared to 
remodeling.1  
There are three types of fully differentiated bone cells: osteoblasts, osteocytes and 
osteoclasts (Figure 2). Apart from these cell types, osteoprogenitor cells are present in the 
periosteum, endosteum and bone-marrow. Osteoprogenitor cells can be defined as 
persistent migratory stem cells, which can proliferate and differentiate into osteoblasts.3  
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Osteoblasts are present at the bone surface, where they form a tight layer of cells 
(Figure 2). The primary function of osteoblasts is to actively synthesize and deposit the 
organic components of the bone matrix: the ground substance and the collagen fibers. The 
non-mineralized bone matrix secreted by osteoblasts is called osteoid. Extracellular matrix 
vesicles are also synthesized by the osteoblast. These serve as protected 
microenvironments in which calcium and phosphate concentrations can increase sufficiently 
to precipitate apatite crystals within the osteoid. Osteoblasts transform into osteocytes after 
becoming embedded in their own bone matrix (Figure 2). Osteocytes lie within lacunae within 
mineralized bone where they maintain the bone matrix and regulate mechanotransduction. 
Osteoblasts are also responsible for the regulation of osteoclast differentiation and activity. 
Osteoclasts are the only cells that are known to be capable of resorbing bone. Bone 
resorption depends on osteoclast secretion of hydrochloric acid, which dissolves the mineral 
component of the bone matrix, and proteolytic enzymes such as cathepsin K, which digest 
the proteinaceous matrix. The released calcium and phosphate ions enter the tissue fluid and 
the blood stream, whereas the collagen is taken up by the osteoclasts by phagocytosis.1,3  
Figure 2: Bone trabeculae section showing the position of 
the bone cells. © 2011 John Wiley & Sons, Inc. 
 
 
 
 
1.3 Bone healing 
Bone is a dynamic and active tissue that is constantly being remodeled in response to 
mechanical stress and hormonal stimuli. The spongy bone in the skeleton is entirely replaced 
every 3 to 4 years, the compact bone every 10 years.3 Due to this remarkable property, bone 
has a high regenerative capacity including the ability to repair fractures with complete 
restoration of form and function.  
1.3.1 Spontaneous bone healing 
Repair is divided into four subsequent biological processes, each characterized by a 
specific set of cellular and molecular events (Figure 3): 
Stage 1: Inflammation and hematoma formation (Figure 3A) 
When a bone fracture occurs the local soft tissue, including blood vessels and 
marrow, is damaged. The bleeding within the defect is contained by the surrounding tissue 
and forms a hematoma. Degranulating platelets, macrophages and other inflammatory cells 
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infiltrate the hematoma between the fractured fragments and remove degenerated cells and 
necrotic tissue and secrete cytokines and growth factors.13 
Stage 2: Soft callus (fibrocartilage) formation (Figure 3B) 
Within a few days blood vessels, osteoblasts and fibroblasts infiltrate the hematoma. 
The fibroblasts secrete collagen fibers that bridge the defect site. Some of the fibroblasts 
differentiate into chondrocytes that lay down cartilage. At this moment a semi-rigid soft callus 
is formed which provides some mechanical support to the fracture. As more fibers and 
cartilage are produced, the soft callus becomes a fibrocartilaginous callus.3,13 
Stage 3: Hard callus (bony) formation (Figure 3C) 
This stage represents the most active period of osteogenesis and starts within a 
week.  It is characterized by high levels of osteoblast activity and the formation of mineralized 
woven bone directly in the peripheral callus. Trabeculae of new bone span the width of the 
callus, uniting the two fragments of the broken bone. The new woven bone or hard callus is 
typically irregular.13 
Stage 4: Bone remodeling (Figure 3D) 
The final stage of fracture repair takes many months and involves the remodeling of 
the woven bone in the hard callus into the original lamellar bone configuration. The process 
of neo-vascularization is maintained. The key cells involved in the resorption of mineralized 
bone are the osteoclasts. Once completed, osteoblasts are able to lay down new bone on 
the eroded surfaces. Eventually, the bone structure will be identical to the original bone 
morphology.3,13 
Figure 3: The four stages of bone healing. Copyright © 2010 Pearson Education, Inc. All rights 
reserved. 
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 The fracture healing time will depend on its complexity, its place in the human body 
and the patient’s age. In adults, a simple fracture the bone is healed in about 6 to 8 weeks.3 
Despite the high regenerative capacity of bone tissue, the healing process can be 
compromised by an unfavorable wound environment and biomechanical instability. In 
addition, large osseous deficiencies arising from disease, trauma, congenital disorders or 
surgery will not heal spontaneously  and can generate critical sized defects. These bone 
defects are defined as, “the smallest size intraosseous wound in a particular bone and 
species of animal that will not heal spontaneously during the lifetime of that animal”.14 The 
repair of such bone defects remains a major clinical challenge.14-16  
1.3.2 Repair of critical sized bone defects 
1.3.2.1 Bone grafts 
Current procedures to repair critical sized bone defects are autologous or allogeneic 
bone grafts. These grafts provide structural and mechanical support. 
a Autografts 
In autografting, ‘donor’ bone is harvested from a non-load-bearing site in the patient 
(mostly iliac crest, but also femur, tibia, mandible and calvarium) and implanted in the defect. 
A bone autograft has osteogenic, osteoinductive and osteoconductive properties. 
Autografting is considered the gold standard of bone grafting because it contains the 
patient's bone cells, proteins, and calcified matrix. Although the graft does not provide 
mechanical stability, it is rapidly incorporated into the host tissue.17,18 While clinical 
successes with autografts are notable, limited supply and donor site morbidity are a major 
concern.18 
b Allografts 
In allografting the bone is harvested from a donor from the same species. Bone is one 
of the two most commonly transplanted tissues, second only to blood.19 As the allograft is 
obtained from a human donor the need for an additional surgery on the patient is avoided. 
Allograft bone has different properties depending on its preparation, but allograft bone has no 
osteogenic potential. An allograft mostly serves as an osteoconductive scaffold in which 
revascularization and new bone formation can occur. Nevertheless, there are risks of 
disease transmission and a high rate of non-union and fracture with an approximate 
prevalence of 15-30% in the case of large structural bone allografts.18 In addition, the 
maintenance of bone banks is expensive and the problem with insufficient donor tissue 
availability remains.15,16,20-25  
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1.3.2.2 Biomaterials 
The problems associated with auto- and allografts, have led to the exploration of 
biomaterials and their development as bone grafts substitutes or implants.26 These 
biomaterials are synthetic preformed materials such as metals, ceramics and polymers.27  
a Metals 
Metals such as stainless steel and various alloys with cobalt, titanium and magnesium 
have played an important role as structural implants in reconstructive surgery, especially 
orthopedics and reconstructive maxillofacial surgery. These metallic materials provide the 
strength and toughness that are required in load-bearing parts of the body. Nevertheless, 
concerns include the systemic toxicity of released metal ions due to corrosion and fatigue 
failure of structural components caused by repeated loading. In addition, metals generally 
are not able to form a strong bond with the surrounding tissues.28,29 
b Bioactive ceramics 
This category of ceramics includes calcium phosphates (hydroxyapatite (HAp) in 
particular), calcium carbonate, glass, and their composites. These materials contain ions 
commonly found in the physiological environment (such as K+, Mg2+, Na+) and/or ions 
showing very limited toxicity to body tissues. Hence, these materials can be called 
biocompatible. In addition, they have the capability to interact with the biological environment 
to improve host response as well to form a direct bond with the surrounding tissue. However, 
due to their brittle nature and low strength the clinical use of ceramics alone is limited. 17,26,29 
c Synthetic polymers 
For orthopedic and craniofacial applications, polymers currently used include acrylics, 
polyamides, polyurethanes, polyetheretherketone (PEEK), ultra-high molecular weight 
polyethylene (UHMWPE) and polypropylene (PP). These polymer materials are considered 
biocompatible and bioinert in the human body. The main advantage of these materials 
include the possibility to tailor their composition and structure according to the specific need. 
However, due to their hydrophobic nature, polymers generally show unfavorable protein 
adsorption which leads to poor cell attachment. The latter can be enhanced by the addition of 
a bioactive material to the polymer.29 
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2 Bone tissue engineering 
Since current techniques for the reconstruction of bone defects have significant 
drawbacks, there is a strong need for alternative bone substitutes. Bone tissue engineering 
(BTE) holds promise in providing an improved clinical therapy for the functional and structural 
restoration of damaged or lost bone tissue.  
In general, tissue engineering has been defined as “The interdisciplinary field of study 
that applies the principles of engineering and life sciences towards the development of 
biological substitutes that restore, maintain or improve function or a whole organ”.30 Recent 
scientific progress in biomedical research has created exceptional advances in the 
development of engineered tissues. There are three main components, the so-called tissue 
engineering triad, in the field of tissue engineering. These include (1) a scaffold that provides 
structure and acts as substrate for tissue growth and development, (2) a source of cells to 
facilitate required tissue formation, and (3) growth factors to direct the growth and 
differentiation of cells within the scaffold (Figure 4).16,31  
Figure 4: The tissue engineering triad.16  
Even though ideally all three components should be incorporated, the generally 
applied BTE strategies can be divided in three categories: cell/scaffold-based strategies, 
scaffold-based strategies and growth-factor/scaffold-based strategies.32,33 
2.1 BTE strategies 
2.1.1 Cells/scaffold-based strategies 
Bone regeneration is biologically driven by osteoprogenitor cells that are able to form 
new osteoblasts. In the cellular approach specific cells are harvested directly from the patient 
(autologous cells) or from a donor (allogenic cells) and expanded in culture. Next, the cells 
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are seeded ex vivo onto the scaffold. The cellularized scaffold is then cultured in a bioreactor 
that is capable of providing the multi-parametric signals needed for graft development and 
maturation. Finally the construct is implanted in the patient where it can integrate with the 
surrounding tissue.16 For BTE purposes, bone marrow derived mesenchymal stem cells 
(MSCs) are popular due to their multipotency.34 Adipose tissue has also been shown to 
contain a population of multipotent cells, the adipose tissue-derived stem cells (ADSCs).35 
The isolation and expansion of autologous stem cells was once considered to be the 
future of BTE. However, as somewhat contradictory results exist regarding the (pre)clinical 
successes of cell-based tissue engineering constructs, no products have yet reached the 
clinic.36 Additional challenges associated with production costs, storage, culture times, the 
transport of cell-cultured scaffolds and the practical handling for the surgeon as well as 
limited demonstrations of efficiency have led to a re-focusing on the acellular scaffold-based 
approach.  
2.1.2 Scaffold-based strategies 
In this approach the tissue formation is due to cells which are already present in the 
body. The advantage of the latter is the reduced amount of operations needed, resulting in a 
shorter recovery time for the patient. Even though the amount of cells that migrate in the 
acellular scaffold is few, the osteogenic response can be enhanced by adding growth factors 
to the scaffold.16,37 Such scaffold could offer a more economical and practical alternative.   
2.1.3 Growth factors/scaffold-based strategies 
Growth factors, such as vascular endothelial growth factor (VEGF), basic fibroblastic 
growth factor (bFGF) and bone morphogenetic proteins (BMPs), can be incorporated onto 
the scaffold by simple soaking, encapsulation or covalent immobilization. The addition of 
growth factors to the scaffold is a relatively easy and widely studied approach. Because 
growth factor delivery is either driven by passive diffusion or coupled to the rate of material 
degradation, growth factor release may be altered only to some extent by the amount of 
growth factor added or by varying the degradation rate of the material. The release profile for 
this method is, therefore, often not in tune with the actual healing process and cellular 
demands. In general, the incorporation of growth factors into the scaffold is not an efficient 
method. Adding the high cost associated with the human recombinant growth factors makes 
the growth factor-loaded scaffold approach less attractive.38,39 
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2.2 Basic requirements of a BTE scaffold 
As the structure of bone depends on the type of bone and its location in the body, the 
properties of the scaffold are of the utmost importance if the construct needs to mimic the 
organization, functionality and structure of the bone as closely as possible. For instance, 
fractures in load-bearing long bones require scaffolds with high mechanical stability. This 
factor is less crucial for non-load-bearing applications such as the reconstruction of 
craniofacial defects. For the reconstruction of these defects the scaffold should preferentially 
be shapeable in order to be fitted into the defect. 
An ideal scaffold should fulfill the following requirements: 
a Biocompatibility 
First, biocompatibility of the substrate material is imperative; the material and any 
degradation by-products must not elicit any inflammatory response nor demonstrate 
immunogenicity or cytotoxicity so that fibrous capsule formation and/or cell death is avoided.  
b Biodegradability and/or bioresorbability 
The scaffold should degrade and/or resorb at a controlled rate.20 In an ideal case, the 
in vivo degradation and/or resorption rate of the scaffold is comparable with the rate of new 
bone formation. In this way, the scaffold can be replaced by new bone without affecting the 
mechanical stability. Importantly, biodegradation and/or resorption of the scaffold eliminates 
the need for a second surgery to remove the implant.37 
c Osteoinductiviy and osteoconductivity 
An osteoinductive material has the ability to induce bone formation by attracting 
pluripotent progenitor cells from the surrounding tissue and stimulating them to differentiate 
into chondrocytes and osteoblasts. An osteoconductive scaffold supports bone growth and 
encourages the ingrowth of capillaries and cells from the surrounding host tissue.20,21 
Due to the osteoinductive and osteoconductive properties, the implant forms a direct 
and strong bond with the bone tissue and is considered bioactive.40 
d Porosity 
The goal of the scaffold is to provide a 3D environment for cell adhesion, proliferation 
and differentiation. A porous structure with interconnected pores promotes tissue ingrowth 
into the interior of the scaffold and the exchange of nutrients and metabolites between its 
interior and exterior.41-43 In vitro, lower porosity stimulates osteogenesis, whereas, in vivo  
higher porosity and pore size result in greater bone ingrowth.44 Certain cell types thrive at 
different pore sizes. For example, it was found that osteoblasts and chondrocytes grow better 
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within a pore size of 380-405 µm, whereas fibroblasts prefer a pore size of 186-200 µm.45 
Moreover, a pore size of at least 100 µm is known to be compulsory to allow cell penetration 
and proper vascularization of the ingrown tissue and it was recommended that the pore size 
should be greater than 300 µm for increasing the formation of new bone.42,46 As the average 
size of a human osteon is 223 µm, it was also suggested that the optimal pore size range is 
200-400 µm.20 Overall, as osteogenesis progression is affected by pore size, large pores 
(>300 µm) that are well vascularized are expected to induce direct osteogenesis.46 
e Mechanical stability 
The mechanical strength of the scaffold needs to be similar to that of the surrounding 
tissue. The scaffold should offer adequate mechanical integrity to provide stable fixation, as 
mechanical loading is expected in patients during bone regeneration.20,24 In addition, the 
Young’s modulus value for the scaffold should be similar to that of the surrounding tissue. 
Scaffolds that are stiffer than the surrounding and regenerating tissues can cause adverse 
physiological responses, such as tissue resorption and stress-shielding.24,47 
f Sterilization 
The material needs to be easily sterilizable to prevent infection without affecting the 
material properties.20 Different sterilization techniques are available such as exposure to 
ethylene oxide vapour, heat sterilization, ethanol treatment and irradiation with γ-rays or UV 
light.48,49 In recent years, various reports describing the noxious effects of ethylene oxide 
have been published. Due to the growing concern on the effects of this sterilizing agent, 
sterilization by radiation is now considered more appropriate for the sterilization of complex 
geometries.49 
2.3 Scaffold fabrication techniques 
Whether or not cells and/or growth factors are added to the BTE construct, the scaffold 
plays a crucial role in cell seeding, proliferation and new tissue formation in three 
dimensions. A scaffold with a 3D structure and high porosity with interconnected pores is 
imperative to allow cells to migrate into the scaffold. Currently, scaffold design is a complex 
science, in which several aspects are carefully addressed in order to produce successful 
constructs. Various fabrication techniques have been investigated in order to fabricate 3D 
scaffolds with high porosity and surface area.22,41,50-52 These techniques can be classified in 
two categories: conventional and advanced processing techniques.  
 
 
Introduction 
14 
 
2.3.1 Conventional processing techniques 
2.3.1.1 Freeze-drying 
 In this technique an emulsion is created by homogenization of two immiscible 
solutions, a polymer solution (dissolved in an organic solvent) and water. The emulsion is 
then rapidly cooled down to a certain temperature at which all materials are in a frozen state. 
Next, the solvent and water are removed by applying pressure lower than the equilibrium 
vapor pressure of the frozen substances. When all the water and solvent are completely 
sublimated, a scaffold with a porous microstructure remains.50,53  
2.3.1.2 Thermally induced phase separation (TIPS) 
In this approach, the polymer is first dissolved in a solvent at a high temperature. The 
polymer solution is then quenched and undergoes a liquid-liquid phase separation to form 
two phases; a polymer-rich phase and a polymer-poor phase. The polymer-rich phase 
solidifies and subsequent removal of the solvent-poor phase by sublimation leaves a porous 
polymer scaffold. In general, the micro-and macrostructure is controlled by varying the 
polymer type, polymer concentration, quenching temperature and solvents.53-55 
2.3.1.3 Solvent-casting 
 Solvent casting, salt leaching or particulate leaching has shown promise for its ability 
to produce scaffolds at room temperature. In this technique, a scaffold is produced by mixing 
a polymer solution, dissolved in an organic solvent, with  water-soluble salt particles of a 
specific diameter. The mixture is then cast into a mold of desired shape, after which the 
solvent evaporates leaving behind a polymer matrix embedded with salt particles. During  
subsequent processing the porogen is leached out by immersing the scaffolds in water to 
form a pore structure within the scaffold. The pore size can be varied by changing the size of 
the porogen particles. In order to have a uniform pore structure, the thickness of scaffolds 
made by this technique should be less than 4 mm, making it difficult to produce larger 3D 
scaffolds.22 To overcome this, a centrifugal technology56 and the addition of polyethylene 
glycol (PEG)57 have been used to improve the pore uniformity of the scaffolds.  
The conventional techniques enable the fabrication of scaffolds with interconnected 
porous structures but offer limited capacity to control pore size, pore geometry, pore 
interconnectivity and spatial distribution of the pores (Table 2).46 As an alternative, advanced 
fabrication techniques have been evolving in tissue engineering, such as electrospinning and 
rapid prototyping.53 
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Table 2: Advantages and disadvantages of conventional polymer processing techniques. 
 
2.3.2 Advanced processing techniques 
2.3.2.1 Electrospinning 
Although the process of electrospinning has been known for 80 years and the patent 
was issued to Formhals in 1934 (U.S. Patent, 1-975-504), polymeric nanofibers produced by 
electrospinning have only recently become a topic of great interest in BTE.58-60 Polymer 
materials that have been investigated to form a 3D scaffold with the electrospinning 
technique are synthetic aliphatic polymers such as poly(hydroxyalkanoates)61 and poly(α-
hydroxyesters)62. Also natural polymers such as hyaluronic acid, collagen and gelatin have 
been investigated.51,63 
An electrospinning system consists of four major components: the polymer solution, a 
high voltage source, a spinneret and a grounded collecting plate (Figure 5). A polymer 
solution is loaded into a syringe and forced through a needle connected with the high voltage 
source. When the voltage source is turned on, the charge is transferred into the polymer 
solution. Increasing the electric field strength causes the repulsive interactions between 
equal charges in the liquid and the attractive forces between the oppositely charged liquid 
and collector to begin to exert tensile forces on the liquid, elongating the pendant drop at the 
tip of the needle. As the electric field is increased further a point will be reached at which the 
electrostatic forces balance out the surface tension of the liquid leading to the development 
of the Taylor cone. If the applied voltage is increased beyond this point a fiber jet will be 
drawn from the apex of the cone. As the jet moves towards the collector plate, it is elongated 
by electrostatic interactions between charges on nearby segments of the same jet. 
Meanwhile, the solvent evaporates and finally the jet solidifies into a fiber which is collected 
onto the collector surface where it forms a mesh with an ordered or random network of fibers 
with a high surface to volume ratio.58,59,64,65 The diameter of the fibers can vary between tens 
of nanometers to several micrometers and depends on the electrospinning parameters such 
as polymer solution (viscosity, conductivity, molecular weight of polymer, solvent), 
Fabrication method Advantages Disadvantages 
Freeze Drying41,50,55 High porosity (~ 90%) 
Controlled pore size 
Closed pore structure 
Low reproducibility 
Thermally induced 
phase separation 
(TIPS)50,53-55 
High porosity (~ 95%) 
Highly interconnected porous structure 
Good mechanical properties 
Small pore size (10-100µm) 
Small scale production 
Low reproducibility 
Use of organic solvents 
Solvent 
casting/Particulate 
leaching22,50 
Controlled porosity 
Controlled interconnectivity 
Use of organic solvents 
Low reproducibility 
Limited scaffold size 
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processing parameters (applied voltage, distance between needle-tip and collector surface, 
flow rate) and environment parameters (humidity, temperature).53 Once these parameters are 
optimized electrospinning is a simple and cheap technique to fabricate scaffolds with an 
interconnected pore system, a reproducible fiber morphology and nano – to microscale 
topographies similar to the natural ECM.  
Fiber orientation, porosity and surface-to-volume ratio of electrospun scaffolds are 
shown to influence cell response.58  
 
Figure 5: A) Schematic diagram of an electrospinning set-up and B) SEM image of electrospun 
nanofibers. 
 
2.3.2.2 Rapid prototyping 
A few rapid prototyping (RP) technologies, also called solid freeform fabrication (SFF) 
or additive manufacturing, have been developed to fabricate 3D scaffolds consisting of 
various polymers, ceramics and their composites.66-69 The process of RP begins with the 
scanning of an object (or patient) using computed tomography (CT) or magnetic resonance 
imaging (MRI) scans. These data are used to generate a 3D model by Computer-Aided 
Design (CAD) software. The CAD file is typically converted to a stereolithography file format 
(STL), which is then numerically sliced into 2D cross-sections. These 2D elements are 
fabricated and stacked in such a manner that the 3D object is formed with the desired 
dimensions.22,46  
With the RP technology both the geometry and material composition can be 
controlled in a reproducible manner. RP technologies enable the fabrication of well-defined 
and highly reproducible 3D tissue engineering scaffolds with controllable porosity, pore size, 
permeability and mechanical properties, with varying internal architectures.22,46 Compared to 
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electrospinning, that produces fibers in the nanometer range, 3D scaffolds fabricated with RP 
techniques have filaments in the micrometer range and larger pore sizes. 
 Various methods for RP have been developed over the past 30 years starting with 
the invention of stereolithography (SLA) in 1986 (U.S. Patent 4575330 A). Several common 
RP processes, which have been used for the fabrication of BTE scaffolds have been 
reviewed in literature22,46,70-74 and will be discussed briefly in the following sections. The 
advantages and disadvantages of the different RP techniques are summarized in Table 3. 
a Stereolithography 
In SLA the base material is a resin of photo reactive monomer liquids like acrylate 
and epoxies. A platform supporting the developing model is brought near the surface of a 
liquid vat, and a laser of UV source is used to solidify the first cross-sectional layer of the 
model. By lowering the platform and repeating the process layer by layer the complete 3D 
structure is formed.22,46 A disadvantage of SLA is the limited choice of material, as the base 
material needs to be photocrosslinkable. Recently, photocrosslinkable PCL75- and PDLLA76-
based resins were developed and applied in the fabrication of tissue engineering scaffolds. 
Furthermore HAp scaffolds with well-defined channel size can be fabricated with SLA. The 
bioceramic powder is then mixed with a photopolymer, which acts as a binder, prior to SLA 
processing.77 However, to date the use of SLA in biomedical industry has mainly focused on 
building anatomical models for surgical planning.46 
b Selective laser sintering 
In selective laser sintering (SLS) parts are made by passing a laser beam (mostly 
CO2 source) over a powder bed. The laser will raise the temperature of the powder, which will 
cause neighboring particles to fuse together both laterally and to the preceding layer 
below.22,46 SLS showed great potential in producing complex porous ceramic78 and titanium-
based79 scaffolds suitable for implantation in a bone defect. Williams et al. have fabricated 
porous polyester scaffolds with sufficient mechanical properties for BTE applications using 
SLS.80 
c Three-dimensional printing 
3D printing (3DP) uses ink-jet printing technology to precisely place a “binder” 
solution on a bed of powder thus gluing the powder together in a cross-sectional layer. A 
platform is lowered and more powder is deposited and processed in a layer by layer 
fashion.22 As reviewed by Bose et al.81, a large variety of ceramic, polymeric and composite 
materials can be processed using 3DP. In general, the binder selection and process 
parameter optimization are the keys to a successful scaffold fabrication.81   
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d  Extrusion based systems 
Among the available RP techniques, the extrusion based techniques are the most 
advanced scaffold fabrication techniques due their ability of using different materials and 
their feasibility of deposition on demand with high precision.82 
In 1992 Crump developed the first commercially available extrusion based system 
known as fused deposition modeling (FDM) (U.S. Patent 5121329 A). In this system, a thin 
thermoplastic filament is melted by heating and the semi molten material is extruded through 
a small opening and deposited onto a platform while it is guided by a robotic device. At the 
end of the deposition of each layer, the platform is lowered so that the next layer can be 
deposited (Figure 6A). By changing the direction of each layer and the spacing between 
materials, scaffolds with highly uniform internal structures are obtained.82,83 However, the 
commercial FDM system requires the material in the form of filaments with specific size and 
material properties to ensure regular material flow. This imposes a limitation on the 
processing window and the number of materials that can be used (Table 3).67,68 
To widen the range of possible materials, a screw-extrusion system (SES) or 3D 
plotting can be used (Table 3). The 3D plotting  system consists of a robotic arm and a 
heated barrel with an extrusion screw inside. The barrel can contain the polymer in its 
original form. A robotic arm enables movement of the barrel in x-y-z directions over a fixed 
platform. The heater melts the material, which is then extruded by pressure created by a 
turning screw feed (Figure 6B). Parameters that determine the quality of 3D plotted scaffolds 
include motor speed, dispensing speed, melt temperature, platform temperature, layer 
thickness and nozzle size.46  
For both FDM and 3D plotting, different process parameters like melt flow behavior, 
pore size and porosity of extrusion based systems have been investigated for various 
scaffold materials such as polyesters66,84,85, polyurethanes82,86 and polyester/HAp 
composites87. 
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Figure 6: Graphical illustration of (a) the conventional fused deposition modeling (FDM) system and 
(b) the screw extrusion system or 3D plotting.46 
 
The main difference between 3D plotting and FDM is that FDM uses a coiled filament as 
precursor material and 3D plotting uses the raw (granulate, powder or even regrind) polymer. 
This results in some distinct advantages for 3D plotting compared to FDM, which are: 
(i) There is no need for the polymer to be supplied in a filament shape, something 
which requires a separate extrusion procedure prior to actual processing on the 
FDM device. Therefore: 
a. The thermo-mechanical load on the  polymer, which is induced by this first 
extrusion is avoided;  
b. There is no dependency on the limited number of commercially available 
material types for the precursor filaments. Any thermoplastic polymer can be 
processed;  
(ii) In 3D plotting, the size of the plotted filaments (and subsequently, the layer 
thickness) is not restricted by the dimensions of the precursor filament used.88 
 
Furthermore, the major advantages of extrusion based systems compared to material 
solidification techniques (such as SLA and SLS) are that: 
(i) Much smaller amounts of material are required for start-up: a large amount of 
base material is required for both the standard SLA and SLS, while a little more 
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than the material required for the scaffold itself is sufficient for FDM and 3D 
plotting. 
(ii) The technique can be used for the processing of any thermoplastic material and is 
not restricted to photopolymers (SLA) or the limited spectrum of polymers which 
are available in the appropriate powder form for SLS.88 
Table 3: Advantages and disadvantages of common rapid prototyping techniques.22,46,74,81,88 
Fabrication method Advantages Disadvantages 
Stereolithography (SLA) High-resolution and accuracy Only photocrosslinkable  resins 
Only possible to use a single resin at a 
time 
Post-processing 
Expensive material and equipment 
 
Selective laser sintering (SLS) Good accuracy 
Low material cost 
Only thermostable polymers 
Expensive equipment 
Small pore size (<50µm) 
3D printing Processing at room temperature Small pore size (<50µm) 
Fused deposition modeling (FDM) High pore interconnectivity 
High reproducibility 
Only thermostable polymers 
Materials may degrade during process 
3D plotting High pore interconnectivity 
High reproducibility 
Wider variety of materials 
Materials may degrade during process 
 
3 Materials for BTE scaffold fabrication 
One of the major components of a tissue engineering construct is the material used to 
make the scaffold. There are numerous biomaterials that have been used for the fabrication 
of BTE scaffolds. The material selection depends on multiple factors including the intended 
application of the scaffold and the processing technique to fabricate the scaffold. Among all 
types of biomaterials, polymers offer great potential in design and processing of scaffolds as 
they can be processed by some interesting scaffold fabrication techniques, such as 
electrospinning and 3D plotting. In addition, the implementation of biocompatible and 
biodegradable polymers enables the fabrication of temporary porous construct that mimics 
the ECM in supporting cell proliferation and organization.41,50 
3.1 Natural polymers 
Natural polymers such as polysaccharides (e.g. starch, chitosan, hyaluronic acid) and 
proteins (e.g. collagen, gelatin, silk), are interesting candidates for tissue engineering since 
they are biocompatible, promote cell attachment and stimulate the normal cellular function.42 
However, concern exists about antigenicity, toxicity and the potential risk of disease 
transmission. In addition, natural polymers are expensive, have weak mechanical properties 
and special care must be taken to prevent denaturation when proteins are used.9,21,63,89 
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3.2 Synthetic polymers 
Synthetic polymers have a longer shelf-life, are producible in large-scale and are easy 
to handle. The most extensively used synthetic biodegradable and resorbable polymers are 
the Food and Drug Administration (FDA) approved aliphatic polyesters poly(glycolic acid) or 
polyglycolide (PGA), poly(lactic acid) or polylactide (PLA), poly(ε-caprolactone) (PCL) (Figure 
7; Table 4) and their copolymers, such as poly(lactic-co-glycolic acid) (PLGA).41,42,63,90,91 
These thermoplastic polymers are easy to manufacture into different shapes and the 
mechanical properties and degradation kinetics can be tailored.  
3.2.1 PGA 
The semicrystalline (45-55% crystallinity) thermoplastic PGA has a high melting 
temperature (>200°C) and a high tensile strength (12.5 GPa). In vivo the hydrolytic 
degradation of PGA produces glycolic acid monomers, which are converted enzymatically 
into glycine or pyruvate. Glycine can be used in protein synthesis, whereas pyruvate enters 
the Krebs cycle yielding energy, CO2 and water.92 Due to its low solubility in organic solvents, 
lack of sufficient mechanical integrity and very fast degradation (2-4 weeks), PGA is less 
suitable for the fabrication of BTE scaffolds.89  
3.2.2 PLA 
PLA is more hydrophobic than PGA due to the additional methyl group in its structure 
(Figure 7) and thus has a slower degradation rate. This makes PLA more suitable for both in 
vitro and in vivo applications where long-term mechanical integrity is required. Lactic acid, a 
normal human metabolic by-product, is the degradation product of PLA and it is also 
converted to water and CO2 in the Krebs cycle.92 PLA exists in three isomeric forms D, L and 
racemic (D, L) due to the chiral nature of its monomer. PDLA and PLLA, the two stereo-
regular polymers are semicrystalline and have similar physical characteristics, provided that 
molecular weights are comparable. PDLLA is the racemic polymer obtained from a mixture of 
PDLA and PLLA in a 1/1 ratio and is amorphous. For the semi-crystalline polyesters, 
degradation takes place preferentially in the amorphous regions because these sections 
exhibit a higher rate of water uptake due to the less dense, less ordered structure than the 
crystalline regions. In comparison with the semi-crystalline polyesters, the amorphous 
PDLLA degrades faster which makes it potentially useful as drug delivery system or for 
tissue reconstruction.93 
3.2.3 PCL 
PCL is the most widely studied in the family of the aliphatic polyesters. PCL is a 
semicrystalline (crystallinity 45 – 67%) polymer with a low melting temperature (55 – 60°C) 
(Figure 7; Table 4). Since PCL is one of the most hydrophobic polymers, it degrades much 
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slower than PGA and PLA which makes PCL suitable for use in tissues that have a long 
regeneration process.91,94,95 Based on a large number of tests, PCL is currently regarded as 
non-toxic and biocompatible on both short-term and long-term in different animal models.95,96 
 
Figure 7: Structures of the biodegradable polymers 
 
Table 4: Properties of most extensively used biodegradable polymers for BTE applications.41,63,91,97 
3.2.4 Biodegradation of aliphatic polyesters 
The aforementioned polyesters are hydrolytically degradable due to their 
hydrolytically unstable ester bonds in their backbone. In aqueous environments, their 
degradation mainly comprises chemical hydrolysis of the ester bonds in the polymer chain. In 
short, water penetrates the scaffold, preferentially attacking the chemical bonds in the 
amorphous phase. The long polymer chains are converted into shorter fragments of different 
lengths with both hydroxyl and carboxyl end groups (Figure 8). The latter are capable of 
catalyzing the hydrolysis of other ester bonds.  
The degradation rate depends on the size of the scaffold, acidity of the environment, 
the amount of ester groups, copolymer ratio, crystallinity, molecular weight, porosity, 
incorporation of different biomaterials and site of implantation.91  
For instance, in large compact scaffolds, the soluble degradation products close to 
the implant surface leach out towards the aqueous medium faster than the degradation 
Polymer Melting temperature 
(Tm) (°C) 
Glass transition 
temperature (Tg) 
(°C) 
Lose strength 
(months) 
Mass loss 
(months)* 
Degradation product 
PGA 225 36 1-2 6-12  glycolic acid 
→ urine and respiration 
PLLA 175 60-65 9-15 > 24 L-lactic acid 
→ respiration and urine 
PDLLA Amorphous 55-60 1-2 12-16 D,L-lactic acid 
→ respiration and urine 
PCL 58 -72 9-12 > 24  caproic acid 
→ urine and feces 
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products located inside the bulk matrix. As a result, acids accumulate inside the matrix, 
accelerating the acid catalyzed degradation process in these areas (Figure 8).24,41  
For porous scaffolds with interconnected pores, the degree of porosity and the pore 
size determine the degradation rate. Scaffolds with a higher porosity or a smaller pore size 
degrade slower than scaffolds with lower porosity or larger pore size. The effect is attributed 
to both a wall effect and a surface area effect because scaffolds with a lower porosity or 
larger pores possess thicker pore walls and smaller surface area, which depress the diffusion 
of acidic degradation by-products and thus results in a stronger acid-catalyzed hydrolysis.24,98 
Figure 8: Acid catalyzed hydrolysis of a polyester. 
 
3.2.5 Biomedical use of aliphatic polyesters 
Both in vitro and in vivo studies have been carried out to evaluate the biocompatibility 
of PGA, PLA and PCL. Although many studies suggest that these polymers are sufficiently 
biocompatible99,100, certain studies emphasize that the release of acidic degradation by-
products, especially from PGA and PLA, can result in an inflammatory reaction around the 
implanted biomaterial.63 Such response is attributed to a slow metabolism or a hampered 
blood flow, both resulting in a too slow elimination of the acid degradation by-products. The 
concomitant local pH drop can be detrimental for the surrounding tissue.41,101 
Despite the occasional inflammation reactions, PGA, PLA, PCL and their copolymers 
are extensively investigated in the biomedical field. The major applications include 
resorbable sutures, drug delivery systems and orthopedic fixation devices.89,102 These 
polyesters are also studied intensively as scaffold materials for (B)TE purposes.42,91,96,103 
However, it is widely observed that cell adhesion and subsequent bioactivity are generally 
low on hydrophobic materials such as PCL and, to some extent, PLA. This imposes a 
problem for the use of these biomaterials in tissue engineering applications. Modifications 
can be made to ensure that newly synthesized polymers become bioactive, for instance the 
addition of HAp.9,104,105  
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3.3 3D biodegradable polyester scaffolds for BTE 
3.3.1 Electrospun scaffold 
Electrospinning and the nanofibrous matrices thus fabricated have gained tremendous 
interest, mainly due to the structural similarity to the ECM, the processing availability to a 
wide range of biomaterials, as well as a simple set-up (Figure 5) and operation at low cost. In 
BTE, the electrospun nanofibers have also attracted considerable attention aimed at 
identifying suitable biomaterials and exploiting them into electrospinning.  
 In literature, numerous reviews are available on the electrospinning of biodegradable 
polyester scaffolds.9,60,106-109 Table 5 represents a small selection of the most recent studies 
published on electrospun polyester scaffolds. It is clear that PCL, PLA, PGA and their co-
polymers have been studied extensively. Earlier studies mainly focused on the optimization 
of the electrospinning process, in which various polymer solution properties (polymer 
concentration and solvent system) and processing parameters were investigated for 
polyesters such as PGA62, PLGA110, PLA111-113 and PCL108,114. As can be seen in table 5, 
more recent studies investigate the BTE scaffold potential of electrospun scaffolds by means 
of in vitro cell viability, proliferation and differentiation studies. Several studies showed a 
higher osteoblastic cell attachment and enhanced osteogenic differentiation on electrospun 
matrices compared to solid films.115-117 However, in most cases cell adhesion, proliferation 
and differentiation is still low on electrospun samples compared to a positive control (Table 
5).118-122 This could be explained by the hydrophobic nature of most polyesters and lack of 
functional groups. In addition, as the pore diameters of electrospun samples are very small 
(< 100 nm), cells are not able to infiltrate into the interior of the scaffold leading to the 
formation of a monolayer of cells on the scaffold surface rather than a 3D cellular construct 
(Table 5).58,64,109,123,124 
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 Table 5: A small selection of literature on electrospun biodegradable polymer scaffolds for BTE 
purposes. 
 
 
HFIP: 1,1,1,3,3,3-hexafluoro-2-propanol; MC: methylene chloride; DMF: dimethylformamide; TFE: 2,2,2-
trifluoroethanol 
Polymer 
 
Solvent Fiber 
diameter 
Application Results Ref 
PCL Acetone 2.34 µm In vitro culture of MC3T3-E1 pre-
osteoblasts 
Hydrophobic surface and lack 
of functional groups: no good 
substrate for cell adhesion 
118 
PCL Chloroform/DMF 
(70/30) 
n.a. In vitro culture of Saos-2 cells 
and MG63 cells 
Cell attachment and 
proliferation low compared to 
positive control 
119,120 
PCL MC/DMF 
(80/20) 
418±164 
nm 
In vitro culture of Vero cells Lack of cell infiltration due to 
the small pore diameters of the 
pores of nanofibrous scaffold 
(< 10 µm) 
125 
PLGA 
(85/15) 
HFIP 1.4 µm • In vitro culture of MC3T3-E1  
pre-osteoblasts 
• In vitro differentiation of rat 
MSCs 
 
• Low cell attachment, 
spreading and proliferation 
• Low osteogenic 
differentiation and calcium 
deposition 
121 
PLA 
(95DL/5L) 
TFE 1.09 µm In vitro culture of HDF cells Low cell proliferation due to 
lack of surface functional 
groups
 
122 
PDLLA HFIP 850 nm In vitro cell infiltration study of 
3T3/NIH fibroblasts 
Cells are unable to infiltrate 
the electrospun scaffolds due 
to small pore size (17 µm) 
124 
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3.3.2 3D plotted scaffolds 
Among the available RP techniques, 3D plotting is the most advanced scaffold 
fabrication techniques due to its milder operation conditions, ability of using different 
biomaterials, possibility of manufacturing scaffolds in a cell-friendly environment, and 
feasibility of controlled drop-on demand high precision deposition.82,84 Thus, 3D plotting 
appears to be a very appropriate method for producing BTE scaffolds. 
3D plotted biodegradable scaffolds for BTE purposes, which are investigated in 
literature, are given in Table 6. Due to its superior thermostability in molten state (Table 4),  
PCL is the preferred and most studied thermoplastic polyester for 3D plotting.  
Son et al.125 and Lee et al.126 compared the mechanical properties of conventional PCL 
scaffolds fabricated by a salt-leaching process and PCL scaffolds manufactured by the 3D 
plotting process and showed that the latter have superior mechanical properties. 
In 3D plotting, the filament diameter (FD; Figure 9), which depends on the inner 
diameter of the mounted nozzle tip, and the strand distance (SD; Figure 9) are adjustable. By 
setting the SD, the scaffold porosity can be regulated. The pore geometry can be varied by 
changing the deposition angle between adjacent layers. The simplest scaffold has cube-cube 
shaped pores formed by orthogonal rasters in the 0°/90° lay-down pattern (Figure 10A). 
Upon introducing an angle shift between each layer,  scaffolds with so-called honeycomb-like 
patterns are created. Figure 10B and 10C illustrate examples of a 60° and a 45° stacking 
sequence, respectively. The stacking sequence refers to the pattern angle shift between 
each layer.88,127  
A number of in vitro studies showed that the large porous structure of 3D plotted 
scaffolds enables the migration of cells through the construct with cell adhesion and 
proliferation throughout the whole scaffold (Table 6).85,126,128,129 These large pores (> 50 µm) 
could also facilitate diffusion of nutrients during in vitro culture. However, the study of Yilgor 
et al.84 reported an important relation between the lay-down pattern of the filaments and the 
cell seeding efficiency and proliferation. The lowest cell seeding efficiency and proliferation 
was obtained on the 0/90° design. This could be attributed to the scaffold open channels and 
the relatively large pore sizes, which increases the likelihood of cells passing the scaffold. In 
addition, it is reported that cells attached to neighboring filaments are hardly able to interact 
with each other due to the large interfilament distance of hundreds of micrometers, causing 
limited bridging between cells.68,130,131 Yilgor et al.84 found that scaffolds with a 0/45° design 
resulted in significantly higher cell attachment and proliferation. This was explained by the 
fact that the PCL fibers act as obstacles to cell suspension flow and higher available fiber 
surface area for cells to attach to. 
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However, irrespective of the specific scaffold architecture, the pore size of 3D plotted 
scaffolds is relatively large as compared to the dimensions of a cell. This, in combination with 
the smooth nature of the filaments and the hydrophobic nature of PCL, tends to hinder initial 
cell attachment.130,132 Therefore, a high number of cells is needed to obtain sufficient 
attached cells that produce enough ECM to successfully engineer a 3D tissue construct.  
 
 
 
 
 
 
 
 
 
Figure 9: Illustration of the concepts filament diameter (FD) and strand distance (SD) in a 3D plotted 
scaffold.66  
 
 
 
 
 
 
 
 
 
Figure 10: Some examples of lay-down patterns of 3D plotted scaffolds. A) 0°/90°, B) 0°/60°/120° and 
C) 0°/45°/90°/135° or 0°/45°/90°/-45°.127 
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Table 6: Literature on 3D plotted biodegradable polymer scaffolds for bone tissue engineering 
purposes. 
Polymer 
 
Lay-
down 
pattern 
Filament 
diameter 
Strand 
distance 
Application Results Ref 
PCL 0/90° 200 µm 
250 µm 
330 µm 
300 µm 
500 µm 
700 µm 
• Mechanical testing 
• In vitro culture of 
porcine derived 
chondrocytes 
• Compressive modulus of scaffolds with lowest 
strand distance is the highest. Compressive 
modulus of 3D plotted scaffolds is 20-50 times 
higher than that of salt-leached scaffolds. 
• Higher migration and attachment through the 
interconnected scaffold compared to salt-leached 
PCL scaffold 
126 
PCL 0/90° 
0/45° 
n.a. n.a. In vitro culture of rat 
MSCs 
0/45° scaffolds show higher cell proliferation than 
0/90° scaffolds 
84 
PCL 0/90° 200 µm 900 µm In vitro culture of 
human MSCs 
Cells only adhered to and grew on the strands of 
the scaffolds but did not fill the pores.  
128 
PCL 0/90° 300 µm 200 µm In vitro culture of D11 
mouse MSCs 
Cells are located across the entire surface of the 
scaffold.
 
85 
PCL 0/90° 300 µm 200 µm In vitro culture of 
MC3T3-E1 pre-
osteobalsts 
Low initial cell adhesion, but complete colonization 
of the scaffold after 14 days of culture. 
129 
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3.3.3 Multiscale scaffolds 
In order to overcome the limitations of both electrospinning and 3D plotting, multiscale 
scaffolds fabricated by a combination of RP and electrospinning are very recently being 
investigated. A combination of nanofibers and microfibers is a promising approach to attempt 
to mimic the hierarchical tissue structure of bone. In these multiscale scaffolds, the 
microfibrous structure provides the porous 3D structural environment with a porous structure 
large enough for the migration of cells through the construct, while the nanofibers provide the 
favorable surface topography with nanoscale features for cell attachment and cell 
viability.90,130,131,133-135 An overview of the recent literature on multiscale scaffold research is 
summarized in Table 7.  
Pham et al.136 were one of the first to develop a bimodal scaffold. These scaffolds 
were developed by a sequential electrospinning technique wherein the multiscale PCL layers 
were electrospun with different fiber diameters. The scaffolds consisted of a top layer of 
nanofibers and a bottom microfiber layer. The extent of nanofiber deposition was evaluated 
as a function of the duration of electrospinning. Electrospinning for longer periods resulted in 
an increased thickness of the nanofibrous top-layer. Hence, the thickness and coverage of 
the nanofibrous layer could be controlled by modulating the electrospinning time. An in vitro 
cell culture study with rat MSCs showed that cell attachment at different time intervals was 
similar, whereas cell spreading, proliferation and differentiation were affected by the 
presence of nanofibers. However, the presence of nanofibers was also found to hinder cell 
migration. This could be due to the nanofibrous layers which were formed in a sheet-like 
structure around the microfibrous structure and prevented the cells from infiltrating 
adequately into the scaffold.  
 In order to overcome the shielding effect of a nanofibrous outer layer, later studies 
fabricated multiscale scaffolds with randomly mixed nanofibers and microfibers137,138, 
successive layers of nanofibers and microfibers130 or more centrally positioned 
nanofibers132,133,135. These studies showed enhanced adhesion, proliferation and spreading 
of chondrocytes130,134,135, MSCs134 and pre-osteoblastic cells131 on the multiscale polyester 
scaffolds compared to scaffolds built up by either nanofibers or microfibers alone. The 
interaction between the cells and the hybrid scaffold were improved as the cells were able to 
colonize the interfilament gap due to the presence of a nanofibrous layer between the 
microfibers. The multiscale scaffolds also showed a higher amount of cells distributed 
throughout the scaffold.   
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However, the initial problem with the hydrophobicity of the polyesters remains. In 
order to enhance the bioactivity of all polyester scaffolds, a surface modification, such as a 
calcium phosphate coating, can be applied. 
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4 Bioactivation of polymer scaffolds 
Although several biodegradable synthetic polymers have been used as tissue 
engineering scaffolding materials, a shortcoming of these biomaterials is their lack of 
biological recognition.9 In recent years biomaterial research has focused on the improvement 
of implant design features in an attempt to accelerate bone healing after implantation. 
Considering the surface is the first part of the implant that interacts with the host, various 
types of modifications have been investigated in order to enhance biocompatibility and 
osteoconductivity of the implant. Cellular responses to an implanted biomaterial are highly 
complicated biological and chemical processes related to several surface properties. It has 
been reported that the cell-substrate interactions are influenced by both the surface 
chemistry and the surface structure of the biomaterial, such as topography, roughness and 
architecture. These surface aspects affect cells and tissues because they modify the 
adsorption of proteins from biological fluids. The adsorption of proteins onto an implant 
surface has been shown to be one of the key events to occur within a few minutes after 
implantation. Furthermore, it is with these adsorbed proteins that the cells will interact 
because cells are not able to interact directly with the biomaterial.139  
4.1 Apatite coating 
Coating of a synthetic implant with a thin layer of calcium phosphate has been proven 
to be an effective, easy and convenient approach making the scaffold more bioactive, 
biocompatible and osteoconductive.139-142 In general, calcium phosphates, or more accurately 
calcium orthophosphates, are salts of the orthophospheric acid (H3PO4), and thus contain 
H2PO4-, HPO42- or PO43-. The calcium phosphate salts constitute a wide group of compounds 
that are described below and summarized in Table 8 and 9. Calcium phosphates come in 
different amorphous and crystalline forms which have different physico-chemical 
properties.143  
Especially apatite is an interesting calcium phosphate for use in BTE as bone tissue 
itself consists of up to 70%  biological apatite. Stoichiometric apatite is a group of calcium 
phosphate mineral with general formula Ca10(PO4)6OH2 (Table 8). However, both the 
composition and the structure of the mineral are flexible as apatite has a strong tendency to 
incorporate numerous impurities. Such substitutions can change the crystallite size and often 
influence mineral properties such as solubility, hardness and brittleness. The variations that 
may occur must fulfill the overall charge balance in the mineral and provide a geometric fit of 
the substituting ions within the apatite lattice. For example, Ca2+ can be partially substituted 
by cations such as Na+, K+, Sr2+ and Mg2+, and PO43- can be substituted by anionic species 
such as CO32- (B-type substitution) and HPO42-. In addition, OH- can also be replaced by 
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CO32- (A-type substitution). The replacement of PO43- by either CO32- or HPO42- causes the 
creation of a deficit in negative charge, which can be compensated by the loss of positive 
charge, as through removal of Ca2+ from the lattice. As a result HPO42- containing apatites 
are calcium-deficient, with a Ca/P ratio smaller than 1.67 (Table 8). With regard to 
stoichiometry, the substitution by CO32- creates lacuna in the crystals and affects the lattice 
parameters. The crystal size is decreased, and thereby the surface area is increased. In 
addition, Ca-CO32- bonds are weaker than Ca-PO43- bonds, which results in a higher solubility 
than carbonate-free apatites. 6,144,145 
Biological trials in which MC3T3-E1146-150, SaOS-2120 and MSCs85 were seeded on 
apatite coated biomaterial revealed that these coatings enhance cellular adhesion, 
proliferation and differentiation to promote bone regeneration compared to the pure scaffolds. 
Apatite-based coatings typically increase the ALP activity and the osteocalcin and protein 
levels.139,151 Moreover, Pieters et al.152 showed that apatites with a high carbonate content (> 
11 wt%) support high cell adhesion and proliferation. A decrease in charge density and 
crystallinity at the apatite surface, as well as the formation of more spheroidal crystals with 
increasing carbonate content might attribute to changes in composition and three-
dimensional structure of the protein adsorption layer and hence the observed cell behavior. 
Table 8: Possible stoichiometry for apatitic calcium phosphates 6,145 
Chemical formula Name Ca/P ratio 
Ca10(PO4)6(OH)2 hydroxyapatite 1.67 
Ca10(PO4)6 (OH)2-2x(CO3)x A-type carbonated apatite 1.67 
Ca10-x[(PO4)6-2x(CO3)2x](OH)2 B-type carbonated apatite ≥ 1.67 
Ca10-x[(PO4)6-2x(CO3)2x](OH)2-2y(CO3)y 
with 0≤x≤1.1 and 0≤y≤0.2
 
AB-type carbonated apatite ≥ 1.67 
Ca10-x[(PO4)6-x(HPO4)x] (OH)2-x Calcium deficient apatite
 
≤ 1.67 
 
After implantation the implant surface is in direct contact with the surrounding 
physiological fluid, which contains numerous ions and proteins that guide the adhesion of 
particular cell types to the surface. One of the first events to occur upon contact of an apatite 
coating with body fluid, is its physiological dissolution or active resorption, which is believed 
to be at the origin of the bioactivity and osteoconductivity of apatite.143,153 Schematically, the 
process of osteoconduction induced by a calcium phosphate coating such as apatite on a 
biomaterial after implantation into bone tissue is shown in figure 11. Active resorption is the 
result of the cellular activity of osteoclasts. These cells decrease the pH of their surroundings 
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to about 5.5 so that the dissolution rate of the apatite is decreased. Partial dissolution of 
apatite results in the release of Ca2+ and PO43- ions. This dissolution is followed by the 
reprecipitation of a biological apatite layer with the adsorption of proteins. The increased 
concentrations of Ca2+ and PO43- ions also stimulate chemotaxis. As a result cells like 
osteoprogenitor cells, osteoclasts and osteoblasts colonize the biomaterial.139,143,144 
 
 
Figure 11: Schematic representation of osteoconduction induced by a calcium phosphate coating.154 
 
The degree of crystallinity and the specific surface area of the apatite coating affect 
the physico-chemical dissolution in vitro and hence the cellular activity.143,155,156 Several 
studies have shown that there is no new bone formation on highly crystalline calcium 
phosphates, but bone regeneration has been observed on poorly crystalline calcium 
phosphates. Hence the use of poorly crystalline apatites should increase the bioactivity, 
which in turn could lead to a faster establishment of a strong bond between the implant and 
surrounding tissue.140 
Besides the positive effects on a cellular level, mineralization of a polyester scaffold 
has additional advantageous effects for tissue engineering. Multiple studies found that the 
addition of a mineral coating improves the mechanical strength of the scaffold.106,157 In 
addition, the presence of a mineral phase can, due to the alkalinity of calcium phosphates, 
neutralize the acidic degradation by-products of the commonly used degradable 
Introduction 
36 
 
polyesters.158,159 The latter is ascribed to the reaction of calcium ions and the carboxyl end-
groups generated during degradation of the polymer, to form calcium carboxylate chain ends. 
This complexation results in an increased solubility of the calcium phosphate, causing an 
increase of the pH. As a result the acidic autocatalytic degradation of the polymer is slowed 
down, so that the risk of inflammation is reduced. 41 
4.1.1 Other calcium phosphates of biological interest 
Octacalcium phosphate (OCP; Ca8(HPO4)2(PO4)4.5H2O; Table 9) is often found as 
an unstable transient intermediate during the precipitation of a thermodynamically more 
stable hydroxyapatite and biological apatite. Structurally OCP consists of alternating “apatite 
layers” (arrangements of calcium and phosphate groups similar to that of apatite) and 
“hydrated layers” (water molecules). The close relationship between hydroxyapatite and OCP 
has been used to explain the incorporation of impurities, particularly carbonate, magnesium 
and sodium ions.160,161 
Dicalcium phosphate dihydrate or brushite (DCPD; CaHPO4.2H2O (correct IUPAC 
name is calcium hydrogen phosphate dihydrate); Table 9) can be easily crystallized from 
aqueous solutions. It is one of the most soluble calcium phosphates and is the most stable at 
a pH of 5. DCPD has been proposed as an intermediate in both bone mineralization and 
dental erosion. In medicine, DCPD is used in calcium phosphate cements.161 
Amorphous calcium phosphates (ACP; CaxHy(PO4)z.nH2O, n = 3 - 4.5; 15 - 20% 
H20; Table 9) vary widely in composition due to the possible insertion of several secondary 
ions. Usually, ACP is the first phase to precipitate from a supersaturated solution prepared 
by rapid mixing of solutions containing calcium and phosphate ions. It is thought to be formed 
at the beginning of precipitation due to the lower surface energy than that of OCP and 
apatites. ACP is a transient phase during the formation of calcium phosphates in aqueous 
systems. Its lifetime was reported to be as a function of the presence of additive ions, pH, 
ionic strength and temperature. Also, the chemical composition of ACP strongly depends on 
the pH of the solution and the concentrations of the mixing solutions. As for all amorphous 
compounds, ACP is characterized by broad X-ray diffraction bumps, which makes it hard to 
analyze its crystal structure. In medicine, pure ACP is used in calcium phosphate cements 
and as a filling material in dentistry. 
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Table 9: non-apatitic calcium phosphate phases 145 
Name Chemical formula pH 
formation 
Precursor for Typical 
shape 
Ca/P 
ratio 
OCP Ca8(HPO4)2(PO4)4.5H2O 5-6 hydroxyapatite - 1.33 
DCPD 
Brushite 
CaHPO4.2H2O 4-5 hydroxyapatite Large 
plates 
1 
ACP CaxHy(PO4)z.nH2O All various crystalline 
phases 
Beads 1.5 
 
Recently, calcium phosphates have been found to induce bone formation when 
implanted in ectopic sites such as muscles of dogs162,163, mice164 and rabbits165 which could 
indicate osteoinductivity of calcium phosphates. The exact mechanism behind osteoinduction 
is incompletely understood. Indications and hypotheses exist identifying surface features, 
including microporosity and grain size, as well as dissolution/reprecipitation events occurring 
on the surface, as properties responsible for the osteoinductive potential.162,165,166 
4.2 Incubation in simulated body fluid 
A well-known technique for the coating of polymer scaffolds with an apatite layer is 
based on the incubation in solutions supersaturated with respect to apatite, such as 
simulated body fluid (SBF). 
4.2.1 SBF 
SBF is a type of medium with ion concentrations approximating those of human blood 
plasma (HBP). Since the introduction of SBF by Kokubo et al. the biomimetic mineral 
formation has attracted extensive research interest as it is similar to biological mineralization 
in bone.167-169 The original SBF used by Kokubo et al.170 lacks SO42- ions present in HBP 
(Table 10). The composition of the SBF was corrected by Kokubo et al.171 and since then the 
corrected SBF (c-SBF) has been used as SBF by many researchers. However, as the 
corrected SBF was still richer in Cl- ions and poorer in HCO3- ions than HBP, Oyane et al.172 
prepared a revised SBF (r-SBF) in which the concentration of Cl--ions and HCO3--ions are 
equal to the concentrations in HBP. In this r-SBF however, calcite has a strong tendency to 
precipitate. Hence, a newly improved SBF (n-SBF) was proposed in which only the Cl- ion 
concentration was decreased to that of HBP, leaving the HCO3- concentration equal to that of 
c-SBF.167 Several tests on both the c-SBF and n-SBF concluded that c-SBF does not differ 
from n-SBF in stability and reproducibility. As a result, c-SBF is predominantly used in 
research. The detailed description for the preparation of this c-SBF or simply SBF with pH 
7.4 at 36.5°C is described by Kokubo et al.167. Generally, in order to maintain the pH of the 
solution at the physiological pH of 7.4, SBF is buffered with a mixture of 
trishydroxymethylaminomethane (TRIS; CH2OH)3CNH2) and HCl. Under these physiological 
conditions of pH and temperature, SBF is supersaturated with respect to apatite. 
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Table 10: Ion concentrations of human blood plasma (HBP) and different SBFs described in literature. 
 
Research involving SBF focuses on three main areas: the precipitation of bioactive 
calcium phosphate in SBF solutions 173,174, the coating of potential bone implants with a 
calcium phosphate coating 168,169 and the assessment of bioactivity of implants 167. For the 
first two research areas the compositions of the SBFs vary and are often denoted by a 
multiplier such as 1.5xSBF120, 5xSBF175 and even 10xSBF146,176,177, indicating the 
concentration of components relative to normal SBF. The specific composition and 
concentration of the SBF, but also the temperature, agitation and renovation used for mineral 
formation have been shown to influence the chemical composition and morphology of the 
resultant mineral phase.178,179 For the utility of mineralization in SBF as a marker of in vivo 
bone bioactivity it was found that only mineralization in normal SBF correlated well to in vivo 
bioactivity.167,178 
4.2.2 Coating 
As SBF is supersaturated with respect to apatite under physiological conditions of pH 
and temperature, immersion of a substrate will result in the heterogeneous nucleation of 
apatite onto the surface, which grows overtime and covers the substrate homogenously. The 
ease of fabrication, the low cost and effectiveness, makes this method one of the most 
popular for creating a bioactive calcium phosphate coating.  
There is a considerable amount of published work using the biomimetic route for the 
formation of calcium phosphate layers on the surface of different biomaterials. To enable the 
calcium phosphate formation on hydrophobic polymer scaffolds, it is necessary to form 
certain functional groups on the scaffold surface.106 Surface charge influences the 
heterogeneous nucleation of calcium phosphate from SBF. It has been shown that negatively 
charged groups are favorable for  the nucleation of calcium phosphates, whereas positively 
charged substrates do not induce the deposition of calcium phosphates under similar 
conditions.180 Hence, the production of anionic surface groups onto the polymer backbone, 
 Ion concentration (mM) Buffer 
Ion solution Na+ 
 
K+ Mg2+ Ca2+ Cl- HCO3- HPO42- SO42-  
HBP 142 5 1.5 2.5 103 27 1 0.5  
Original SBF 142 5 1.5 2.5 148.8 4.2 1 - TRIS/HCl 
Corrected SBF (c-SBF) 142 5 1.5 2.5 147.8 4.2 1 0.5 TRIS/HCl 
Revised SBF (r-SBF) 142 5 1.5 2.5 103 27 1 0.5 TRIS/HCl 
Newly improved SBF (n-SBF) 142 5 1.5 2.5 103 4.2 1 0.5 TRIS/HCl 
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the so-called activation of the fiber surface, is a common approach to induce mineralization 
of polymer scaffolds.178 In addition, the creation of functional groups on the surface will also 
increase the wettability of the substrate. In order to introduce these functional groups, a 
chemical activation can be used such as plasma treatment177,181,182 and surface 
hydrolysis119,157,183,184. The mechanism of alkali surface hydrolysis is shown in figure 12. 
During this activation step, the ester bonds in the polyester backbone are broken with 
formation of reactive carboxyl – and hydroxylgroups. The mechanism of calcium phosphate 
deposition upon SBF immersion of the activated substrate is based on the interaction of the 
calcium ions present in the solution with the anionic functional groups on the polymer 
surface, followed by the binding of phosphate ions. 
 
Figure 12: Hydrolysis of the ester bond in alkali medium with the formation of reactive hydroxyl – and 
carboxylgroups. 
 
Additionally, the use of more concentrated SBF solutions accelerates the 
mineralization process, whereas the chemical composition and morphology of the deposited 
mineral phase can be adapted by varying the specific formulation of the SBF solution.178,185 
For instance,  
(i) The pH of the solution is known to affect the apatite formation kinetics in the SBF 
solution, so that an apatite coating only forms when the SBF is within a critical pH 
range.186,187 Chou et al. showed apatite crystals formed in SBF with pH 6.5 were 
smaller than the apatite crystals formed in SBF with pH 5.8.188  
(ii) Qu et al.187 studied the effect of the immersion temperature of the solution on 
biomimetic coating formation. At higher temperatures, a lower amount of 
carbonate/bicarbonate ions remained in the SBF solutions as the decomposition 
rate of bicarbonate is increased. It was reported that the decomposition of 
bicarbonate ions increases the pH of the solution (HCO3-→CO2 + OH-). 
(iii) The concentration of specific ions like CO32- and Mg2+ ions, which are known to 
inhibit apatite crystal growth, have a great influence on the crystallinity and 
surface morphology of apatite coatings.175,187 
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4.3 Alternate soaking in calcium and phosphate- rich solutions 
Immersing polymer scaffolds in alternating calcium and phosphate rich solutions is 
another method of creating a biomimetic calcium phosphate coating. 69,182,189,190 The 
schematic representation of the alternate dipping procedure is shown in figure 13. Just like 
with the incubation in SBF, the surface of the polymer has to be functionalized with anionic 
functional groups prior to the alternate soaking treatment. The coating mechanism is similar 
to that of coating in SBF solutions. It has been suggested that the alternate soaking 
procedure is more effective to induce a calcium phosphate coating, probably due to the 
introduction of larger amounts of calcium and phosphate ions in the highly concentrated 
solutions.106 Nucleation is initiated as large amounts of calcium ions are introduced to the 
anionic functional groups present on the polymer surface, which allows for mineral growth. 
 
Figure 13: Schematic representation of the alternate dipping procedure. 
 
For this method, the calcium solution typically consists of CaCl2120,147,182,190 and the 
phosphate solution typically used is K2HPO4120,182 or Na2HPO4147,190.  
Often, the alternate dipping procedure is applied prior to the incubation in SBF, as it 
was shown that the calcium phosphate nuclei deposited during the alternate dipping 
procedure enhance and accelerate calcium phosphate coating upon subsequent incubation 
in SBF.119,147,183  
4.4 Biomimetic calcium phosphate coating on biodegradable polyester 
4.4.1 Electrospun scaffolds 
A selection of electrospun polymer scaffolds coated with a calcium phosphate layer by  
an alternate soaking treatment (nucleation) and/or incubation in a SBF solution (maturation) 
studied in literature are summarized in Table 11.  
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Focusing on the fabrication of BTE scaffolds, the most commonly electrospun 
polymers are PCL119,146,147,177,191-193 and PLA (both PDLLA149,194 and PLLA195). In some cases, 
PLA is co-electrospun with the hydrophilic polymer gelatin in order to overcome the 
hydrophobic nature of the polyester.196,197 However, due to the weak mechanical properties 
of gelatin, co-electrospun scaffolds show reduced mechanical properties compared to pure 
polyester scaffolds.198  
Coating of the electrospun scaffolds is generally achieved in several consecutive 
steps. In most studies the first step is the activation of the fiber surface with plasma177 or 
NaOH treatment119,147,191-193,195. Various NaOH concentration and incubation times are used. 
In the studies of Vaquette et al.193, Zou et al.194 and Cui et al.199, the samples are first treated 
with ethanol. Since ethanol is a well-known wetting medium of polyesters, it can be applied to 
enhance the wettability of the scaffolds.200,201 
After activation of the fiber surface, mineralization of the electrospun fibers is 
achieved either by alternate dipping in calcium – and phosphate rich solutions197, by 
incubation in a SBF solution177,193-195,199, or by a combination of both procedures147,191,192. 
There is a great variation in the applied concentrations, the duration of each treatment and 
the number of cycles of the alternate dipping procedure between different studies. 
Regardless of the conditions of the activation and nucleation step, the mineralization 
treatment results in the deposition of ACP149,119,192,194, or semi-crystalline HAp147,191,197  with a 
low carbonate content of about 3 wt%. In the study of Yu et al.147,191 rat MSCs and MC3T3 
pre-osteoblast cells showed enhanced adhesion, spreading and growth on the surface-
mineralized electrospun PCL scaffolds compared to untreated scaffolds.  
When highly concentrated SBF solutions are used, such as 5xSBF196 or 
10xSBF177,146,193, the calcium phosphate deposition is accelerated. However, a DCPD coating 
is deposited onto the fiber surface and bone cells showed a lower cell adhesion on DCPD 
compared to apatites.156 
It is clear that there is a great variety in the mineralization parameters reported in 
literature, even for the same type of polyester. The mineralization parameters not only 
influence the composition and the morphology of the deposited calcium phosphate layer, but 
also the reproducibility of the procedure. Moreover, the scanning electron microscope (SEM) 
images of the electrospun samples show fibers with a broad diameter distribution, indicating 
the electrospinning process was not optimized. 
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As there is no general protocol for the calcium phosphate coating of electrospun 
polyester scaffolds, there is a strong need for the optimization of the procedure for every type 
of polyester. 
Table 11: Selection of electrospun polyester scaffolds coated with a calcium phosphate layer 
investigated in the literature. 
* SBF with double the concentrations of calcium and phosphate 
RT: room temperature 
 
4.4.2 Rapid prototyped scaffolds 
Table 12 shows an overview of the literature on the calcium phosphate coating of 
polymer scaffolds produced by extrusion based rapid prototyping techniques. To date, the 
research on the calcium phosphate coating of 3D degradable polyester scaffolds is limited to 
PCL scaffolds. Due to its very good thermal stability, PCL is most suitable for use with melt 
processing techniques like 3D plotting and FDM. Dorj et al.150 used robocasting for the 
fabrication of the PCL scaffold. Robocasting is also an extrusion based RP system, but it is 
less interesting as the material is dissolved in an organic solvent prior to extrusion. The use 
of toxic organic solvents requires thorough washing or solvent evaporation treatment before 
the use with cells. 
Material 
 
Fiber 
diameter 
Activation Nucleation Maturation CP phase Ref 
  Medium Conditions Medium Conditions Medium Conditions   
PCL 1.5 µm Argon 
plasma 
10 min - - 10xSBF RT 
2-6 h 
 
DCPD 177 
PCL 792±345 
nm 
2 N 
NaOH 
 
12h 150 mM 
CaCl2  
150 mM 
Na2HPO4 
30 s 
30 s     6x 
             
SBF 37°C 
Up to 21 d 
HAp 147,191 
PCL 250 nm -
2.5 µm 
0.5 M 
NaOH 
12h 100 mM 
CaCl2 
100 mM 
K2HPO4.3H2O 
1 d 
 
15 min 
1.5xSBF 37°C 
Up to 7 d 
ACP 192,119 
PCL ±15 µm Ethanol 
2 M 
NaOH 
10 min 
5 min 
- - 10xSBF 37°C 
1 h 
 
DCPD/HAp 193 
PDLLA 1.14±0.12 
µm 
Ethanol Until 
soaked 
- - SBF * 25°C 
3 d 
ACP 
 
 
 
194,149 
PLLA/ 
gelatin 
± 1 µm - - - - 5xSBF 36.5°C 
 
DCPD 196 
PLLA/ 
gelatin 
615 nm - - 500 mM  
CaCl2 
300 mM  
Na2HPO4 
30 s           
30 min    5x 
 
 
- - HAp 197 
PLLA 1070±300 
nm 
0.5 M 
NaOH 
5, 10 or 30 
min 
- - SBF 37°C 
Up to 28 d 
 
HAp 195 
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In the study of Oliveira et al.202, PCL was mixed with starch, a natural degradable 
polymer, prior to 3D plotting.  The major common drawbacks of such blend scaffolds is the 
incompatibility between starch and PCL and the poor physical and mechanical properties of 
the blends with increased starch content.203 
A review of the literature shows that the calcium phosphate coating of RP PCL 
scaffolds includes up to three consecutive steps, in analogy with the coating procedure of 
electrospun polyesters; activation, nucleation and maturation.  
Activation of the filament surface is obtained by treatment with NaOH150,157,183 in 
different concentrations and incubations times. The pre-wetting step with ethanol is only 
applied in the study of  Oyane et al.183 It should be noted that in this study, the high NaOH 
concentration in combination with the long incubation time could cause degradation of the 
biomaterial. However, no information is given on the effect of such intense activation 
treatment on the morphology of the PCL filaments. 
Oyane et al.183  and Dorj et al.150 used an alternate dipping step for the nucleation of 
calcium phosphate particles on the filament surface. Choong et al.157 and Oliveira et al.202 
introduced the use of sodium silicate as catalyst for the deposition of calcium phosphate.  
The mechanism for the growth of a calcium phosphate layer on a sodium silicate gel upon 
incubation in SBF was previously studied by Miyaji et al.204. In brief, a calcium phosphate 
layer is grown as a consequence of electrostatic interactions of negatively charged Si-O- 
units, formed by deprotonation of Si-OH groups, with the positively charged Ca2+ ions in the 
SBF solution. A positively charged calcium silicate layer is then formed which will interact 
with the negatively charged PO43- ions in the SBF solution to form calcium phosphate.202,204 
For the coating of 3D plotted PCL, Park et al.85 simply immersed the scaffolds in a 
2xSBF solution, and obtained a HAp coating after 7 days. This is in contrast with the results 
of Oyane et al.183, who showed that the activation of the PCL surface was a prerequisite to 
obtain any coating upon subsequent immersion in a SBF solution.  
Choong et al.157  obtained a HAp coating on the scaffolds in a three-step procedure. An 
in vitro analysis showed more viable human MSCs with a higher proliferation rate within the 
coated scaffold than within the uncoated scaffolds. Similar results were obtained by Park et 
al.85 with D1 mouse MSCs and by Dorj et al.150 with MC3T3-E1 pre-osteoblastic cells. 
Even though the coating of the PCL scaffolds is a successful approach for the 
improvement of the bioactivity of the scaffolds, the pores of RP scaffolds are still too large 
compared to the dimensions of cells, which tends to discourage initial cell attachment. 
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Table 12: Selection of polyester scaffolds fabricated by extrusion based rapid prototyping (RP) 
techniques, coated with a calcium phosphate layer investigated in the literature. 
 
 
 
 
 
Material 
RP 
Technique 
 
Filament 
diameter 
Activation Nucleation Maturation CP 
phase 
Ref 
  Medium Conditions Medium Conditions Medium Conditions   
PCL 
FDM 
n.a. EtOH 
5 M 
NaOH 
30 min 
48 h 
200 mM 
CaCl2 
200 mM 
K2HPO4.3H2O 
10 s 
10 s    x3 
SBF 36.5°C 
24 h 
HAp 183 
PCL 
FDM 
n.a. 5 M 
NaOH 
8 h 
 
 
Na2SiO3 gel 6 h 
 
1.5xSBF 36.5°C 
14 days 
HAp 157 
PCL 
3D plotting 
300 µm - - - - 2xSBF 37°C 
7 days 
HAp 85 
PCL 
Robocasting 
245 µm 1 M 
NaOH 
1h 150 mM 
CaCl2 
150 mM 
Na2HPO4 
x5 1.5xSBF 37°C 
14 days 
HAp 150 
PCL/Starch 
70/30 wt% 
3D plotting 
500 µm - - Na2SiO3 gel 1 h SBF 14 days 
 
HAp 202 
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An ideal bone scaffold should exhibit a porous, interconnected and permeable 
structure to allow for cell infiltration and exchange of nutrients and metabolites and also 
should exhibit the appropriate surface structure and chemistry for cell adhesion and 
proliferation. In addition, the scaffold should be biodegradable, biocompatible and ideally 
bioactive. Evidently, the design of the construct is as crucial as the material it is made of. 
The biocompatible and biodegradable polyesters PCL and PDLLA are interesting 
candidates for the fabrication of BTE scaffolds due to their established safety in clinical use 
and appropriate biodegradation kinetics. Both PCL and PDLLA are easy to manufacture with 
advanced processing techniques currently investigated in BTE research, such as 
electrospinning and 3D plotting. 
With the electrospinning technique nanofibrous scaffolds are produced that are 
characterized by a high surface-to-volume ratio and high porosity with interconnected pores, 
resembling the ECM. In addition, electrospun fibers provide the favorable surface topography 
for cell attachment due to their nanoscale features and random fiber orientation. However, 
many researchers have encountered limitations with regard to cell infiltration and migration 
into the interior of the nanofiber mats due to the relative small pores associated with 
electrospun scaffolds. Consequently, this results in 2D cell layers on top of the scaffold 
instead of the formation of 3D tissues.1-3 
On the contrary, the filaments of 3D plotted scaffold have a fixed geometry and are in 
the micrometer range. The resulting pore sizes in 3D plotted scaffolds are relatively large 
compared to the dimensions of a cell, which enables the cells to infiltrate into the interior of 
the scaffold, but often leads to a low seeding efficiency and to a non-uniform distribution of 
cells throughout the scaffold.4 
Recently, reports have been published on the fabrication of hierarchical structures 
composed of both nanofibers and microfibers and thus combining both fabrication 
techniques. Hence, the inverse pore size limitations encountered with the two techniques 
could cancel each other out, while combining the positive characteristics of the two scaffolds. 
Such multiscale scaffolds possess innovative property combinations, not otherwise attainable 
with a single fiber scale and have been found to be favorable in bone regenerative 
purposes.5-10 
However, irrespective of the fabrication technique or the fiber scale, PCL and PDLLA 
scaffolds lack bioactivity due to their hydrophobic nature.11 In order to enhance the bioactivity 
of polyester scaffolds, coating with an apatite layer has been applied.12-15 These coated 
scaffolds show improved cell response compared to uncoated scaffolds, but the cell viability 
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is still low in comparison to the positive controls. Ideally, the calcium phosphate layer should 
be a nanocrystalline carbonated apatite, resembling the mineral present in natural bones.16 
Moreover, Pieters et al. reported that apatites with a carbonate content equal to or higher 
than 11 wt% show an improved cell adhesion and proliferation in comparison to that on 
carbonate-free apatites.17 
Although the multiscale scaffolds hold great promise in the field of BTE, to date 
research on the calcium phosphate coating of these scaffolds is lacking. Such scaffold could 
come close to the ideal BTE scaffold as it combines the positive effects of electrospinning 
and 3D plotting on the one hand and PCL/PDLLA and bone-like apatite on the other hand. 
Single fiber scale electrospun PCL14,18-20 and PDLLA21-23 scaffolds and 3D plotted 
PCL24 scaffolds have been coated with a calcium phosphate layer. However, the 
reproducibility of the coating procedure, the homogeneity of the coating and obtaining an 
apatite coating with high carbonate content still seems to be challenging. In addition, even for 
the same scaffold type, there is a great variety in the mineralization parameters reported, so 
that the composition and morphology of the obtained coating differ from study to study. The 
challenge upon coating the nano- to micrometer fibers of electrospun scaffolds is not to 
obstruct the pores of the construct with the deposited apatite. Whereas the latter is no 
problem for 3D plotted scaffolds due to their larger pores, the coating procedure for these 
scaffolds is generally more aggressive and longer compared to that for electrospun scaffolds. 
In order to successfully coat multiscale scaffolds it is essential to reckon the large 
difference in fiber diameters throughout the scaffold that range from ~0.5-50 µm for the 
electrospun fibers to ~100-350 µm for the 3D plotted filaments. Hence, a coating procedure 
adequate for the coating of 3D plotted filaments, could possibly be too aggressive and too 
long for the thin electrospun fibers with the risk of damaging the nanofibers and/or 
compromising the porous structure. Vice versa, the coating procedure applicable for 
electrospun fibers could be too mild to obtain a homogenous and reproducible coating on 3D 
plotted filaments. Consequently, in order to coat a multiscale scaffold it will be necessary to 
compromise between the adequate coating procedures for the constituting fibers. 
Based on these considerations, the aims of this study were: 
 To optimize the apatite coating on novel electrospun PCL and PDLLA fiber mats and 
evaluate the osteoblastic cell response on the coatings. 
 To explore the possibility of depositing a homogenous apatite coating with a carbonate 
content of more than 11 wt% on 3D plotted PCL scaffolds and determine to what extent 
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the presence of carbonate in the apatite lattice has a beneficial effect on osteoblastic cell 
behavior. 
 To obtain a multiscale PCL scaffold, fabricated by a combination of electrospinning and 
3D plotting, coated with an apatite containing a high concentration of carbonate and 
evaluate the osteoblastic cell response on this scaffold. 
 
The polyester scaffolds in the present study were fabricated and investigated following a 
similar approach;  
Figure 14: Process diagram of the stepwise approach followed in the present thesis. 
 
The first aspect of the present study was the fabrication of the polyester scaffolds. A 
total of four porous polyester scaffolds were developed and investigated (Figure 15). 
 
Figure 15: Overview of the four scaffolds developed in the present thesis. 
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1 Calcium phosphate coating of an electrospun PCL scaffold 
 
Part of the research is based on the article: 
Optimization of the activation and nucleation steps in the precipitation of a calcium 
phosphate primer layer on electrospun poly(ε-caprolactone). 
Nathalie Luickx, Natasja Van den Vreken, Willem D’Oosterlinck, Lien Van der Schueren, 
Heidi Declercq, Karen De Clerck, Maria Cornelissen, Ronald Verbeeck. 
Journal of Biomedical Materials Research Part A 2015; 103(2): 511-524. 
 
Abstract: Electrospun poly(ε-caprolactone) (PCL) is a potential scaffold for bone tissue 
engineering. However, due to its hydrophobic nature, the material lacks bioactivity. Coating 
the PCL fibers with a calcium phosphate (CP) layer is one approach to overcome this 
problem. In this study the coating of PCL nanofibers with a CP primer layer was optimized in 
a three-step procedure. First, wetting of the hydrophobic PCL samples was enhanced by 
ethanol dipping. Reactive hydroxyl– and carboxylgroups were subsequently generated by an 
ultrasonic assisted hydrolysis of the fiber surface with sodium hydroxide solution. These 
reactive groups served as nucleation point for CP precipitates in the last step in which the 
samples were alternately dipped in calcium and phosphate rich solutions. Hence, a 
reproducible thin layer of CP was deposited onto the fiber surface, with the preservation of 
the porous structure of the scaffold. Infrared spectroscopy was used to identify the deposited 
CP and revealed that a calcium-deficient apatite (CDHAp) was formed. MC3T3-E1 cells were 
seeded on untreated and CDHAp coated PCL scaffolds. Cell viability, adhesion and 
proliferation were analyzed after 1, 7 and 14 days of culture using fluorescence microscopy 
and a Presto Blue TM assay. Cell adhesion and proliferation on the untreated PCL samples 
was low throughout the experiment. The CDHAp coating enhanced the MC3T3-E1 cell 
response, as the number of attached cells was augmented and cells showed similar 
morphologies as the ones found in the positive control. 
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1.1 Introduction 
 Three-dimensional (3D) scaffolds with an interconnected pore system are interesting 
candidates for reconstructive surgery of bony defects. Due to similarity with the extracellular 
matrix (ECM) porous scaffolds promote cell adhesion, proliferation and differentiation 
compared to dense scaffolds.1,2,3 Interconnectivity of the pores is necessary to allow cell in-
growth, vascularization and efficient transport of nutrients, oxygen, growth factors and 
metabolites.4 The scaffold material should be biocompatible, bioactive and 
osteoconductive.5,6 The mechanical strength of the scaffolds should be similar to that of the 
surrounding tissue so that the scaffolds can provide a dimensional stability in the body. In an 
ideal case, the scaffold is biodegradable with a degradation rate comparable with the rate of 
new bone formation. In this way, while the scaffold is degrading, the surrounding bone cells 
simultaneously form new bone without affecting the mechanical stability. Finally, when the 
scaffold is completely degraded, the initial bone defect is filled with newly formed bone 
tissue.7,8  
 Synthetic biodegradable aliphatic polyesters such as the Food and Drug 
Administration (FDA) approved polylactic acid (PLA), polyglycolic acid (PGA), 
polycaprolactone (PCL) and their copolymers are interesting scaffold materials.6,9 These 
polymers are easy to manufacture into different shapes and the mechanical properties and 
degradation kinetics can be tailored by varying the monomer composition and molecular 
weight. These properties give the materials a worldwide attention for use as resorbable 
sutures, drug delivery systems and orthopedic fixation devices such as pins and 
screws.10,11,12 Another advantage of these polyesters is the ability to process them by means 
of an electrospinning process into three-dimensional structures with  high surface-to-volume 
ratio, high porosity and with an interconnected pore system similar to the ECM.13,14 However, 
the polyesters lack bioactivity and are too elastic for bone regenerative purposes.15,16 An 
additional problem is the release of acidic by-products during degradation of the polymer, 
which can cause inflammation.6,17 
 To address these problems, the electrospun fibers can be coated with an apatitic 
mineral phase.8,18,19 The apatite structure is chemically comparable to the mineral phase 
found in natural bone.4 Polymer-mineral composites have shown improved bioactivity and 
mechanical strength as compared to pure polymer scaffolds.20,21 Moreover, the resorption of 
the apatite layer could contribute to the neutralization of the acidic polymer degradation by-
products. The latter is ascribed to the reaction of calcium ions and the carboxyl end-groups 
generated during degradation of the polymer, to form calcium carboxylate chain ends. This 
complexation results in an increased solubility of the calcium phosphate, causing an increase 
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of the pH. As a result, the acidic autocatalytic degradation of the polymer is slowed down, so 
that possible inflammation reactions are avoided or at least less severe.6 
 Various attempts have been made to coat electrospun PLA22,23, PCL18,21 and the co-
polymer poly(lactic-co-glycolic acid) (PLGA)7,19 with bone-like mineral. Despite a great variety 
in the described mineralization procedures, generally a three-step procedure is followed: 
activation, nucleation and maturation. The first step is intended to create hydroxyl groups and 
negatively charged carboxyl groups on the fiber surface by cleaving polyester bonds. The 
second step involves the nucleation of calcium phosphate (CP) particles on the fiber surface 
by an alternate dipping process.18,19,24,25 In the third step a final CP coating is deposited by 
immersing the samples in a supersaturated solution with respect to apatite, such as 
simulated body fluid (SBF). Upon incubation in SBF the CP primer layer acts as a template 
on which apatite grows spontaneously by consuming Ca2+ - and PO43- - ions from the 
solution.18,21,22,26 Differences in the mineralization procedures described in the literature are 
probably due to the use of different types of polyesters, solvents, electrospinning parameters, 
and hence, different fiber diameters of the electrospun scaffolds. Moreover, the scanning 
electron microscope (SEM) images of the coated PCL samples represented in literature 
show profuse mineralization of the nanofibers, which compromised the porous structure.24,26 
In addition, the electrospinning solvents used, such as N,N-dimethylformamide22, 
dichloromethane26, chloroform18 and 2,2,2-trifluoroethanol21 are toxic. During electrospinning 
some of the toxic solvent may be retained in the resulting polymer fiber and could negatively 
affect the biological performance of the scaffold.27 
 Recently, Van der Schueren et al. optimized the electrospinning procedure of PCL 
using a new low-toxic solvent consisting of a mixture of 90% formic acid and 10% acetic 
acid.28 PCL is one of the most commonly used biodegradable polymers for bone tissue 
engineering due to its lack of toxicity, low cost and slow degradation profile.12,29 The objective 
of this study is to coat the PCL fiber mats, electrospun with the solvent mixture formic 
acid/acetic acid, with a thin CP layer. No optimized procedure to reproducibly coat PCL 
nanofibers is recorded in literature. Hence, the initial activation procedure and the 
subsequent deposition of a CP primer layer onto the PCL nanofibers are optimized. In search 
of an optimal procedure the reproducibility of the procedure and preservation of the porous 
structure upon coating is a prerequisite. The optimized parameters giving the most 
reproducible and adequate coating were selected for an in vitro study, comparing the 
adhesion and proliferation of pre-osteoblastic cells (MC3T3-E1) on CP coated samples and 
untreated electrospun PCL samples. 
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1.2 Materials and Methods 
 Freshly prepared demineralized water (Milli-Q system, Millipore, Billerica, USA) was 
used for the preparation of the solutions. PCL pellets were purchased from Sigma-Aldrich 
(St. Louis, US). Sodium chloride (NaCl), ethanol (EtOH; technical 95 vol. %), sodium 
hydroxide solution (NaOH; 1 M), 4 % buffered formaldehyde and acetone (analytical) were 
obtained from VWR BDH Prolabo (Leuven, Belgium). Hydrochloride (HCl; 37 vol. %), sodium 
phosphate (Na2HPO4) and chloroform were purchased from Merck (Darmstadt, Germany) 
and calcium chloride (CaCl2.2H2O) from J.T. Baker (Deventer, The Netherlands). 
1.2.1 Electrospun mats 
 The fabrication process of the electrospun PCL mats is described in detail by Van der 
Schueren et al.28 Briefly, a 14 wt% PCL solution was made by dissolving PCL pellets in the 
binary solvent system 90 % formic acid/10 % acetic acid (both Sigma-Aldrich). The polymer 
solution was then loaded into a syringe (Becton Dickinson, Franklin Lakes, US) and a high 
voltage electric field of 18 kV (Glassman High Voltage Series EH Source, High Bridge, US) 
was applied to draw the fibers from the spinneret (17 G needle) onto the collector plate. A 
constant feed rate of 1 ml/h was applied using a syringe pump (KD Scientific, Syringe Pump 
Series 100, Holliston, US) and a distance of 12 cm was maintained between the tip of the 
spinneret and the collector plate. The electrospun meshes were soaked for 24 h in 0.9 wt % 
NaCl in order to remove any residual solvent present. The thickness of the meshes was 
measured using a digital micrometer (Mitotoyo 293-521-30, Kruibeke, Belgium). The 
morphology of the electrospun PCL fibers was analyzed using a scanning electron 
microscope (SEM; FEI Quanta 200 F, Hillsboro, US). Prior to SEM measurements, the 
samples were coated with gold using a sputter coater (Balzers Union Highland Scientific 
SCD 030, Bedford, UK). Surface hydrophobicity was characterized by means of static water 
contact-angle measurements (WCA). WCA measurements were carried out at room 
temperature using a contact-angle measuring system (DataPhysics OCA20, San Jose, US). 
Each measurement was repeated three times and the average WCA after 10 seconds was 
calculated. 
1.2.2 Surface activation 
 Samples of 1 x 1 cm² were immersed at room temperature in 10ml/cm² EtOH, NaOH 
solution, HCl solution or combinations of these. The composition of the solutions and the 
immersion times are summarized in Table 1. During immersion the samples were either 
continuously stirred on an orbital shaker (Fisher Bioblock Scientific, Hampton, US) at 85 rpm 
or placed in an ultrasonic bath (Elma Transonic 700/H, Ruiselede, Belgium). After each 
immersion, samples were rinsed for 30 seconds in demineralized water. The effect of 
different activation methods on the fiber morphology was analyzed by SEM. The effect on 
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sample hydrophobicity was characterized by WCA measurements. In order to evaluate and 
compare the efficiency of the different activation methods, the activated samples were 
treated with calcium and phosphate rich solutions using a standard nucleation procedure. In 
this procedure the activated samples were first dipped in 20 ml/cm² 75 mM CaCl2.2H2O 
solution for 1 minute, washed with demineralized water for 30 seconds, dipped in 20 ml/cm² 
75 mM Na2HPO4 solution for 1 minute and washed for 30 seconds with demineralized water. 
This cycle of four steps was repeated six times. Subsequently, the samples were stained 
with Alizarin Red S (ARS; Sigma-Aldrich). For ARS staining the samples were rinsed for 30 
seconds with demineralized water and fixed in 4 % buffered formaldehyde for 30 minutes. 
ARS powder was dissolved in demineralized water to a final concentration of 40 mM and pH 
was adjusted to 4.1 using 1 M NaOH solution. The scaffolds were stained on a glass cover 
plate with an excess of ARS solution for 10 minutes after which the scaffolds were rinsed 
repeatedly in demineralized water in order to wash off all unbound dye. At a pH of 4.1 ARS 
stains the surface of fibers coated with a calcium containing layer red. The color intensity is 
linearly correlated with the local calcium concentration.30,31 
 The morphology of the samples after treatment with the standard nucleation 
procedure was analyzed using SEM. All experiments were performed in triplicate. The 
activation method resulting in a reproducible and overall mineralization after treatment with 
the standard nucleation procedure was selected for further testing. 
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Table 1 
The composition of the solution and the immersion times applied in the surface activation experiments. 
During immersion in various solutions samples were either placed on a shaker or in an ultrasonic bath. 
Resulting WCA of the activated PCL samples measured after 10 seconds (with the corresponding 
standard deviation (SD)).  
Sample ID Solution(s) Concentration(s) Immersion time(s) WCA (SD) (°) 
PCL - - - 131.9 (2.8) 
Shaker (85 rpm) 
NaOH-6h NaOH 1M 6h 119.9 (14.9) 
NaOH-24h NaOH 1M 24h 5.6 (9.7) 
NaOH-5M NaOH 5M 6 h 3.4 (5.9) 
HCl HCl 1M 6 h 130.2 (5.4) 
NaOH-HCl NaOH – HCl 1M – 1M 3 h – 3 h 131.6 (4.3) 
EtOH EtOH 95 vol% 1.5 min N.A. 
EtOH-3h EtOH – NaOH  95 vol% – 1 M 1.5 min – 3 h 88.4 (24.5) 
EtOH-6h EtOH – NaOH  95 vol% – 1 M 1.5 min – 6 h 0 (0) 
Ultrasonic bath 
EtOH-10min EtOH – NaOH  95 vol% – 1M 1.5 min – 10 min 0 (0) 
EtOH-40min EtOH – NaOH  95 vol% – 1M 1.5 min – 40 min  0( 0) 
WCA:Water contact angle 
 
1.2.3 Calcium-phosphate nucleation 
 A CP coating was achieved by an alternate dipping process in CaCl2.2H2O and 
Na2HPO4 solutions. Important parameters in this coating procedure were the number of 
cycles, concentration and immersion time of both the CaCl2.2H2O and the Na2HPO4 
solutions. In order to efficiently optimize these five parameters at the same time, a variable 
size simplex algorithm was used.32 An optimized coating was a thin homogeneous primer 
layer of CP particles. In the maturation phase this primer layer can grow thicker while 
incorporating impurities, without compromising the porous structure of the matrix. 
 Samples were immersed in 20 ml of solution/cm² and washed for 30 seconds with 
demineralized water after every immersion. A minimum of three samples was prepared. The 
morphology of the CP coating on the nanofibers was analyzed by SEM. The homogeneity of 
the CP coating and the reproducibility of the procedures were evaluated using ARS calcium 
staining. Following the removal of most of the polymer by dissolution, the type of calcium 
phosphate deposited was identified by infrared (IR) spectrometry. Samples were cut in 
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smaller pieces and immersed in 250 µl/cm² chloroform for 10 minutes. Subsequently 750 
µl/cm² acetone was added. After centrifugation (2 minutes; 7000 rpm) the supernatant 
solution was removed. The remaining pellet was washed with 1ml/cm² aceton followed by 
centrifugation (2 minutes; 7000 rpm) and removal of the supernatant. This washing-step was 
repeated twice, the remaining powder was dried overnight in order to remove residual 
aceton. IR spectra of the CP powder dispersed in KBr tablets were recorded using a Fourier-
transform IR (FT-IR) spectrophotometer (Perkin Elmer Instruments, Waltham, US). 
 In order to select the best and most reproducible procedure, the experiments resulting 
in adequately coated samples were repeated tenfold. 
1.2.4 Cell culture and seeding  
 Monolayers of MC3T3-E1 pre-osteoblasts (subclone 14, ATCC) were routinely 
cultivated in α-minimum essential medium (α-MEM) (glutaMAX-1 TM Gibco, Ghent, Belgium) 
supplemented with 10% fetal bovine serum (FBS) (heat inactivated, EC approved, 
Invitrogen) and 1 mM sodium pyruvate (Invitrogen, Ghent, Belgium) at 37 °C and in 95% 
air/5% CO2 . The medium was changed twice a week.  
 Samples with the most reproducible CP coating on the nanofibers were selected for a 
cell viability study. Untreated PCL was used as control. CP coated and untreated samples 
were transferred into a 24-well suspension tissue culture plate (Greiner bio-one, 
Frickenhausen, Belgium) and sterilized under UV-light for 30 minutes. Forty thousand 
MC3T3-E1 cells diluted in 500 µl culture medium were added to each well containing a 
sample, or to a polystyrene 24-well standard tissue culture plate (Greiner Bio-one; positive 
control) and were incubated for 14 days.  
1.2.5 Cell viability, adhesion and proliferation 
 The PrestoBlueTM assay (Invitrogen) was applied to quantify the number of viable 
cells that are attached on the CP coated and untreated samples after 1, 7 and 14 days of 
culture. 
 The PrestoBlue™ reagent is a blue resazurin-based non-fluorescent solution. 
Resazurin enters the cells where it is transformed to the red and fluorescent resorufin by the 
reducing power of the mitochondria.33 The samples and the control were rinsed with culture 
medium after which 450 µl culture medium and 50 µm PrestoBlue™ reagent was added to 
each well. After 2 h incubation at 37 °C in a dark room, 400 µl medium was transferred to a 
new plate. In order to measure fluorescence the plate was inserted in a multilabel plate 
reader (Victor³, Perkin-Elmer). The number of viable and attached cells is linearly correlated 
with the signal, and viability was calculated as a percentage of the positive control after 14 
days. 
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 Cell viability, adhesion and proliferation after 1, 7 and 14 days on the CP coated and 
untreated samples was visualized using fluorescence microscopy after performing live/dead 
staining  (calcein acetoxymethyl (AM) ester (Tebu-Bio, Boechout, Belgium) /propidium iodide 
(PI) (Sigma-Aldrich)). PI cannot pass through intact cell membranes, but may freely enter 
dead cells with compromised cell membranes where PI intercalates into double-stranded 
DNA and emits red fluorescence (excitation: 535 nm, emmision: 617 nm). Calcein AM is a  
non-fluorescent, membrane-permeable dye. Under intracellular esterase activity the dye 
converts to a membrane-impermeable, green fluorescent compound (excitation: 490 nm, 
emission: 515 nm).34 After 1, 7 and 14 days the samples and positive controls were rinsed 
with 500 µl phosphate buffered saline (PBS) after which 500 µl PBS containing 1 µl PI and 1 
µl calcein AM was added to each well. After 10 minutes incubation in a dark room, samples 
were evaluated with a fluorescence microscope (Olympus Type U-RFL-T, Aartselaar, 
Belgium).  
Each material and the controls were tested in triplicate. 
1.2.6 Statistical analysis 
 Significant differences between the mean WCA were calculated using a student’s t-
test at 0.05 confidence level. Viability was evaluated using 2-factor ANOVA with the 
substrate and the incubation time as independent variables. Significant differences between 
means were calculated using a Holm-Sidak multiple-comparison test at the 0.05 confidence 
level. 
1.3 Results 
1.3.1 Morphology and hydrophobicity of activated PCL nanofibers mats 
 The PCL meshes have a thickness of 57.52 µm with a standard deviation (SD) of 
18.22 µm. SEM images of the electrospun PCL nanofibers are shown in figure 1A. The 
average diameter of the nanofibers is 419 nm with a SD of 100 nm. The untreated PCL 
nanofiber mat is white and the average water contact angle of the untreated PCL is 131.9° 
with a SD of 2.8° (Table 1).  
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Figure 1. SEM images of A) untreated, B) NaOH-24h treated, C) NaOH-HCl treated and D) EtOH-
40min treated PCL nanofiber 
 
SEM images of the PCL nanofibers after activation according to the conditions of 
experiments NaOH-24h, NaOH-HCl and EtOH-40min are shown in figure 1B-D (table 1). In 
figure 1D the EtOH-40min treated sample shows no changes in fiber morphology and is 
representative for all samples except for samples treated with the experimental conditions of 
NaOH-24h and NaOH-HCl. In the latter, fibers appear molten and are conglutinated at 
contact points. The change is more distinct in samples treated with the experimental 
conditions of NaOH-HCl. 
 The effect of the different activation processes on the wettability of PCL, as reflected 
by the WCA, is seen from table 1. Immersion of the samples for 6 hours in 1 M NaOH 
solution, 1 M HCl solution or a combination of both does not affect the WCA (p > 0.075). By 
increasing the immersion time in NaOH solution to 24 h, or the concentration of NaOH 
solution to 5 M, the WCA angle of the PCL samples decreases to 3.4° and 5.6° respectively. 
Dipping the samples in EtOH for 1.5 minute results in a visible increase in wettabilitiy, as is 
shown in figure 2. The PCL sample treated with EtOH absorbs water and appears 
translucent (grey), while untreated PCL remains white and water repellent. However, when 
the EtOH treated sample dries, it colors overall white and no significant difference in WCA 
can be detected between the EtOH dipped and the untreated PCL (130.8° vs. 131.9°, p = 
0.45). EtOH dipping followed by an immersion for 3 h in 1 M NaOH solution results in a slight 
decrease in WCA (88.4°). After a 6 h immersion in 1 M NaOH solution the WCA drops to 
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zero. The WCA is also zero after treating the samples with a combination of EtOH and the 
immersion in NaOH solution under ultrasonic conditions (EtOH-10min/40min; table 1) 
 
Figure 2. Digital image of sample halfway dipped in 
ethanol and subsequently dipped in demineralized 
water. EtOH dipped region is translucent (grey) (A), 
the untreated PCL remains white after dipping in 
water (B). 
 
 
 
 
 
Figure 3. Digital images of Alizarin 
Red stained samples after 
activation and treatment with the 
standard nucleation procedure. A) 
NaOH-HCl activated samples show 
no staining B) EtOH treated 
samples show no uniform staining 
C) EtOH–10min and D) EtOH-
40min activated samples show 
complete staining with some 
difference in color intensities.  
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1.3.2 Comparison of the activation methods 
 The digital image of the PCL samples activated with the experimental conditions of 
NaOH-HCl is given in figure 3A and is also representative for the samples activated with HCl 
solution. The samples activated according to these conditions show, apart from a few colored 
spots no staining, indicating the absence of CP deposits. The samples show few translucent 
spots, the majority of the samples remain white and water repellent. The digital image of the 
PCL samples activated with EtOH in figure 3B is representative for those activated with the 
experimental conditions of NaOH-6h, NaOH-24h, NaOH-5M, EtOH-3h and EtOH-6h. Some 
parts of the samples remain white, whereas some parts of the samples stain, indicating the 
presence of calcium phosphate deposits. The combination of EtOH dipping and ultrasonic 
NaOH solution immersion for both 10 and 40 minutes (figure 3C and D respectively) results 
in staining of the entire surface of the samples, with some differences in color intensities 
across the sample surfaces. 
 
 
Figure 4. SEM images of PCL nanofiber mats activated according to the experimental conditions of A) 
EtOH) B) EtOH – 10min and C) EtOH – 40min followed by treatment with the standard nucleation 
procedure. 
SEM images of samples activated according to the experimental conditions of EtOH, 
EtOH-10min, EtOH-40min and treated with the standard nucleation procedure are shown in 
figure 4. Considering the partial staining of samples activated according to the experimental 
conditions of EtOH, only stained regions were analyzed by SEM. The corresponding SEM 
image in figure 4A is representative for all samples with incomplete staining. The surface 
shows lumps of CP accumulations, in some cases obstructing the pores. Fiber coverage on 
the other hand is minimal with some discrete CP deposits on the fiber surface. For the 
samples activated with the parameters of experiment EtOH-10min, the surface of the fibers is 
partly coated with lumps of CP, with no accumulations of CP precipitates obstructing the 
Electrospun PCL scaffold 
79 
 
pores (figure 4B). For the samples treated with the experimental conditions of EtOH-40min, 
the pore structure is completely preserved and the majority of the fibers are completely 
covered with a CP layer (figure 4C). EtOH dipping followed by a 40 minutes immersion in 
NaOH solution under ultrasonic conditions is the best activation method since it results in the 
most reproducible CP coating with preservation of the porous structure after treatment with 
the standard nucleation procedure. However, since the deposited CP coating is not 
completely homogeneous, the nucleation procedure needed optimization. 
1.3.3 Optimization of the CP nucleation 
 The conditions of the standard nucleation procedure are used as starting point for the 
design of the primary vertex. Five additional experimental conditions are generated by 
varying one factor while holding all other factors constant. The conditions of the experiments 
generated by the simplex are given in table 2. Based on the ARS staining and the 
morphology of the coated fibers, the samples obtained by the different experiments can be 
divided into two categories.  
a  Poor, not reproducible or heterogeneous coating 
 The digital image of samples treated with the parameters of experiment P-5 shown in 
figure 5A is representative for the samples treated with the experimental conditions of 
experiments P-1 to P-7 (table 2). The CP deposition on all these samples is poor, indicated 
by the fact that they remain mainly white after ARS staining. In figure 5B the digital image of 
samples treated with the conditions of experiment N-9 is shown. The figure is representative 
for samples treated with the conditions of experiments N-1 to N-10 (table 2). In this group of 
experiments, treatment of samples using the same experimental conditions results in mutual 
different color intensities, indicating that the procedure is not reproducible. The digital image 
of the samples treated with the experimental conditions of experiment H-9 (figure 5C) is 
representative for samples treated with the experimental conditions of experiments H-1 to H-
10 (table 2). The staining of these samples is not homogeneous, as indicated by the 
differences in color intensities among different regions of the same sample. 
b Homogeneous and reproducible coating 
 The digital and SEM image of samples treated with the experimental conditions of 
experiment D-1 are given in figure 6. The figure is also representative for the samples treated 
with the experimental conditions of experiment D-2 (table 2). The digital image shows intense 
dark coloring of the samples (figure 6(top)). The SEM images show profuse mineralization 
with almost complete coverage of the surface and disappearance of the pore and fiber 
structure (figure 6(bottom)). Samples treated with the experimental conditions of experiments 
A-1 to A-4 stain pale pink. Results of the reproducibility test for these four experiments are 
summarized in figure 7. Samples treated with the experimental conditions of exp A-1 to A-3 
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show variations in staining, with locally white spots and lighter and darker staining. Samples 
treated with the experimental conditions of exp A-4 show a predominantly uniform pale pink 
ARS staining. Although SEM images show no visible coating of the samples treated with the 
parameters of exp A-1 (figure 8A), the SEM images of the samples treated with the 
experimental conditions of exp A-2 to A-4 show an increase in roughness of the fiber surface. 
The latter indicates the presence of a very thin layer on the fibers (figure 8B - D). 
 
 
Figure 5. Digital images of samples treated with 
the conditions of the experiments generated by 
the simplex. A) poor staining: P-5 B) not-
reproducible staining: experiment N-9 C) 
heterogeneous staining: experiment H-9. 
 
 
 
 
 
 
 
 
 
Figure 6. Digital image of ARS stained samples 
(top) and SEM images (bottom) after treatment 
with the experimental conditions of experiment 
D-1. 
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Figure 7. Digital images of reproducibility assay, experiments A-1 to A-4 were repeated ten-fold. 
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Table 2 
Conditions of the experiments used for the optimization of the calcium phosphate nucleation step. 
Based on resulting ARS staining and morphology of coating, experiments are organized as poor (P), 
not reproducible (N), heterogeneous (H), dark (D) and adequate (A). In bold are the experimental 
conditions of the start simplex, including the standard nucleation procedure(*). 
 
CaCl2.2H2O Na2HPO4 
  Exp   # Cycles Concentration (mM) Immersion time (s)   Concentration (mM) Immersion time (s) 
P-1 3 34.01 75.60 34.01 80.16 
P-2 4 45.68 66.22 45.68 68.82 
P-3 4 52.55 54.76 52.55 65.69 
P-4 3 45.40 67.61 87.33 48.76 
P-5 10 3.92 78.71 27.85 33.91 
P-6 8 55.44 64.92 12.33 52.35 
P-7 6 87.99 77.29 8.61 35.82 
N-1 1 75.00 60.00 75.00 60.00 
N-2 4 52.50 48.00 52.50 48.00 
N-3 6 69.38 60.00 69.38 60.00 
N-4 4 53.83 76.29 53.83 50.99 
N-5 5 58.13 62.05 58.13 53.26 
N-6 3 89.06 55.92 52.25 64.38 
N-7 7 32.81 55.92 52.25 64.38 
N-8 5 67.89 72.24 31.07 55.38 
N-9 4 56.31 64.69 64.50 52.66 
N-10 8 60.96 62.98 20.80 37.00 
H-1* 6 
 
75.00 60.00 
 
75.00 60.00 
H-2 6 
 
75.00 30.00 
 
75.00 60.00 
H-3 6 
 
18.75 60.00 
 
75.00 60.00 
H-4 6 
 
75.00 60.00 
 
75.00 30.00 
H-5 6 
 
75.00 60.00 
 
18.75 60.00 
H-6 4 50.25 90.00 50.25 48.00 
H-7 4 48.23 72.00 48.23 43.20 
H-8 5 64.75 63.90 64.75 42.54 
H-9 5 59.07 49.10 59.07 59.61 
H-10 8 30.04 52.22 48.14 57.03 
D-1 5 64.56 35.16 64.56 59.98 
D-2 5 59.98 64.48 59.98 49.11 
A-1 2 
 
75.00 60.00 
 
75.00 60.00 
A-2 4 53.51 69.00 53.51 47.40 
A-3 6 78.81 59.82 42.00 46.92 
A-4 8 32.30 71.11 35.98 44.07 
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Figure 8. SEM images of samples 
treated with the experimental 
conditions of A) A-1 B) A-2 C) A-3 and 
D) A-4. 
 
 
 
 
 
 
 
 
 
 
1.3.4 FTIR analysis 
The FTIR spectrum of the CP precipitated on the samples after calcium phosphate treatment 
with the experimental procedure of experiment A-4 is shown in figure 9. Peaks due to the ν4-
PO43- bending at 500 – 700 cm -1 and the ν1 and ν3 stretching of PO43-  groups around 970, 
1045 and 1100 cm-1 are typical peaks of an apatitic phase. The peak around 878 cm-1 , 
arising from the ν5-P-O(H) deformation of HPO42- and the absorbance at 1138 cm-1 indicate 
the presence of HPO42- groups. Consequently, the CP coating is not a pure apatite but a 
calcium-deficient apatite (CDHAp; Ca10-x(HPO4)x(PO4)6-x(OH)2-x (with 0 < x < 1)). Three weak 
peaks around 1250, 1300 and 1475 cm-1, and three more intense peaks around 1740, 2830 
and 3025 cm-1, can be assigned to PCL since they correspond with intense peaks found in 
the infrared spectrum of untreated PCL. 
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Figure 9. Infrared spectrum of the CP coating on the samples treated with the conditions of 
experiment A-4. For comparison the IR spectra of PCL and CDHAp are shown. The dotted lines mark 
HPO42- absorptions.  
 
1.3.5 Cell viability, adhesion and proliferation on electrospun PCL fiber mats 
 After 24h of incubation, the amount of viable cells attached to the CP coated and 
untreated PCL samples are similar. The cells are round on the untreated PCL samples, and 
elongated on the CP coated samples (figure 10A and 10D). 
 After 7 days of incubation, cell attachment or cellular spreading is not changed in 
untreated PCL. The majority of cells is still small and round, although a limited number of 
cells form extensions. On the CP coated samples, the amount of viable cells increased. Cells 
show elongated morphologies and are forming extensions.  
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 At day 14 the amount of cells attached to the untreated samples slightly increased. 
Regions of high cell density can be observed as shown in figure 10C. The majority of the 
cells are large, round. Cell attachment and spreading increased on the CP treated samples. 
The morphology is similar to the observed morphology of cells in the confluent positive 
culture. On the untreated sample the number of dead cells increased progressively from 1 to 
14 days. An overall low amount of dead cells is present on the CP treated samples. 
 The quantity of viable and attached MC3T3-E1 cells on the CP coated and untreated 
samples after 1, 7 and 14 days (as reflected by the Presto BlueTM assay and expressed as % 
viable cells) is illustrated in figure 11. At day 1 and day 7, the amount of attached cells  on 
the untreated PCL samples is 1.9% of the positive control. After 14 days the amount of 
attached cells increased significantly (p = 0.017) to 6.5%. After 1 day of incubation there is 
no significant difference between the untreated and treated samples. 13 respectively 32.2 % 
of attached cells is observed after 7 and 14 days. This amount of attached cells on the CP 
coated samples are significantly higher than the cell viabilities on the untreated samples (p = 
0), but still low when compared to the control.  
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Figure 10.  Morphology of MC3T3-E1 pre-osteoblast cells attached to untreated PCL fiber mats (A-C) 
or CaP treated PCL fiber mats (D-F) after 1 day (A-D), 7 days (B-E) and 14 days (C-F) of culture. The 
positive control is a tissue culture polystyrene plate.  
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Figure 11. Cell viability on untreated and calcium phosphate treated samples after 1, 7 and 14 days of 
incubation. The cell viability was calculated as a percentage of the positive control at day 14 of culture. 
Error bars represent standard deviations. 
1.4 Discussion 
 An electrospun PCL material is interesting as bone tissue engineering scaffold 
because of its 3D structure, interconnected pore system, biocompatibility and 
biodegradability. However, as a result of the hydrophobic nature of PCL, the scaffold lacks 
cell adhesion domains, minimizing the surface bioactivity.2 In addition, the acidic degradation 
products have detrimental effects on the cells. Coating the fiber surface with a homogeneous 
layer of CP creates a composite combining the flexibility, high porosity and surface area of 
the electrospun polymer, with the biocompatibility, osteoconductivity and bone-bonding ability 
of the CP. 2,9,18 Ideally the polymer fibers are coated with a thin layer of bone-like apatite, 
without compromising the porous structure. Two reported techniques for the coating of 
electrospun polyester fibers are the alternate dipping procedure in calcium and phosphate 
rich solutions and/or the incubation in SBF.18,19,21,22,24-26 Experiments reveal that in the case of 
PCL no CP could be deposited onto the fiber surface using only one of these two 
techniques.25,35 This can be explained by the hydrophobic nature of the material, and hence, 
by the lack of chemical groups on the fiber surface.18 In order to overcome this obstacle the 
scaffold needs to be activated. This involves the rapid and local degradation of the fiber 
surface, creating reactive carboxylated groups on the fiber surface throughout the scaffold. 
1.4.1 Activation 
 Treatment of electrospun PCL samples with an aqueous NaOH solution, is a 
frequently used method to create reactive carboxylated groups on the fiber surface and to 
modify the surface wettability.18,24,25 Partial surface hydrolysis causes random chain cleavage 
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of the ester linkages on the polymer backbones located at the surface, generating reactive 
carboxyl and hydroxyl groups.18,36 The hydrolysis of ester bonds is an acid catalyzed process, 
which makes HCl solution also a possible activating agent.37,38 The present study shows that 
treatment of the electrospun PCL samples with HCl solution alone or in combination with 
NaOH solution has no effect on the hydrophobicity as reflected by WCA measurements 
(table 1). This is substantiated by the fact that these samples show no CP deposition after 
treatment with the standard nucleation procedure.  
Activation with 1 M NaOH solution for 6 h results in PCL samples with a slightly decreased 
WCA (table 1). Increasing the immersion time or the concentration of the NaOH solution 
enhances this effect. However, treatment with the standard nucleation procedure only results 
in local spots of CP precipitation as visualized by the ARS staining. Apparently, the surface 
of the PCL fibers is not homogeneously activated. This can be explained by the surface 
hydrophobicity of the PCL samples, which hinders the diffusion of the aqueous NaOH 
solution into the air-filled pores.39,40 Hence morphology could play a role, as larger pores are 
expected to have a greater ability to be infiltrated with NaOH solution.  
 To overcome the problems associated with the hydrophobic nature of PCL, it is 
necessary to obtain a uniform hydrophilic sample surface prior to immersion in NaOH 
solution. Since EtOH is a well-known wetting medium for polyesters, it is applied as pre-
treatment medium to wet the PCL samples.40 Upon dipping in EtOH the color of the PCL 
samples alters from white to grey as they are soaked with the alcohol, indicating that the 
samples are hydrophilic (figure 3). However, after drying the samples a decrease in WCA is 
not observed, suggesting that hydrophobicity is restored. PCL samples treated with the 
standard nucleation procedure immediately after EtOH dipping only show partial CP 
deposition, indicating EtOH alone is unable to generate a sufficient number of reactive 
surface groups. 
 EtOH treatment followed by an immersion in 1 M NaOH solution for 3h does not 
create a hydrophilic surface, so that samples show no uniform CP deposition after treatment 
with the standard nucleation procedure (table 1; figure 4). After treatment with EtOH and a 6 
h immersion in 1 M NaOH solution, the samples are hydrophilic while samples immersed for 
6 h in NaOH solution alone are still hydrophobic, as reflected by the WCA measurements 
(table 1). Clearly, the EtOH pre-treatment enhances the wettability of the samples. However, 
after treatment with the standard nucleation procedure, even the EtOH pre-wetted samples 
show no uniform CP deposition. This could be explained by the diffusion controlled infiltration 
occurring at the pore sites. When the samples are first pre-wetted with EtOH and then placed 
in an aqueous solution of NaOH, the NaOH solution diffuses into the pores, mixes with EtOH 
and finally replaces EtOH.39 It can be expected that this diffusion controlled infiltration is 
faster when pores are larger. Differences in the pore size result in differences in the 
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infiltration so that the amount of generated carboxylated groups depends on the local 
porosity of the samples resulting in an inhomogeneous activation with the NaOH solution. 
 To promote an effective influx of NaOH solution into the pores, the samples are pre-
wetted with EtOH and immersed in 1 M NaOH solution under ultrasonic conditions. The 
effects of ultrasound are derived particularly from acoustic cavitation as bubble collapses 
near the material surface result in jets of liquid impinging at high velocity onto the surface. 
The micro-jets hitting the samples result in an enhanced contact between the PCL fiber 
surface and the surrounding NaOH solution, enhancing the mass transport and diffusion of 
the solution into the pores.41 An additional physical effect of ultrasound includes the erosive 
action of the micro-jets hitting the surface of the material. The resulted roughening of the 
surface creates an ideal surface for subsequent coating.42 Pre-wetting the samples with 
EtOH followed by immersion in NaOH solution under ultrasonic conditions appears to be a 
fast and effective activation method. A hydrophilic surface was obtained after only 10 
minutes of immersion in 1M NaOH solution (table 1). However, the PCL fibers were only 
partially covered with CP. After subjecting the EtOH pre-wetted samples to 40 minutes of 
ultrasonic immersion in a 1M NaOH solution, the surface is successfully activated as 
reflected by the complete CP coverage of the PCL fibers after subsequent treatment with the 
standard nucleation procedure (figures 3D and 4C). Since the deposited CP layer on these 
samples is not homogeneous, the conditions of the nucleation step need to be optimized.  
1.4.2 Nucleation 
 In the nucleation phase five parameters of the alternate dipping process are 
optimized simultaneously: the number of cycles, concentration of and immersion time in both 
the calcium and the phosphate rich solutions. The ARS staining and SEM images show that 
specific combinations of these five parameters can create ideal conditions for the deposition 
of a homogeneous and reproducible CP coating. Only six combinations result in such CP 
coating on the PCL fibers. The experimental conditions of experiments D-1 and D-2 result in 
a profuse mineralization with almost complete coverage of the surface (figure 7 bottom). 
Such situation leaves no room for maturation of the CP layer in a next step. The parameters 
of experiments A-1 to A-4 result in a thin and homogenous coating. The reproducibility assay 
shows that the parameters of experiment A-4 result in the most reproducible coating. 
 FTIR spectrophotometry reveals that the deposited CP coating obtained by treating 
the activated samples with the parameters of experiment A-4 is calcium-deficient hydroxy 
apatite (CDHAp) (figure 9). SEM images of the corresponding samples show no deposited 
CP crystals, only a slight roughening of the fiber surface, which could indicate the 
nanocrystallinitiy of the CDHAp crystals (figure 8D). CDHAp nanocrystals are shown to 
exhibit physicochemical characteristics similar to those of bone nanocrystals. Due to their 
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calcium deficiency, CDHAp nanocrystals are more soluble and have an increased 
bioresorption rate in vivo compared to stoichiometric HAp.43,44 In line with this it can be 
expected that coating of the PCL nanofibers with nanoscaled CDHAp crystals could improve 
the cellular response as compared to untreated PCL. 
1.4.3 Cell viability, adhesion and proliferation 
 The amount of cells attached on the untreated PCL samples is low (figure 11). Even 
after 14 days of culture cells are not able to attach well to the samples.45 The observed 
cellular behavior could be expected due to the hydrophobic nature of the untreated PCL 
samples (table 1). The hydrophobicity hinders the initial biological responses, such as protein 
adsorption, making it difficult for the cells to adhere to such surfaces.46 The CDHAp coating 
on the PCL nanofibers enhances the MC3T3-E1 cell response. CDHAp coated samples 
show an increase in the amount of attached cells throughout the experiment (figure 11). After 
14 days of culture cells are well attached on the CDHAp coated surface and show similar 
cellular morphologies as the control (figure 10 D-F). Our results corroborate the findings of 
other authors who also compared the response of MC3T3-E1 pre-osteoblasts cultured on 
pure electrospun PCL and electrospun PCL samples coated with an apatite phase. Although 
these studies do not indicate the reproducibility of their coating procedure, nor that the fibers 
are adequately covered, all reports conclude that the hydrophilic CP coating improved the 
pre-osteoblasts cellular attachment and growth.24,26  
 Pieters et al. reported that apatites with a carbonate content equal to or higher than 
11% show an improved cell adhesion and proliferation in comparison to that on carbonate-
free apatite.47  Based on these findings it would be interesting to attempt to incorporate 
carbonate ions in the apatite lattice. In order to do this, the CDHAp coated PCL samples can 
be incubated in a SBF-like solution. During this maturation phase the CDHAp primer layer 
can grow and incorporate carbonate ions, mimicking the apatite phase found in the ECM of 
bone. 
1.5 Conclusion 
 In the present study, coating of electrospun PCL nanofibrous scaffold with a thin 
primer layer of CP was optimized. The electrospun PCL scaffold was produced with a new 
low-toxic solvent mixture of formic acid/acetic acid was used. Adequate coating was 
achieved in a two step procedure. First, the polymer surface was uniformly activated without 
any obvious change in the fiber structure. Next, the fibers were coated with a homogeneous, 
thin and reproducible CDHAp coating, with preservation of the porous structure. Such 
CDHAp coating on the surface of the PCL nanofibers improved the osteogenic response and 
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enhanced the cell affinity when compared to the uncoated PCL samples. In order to further 
enhance the cellular response, the incorporation of carbonate ions in the apatite lattice is 
recommended. Such carbonated apatite more closely resembles the mineral found in bone. 
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2 Calcium phosphate coating of an electrospun PDLLA scaffold 
 
Part of the research is based on the article: 
Optimization of the time efficient calcium phosphate coating on electrospun poly(D,L-
lactide). 
Nathalie Luickx, Natasja Van den Vreken, Jonas Segaert, Heidi Declercq, Maria Cornelissen, 
Ronald Verbeeck  
Journal of Biomedical Materials Research Part A 2015; 103(8): 2720-2730. 
 
Abstract: The coating of fibrous polyester constructs with a layer of bioactive calcium 
phosphate (CP) is efficient to improve the potential use as bone tissue engineering scaffold. 
In the present study a fast procedure for the coating of electrospun poly(D,L-lactide) (PDLLA) 
fibers with a CP layer was optimized. The fiber surface was activated by immersion in 
demineralized water under ultrasonication. The resulting reactive groups served as 
nucleation points for CP precipitation, induced by alternate dipping of the samples in Ca2+ 
and PO43- rich solutions. Variations in the conditions of the alternate dipping procedure, in 
particular the number of cycles, concentration and immersion time of both solutions, not only 
affected the degree of surface mineralization but also the type of deposited CP. For the 
current experimental conditions, in about 30 minutes either a slightly carbonated calcium 
deficient apatite (CDAp; Ca10-x-y(PO4)6-x-y(HPO4)y(CO3)x(OH)2-x-y) or a combination of apatite 
and dicalcium phosphate dihydrate (DCPD; CaHPO4.2H2O) was formed. The cell viability, 
adhesion and proliferation of MC3T3-E1 cells on untreated samples were compared to 
samples coated with either an adequate amount of CDAp, an excess of CDAp or an excess 
of a combination of apatite and DCDP. After 7 days of culture the number of attached cells 
was significantly higher on all CP coated samples compared to the untreated PDLLA. In 
particular the samples coated with an adequate amount of CDAp showed an exceedingly 
enhanced cell response with similar cell morphologies as the ones found on the positive 
control.  
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2.1 Introduction 
For the reconstruction of bone defects, three-dimensional (3D) scaffolds with an 
interconnected pore system are intensively investigated. As such porous scaffold shows 
structural similarity with the extracellular matrix (ECM) cell adhesion, proliferation and 
differentiation is enhanced compared to dense scaffolds.60 In order to allow cell in-growth, 
vascularization and efficient transport of nutrients, oxygen, growth factors and metabolites, 
interconnectivity of the pores is necessary.9 The material used to fabricate the scaffold 
should be biocompatible, bioactive and osteoconductive. Ideally, the scaffold is 
biodegradable with a degradation rate equal to the bone repair rate so as to ensure the 
mechanical stability. Finally, when the scaffold is completely degraded, the initial bone defect 
is filled with newly formed bone tissue.21 
 The aliphatic polyesters polylactic acid (PLA), polyglycolic acid (PGA), 
polycaprolactone (PCL) and their copolymers are interesting scaffold materials. These Food 
and Drug Administration (FDA) approved polymers are biodegradable and easy to 
manufacture into different shapes. 22,41 The mechanical properties and degradation kinetics 
of the polyesters can be tailored by using various molecular weights and copolymers.42 
Special interest goes out to PLA, that exists in three morphologically distinct polymers due to 
the chiral nature of its monomer. PDLA and PLLA, the two stereo-regular polymers are 
semicrystalline. PDLLA is the racemic polymer obtained from a mixture of PDLA and PLLA in 
a 1/1 ratio and it is amorphous. The latter results in a degradation time of PDLLA of 12 to 16 
months in the human body, which is shorter than that of PDLA and PLLA. This relative short 
degradation time is the main reason for the use of PDLLA as surgical suture material and as 
a controlled drug delivery device. PDLLA also has great potential as bone tissue engineering 
scaffold due to its well established safety in clinical use and suitable biodegradation time. 
42,96,103
 By processing PDLLA by means of electrospinning a 3D nanofibrous structure with 
high surface-to-volume ratio, high porosity and an interconnected pore system can be 
manufactured.62 
However, due to the hydrophobic nature of polyesters, the bioactivity of  PDLLA 
scaffolds is low.194,208 In order to enhance the bioactivity without changing the intrinsic 
properties of the material, coating of the polyester surface with an apatite layer is applied. 
Such calcium phosphate (CP) layer is chemically comparable to the mineral phase found in 
natural bone and acts as an excellent cell support to maintain desirable cell-substrate 
interactions.145,190,207,209,210 Polymer-mineral composites apparently have improved bioactivity 
and mechanical strength compared to pure polymer scaffolds.211,212 Moreover, the resorption 
of the apatite layer could contribute to the neutralization of the acidic polymer degradation 
by-products, which could cause inflammation. 22,41,93 The neutralization is ascribed to the 
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reaction of calcium ions and the carboxyl end-groups generated during degradation of the 
polymer, to form calcium carboxylate chain ends. This complexation results in an increased 
solubility of the CP, causing an increase of the pH. As a result, the acidic autocatalytic break 
down of the polymer is slowed down. 
In literature, little is reported on the CP coating of pure PDLLA fiber mats. Chen et al. 
describe a CP coating procedure of electrospun PLLA samples by long-term incubation in a 
simulated body fluid (SBF). After 7 days of incubation  CP deposits are visible and after 14 
days the fibers are completely covered  with a layer of slightly carbonated apatite.195 Cui et 
al. showed that a CP coating was not formed on electrospun PDLLA samples after an 
incubation of 6 days in a SBF solution with a 1.5 times higher ion concentration than regular 
SBF (1.5xSBF). Due to its hydrophobicity and  inability to induce nucleation and growth of 
CP on the fiber surface, PDLLA lacks bioactivity.207 On the other hand, when PDLLA 
samples were subjected to an activation procedure prior to the SBF incubation, a CP coating 
was formed after 7 days of incubation in 2xSBF.211 The activation procedure is necessary to 
create reactive carboxyl groups on the fiber surface by cleaving the polyester bonds. 
Apparently the presence of carboxyl groups is required to promote the deposition of a CP 
layer on the fiber surface.211,213 Despite the fact that incubation in SBF is a relative easy 
coating procedure, an inherent drawback of the method is the time required to deposit an 
adequate amount of CP.214 
In order to accelerate the process of CP formation on porous polymer scaffolds, an 
alternate soaking procedure is interesting.189,214 In this process, the polymer samples are 
alternately dipped in solutions containing high concentrations of calcium and phosphate  ions, 
which accelerates the process of CP coating compared to the conventional incubation in 
SBF. 
As for electrospun PDLLA no rapid and reproducible procedure to coat the fiber 
surface with a CP layer is available, the objective of this study is to optimize the CP coating 
of electrospun PDLLA by a two-step procedure. In the first step the surface of the fibers is 
activated to create the necessary carboxyl groups. In the second step, activated samples are 
subjected to an  alternate dipping process in Ca2+ and PO43- rich solutions in order to deposit 
a CP coating. In search of an optimal procedure, not only the time required to deposit an 
adequate CP layer, but also the reproducibility of the procedure, the homogeneity of the 
coating and preservation of the porous structure upon coating are a prerequisite. The 
optimized parameters giving the most reproducible and adequate coating were selected for 
an in vitro study, comparing the adhesion and proliferation of pre-osteoblastic cells (MC3T3-
E1) on CP coated samples and untreated electrospun PDLLA samples.  
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2.2 Materials and Methods 
Freshly prepared ultra-pure demineralized water (Milli-Q system, Millipore, Billerica, US) 
was used for the preparation of the solutions.  
2.2.1 PDLLA electrospun mats 
 PDLLA pellets were purchased from Purac (Purasorb PDL20, inherent viscosity ~ 2.0 
dl/g, Gronichem, The Netherlands). A 17 wt%  PDLLA solution was prepared by dissolving a 
measured amount of PDLLA pellets in a mixed solvent of N,N-dimethylformamide (DMF; 
Merck, Darmstadt, Germany) and acetone (VWR, Leuven, Belgium) with a volume ratio of 
2/1 (DMF/acetone), at room temperature. To ensure complete dissolution the 
polymer/solvent mixture was magnetically stirred at room temperature for 4 h, and then 
loaded into a 50 ml syringe (Becton Dickinson, Franklin Lakes, US). During the 
electrospinning process the polymer solution was pumped from the syringe into a 17 G 
needle. A constant feed rate of 1 ml/h was applied using a syringe pump (Syringe Pump 
Series 100, KD Scientific, Holliston, US) and a distance of 13 cm was maintained between 
the tip of the spinneret and the collector plate. A high voltage electric field of 6-7 kV (Series 
EH Source, Glassman High Voltage, High Bridge, US) was applied to draw the fibers from 
the spinneret onto the collector plate. The electrospinning was performed in a flow hood, at 
room temperature (22 ± 2°C) and at an ambient relative humidity of max. 55%.  
 The thickness of the resulting fiber mats was measured with an electronic micrometer 
(Digimatic Micrometer Series 293, Mitutoyo, Kruibeke, Belgium). The morphology of the 
electrospun fibers was evaluated using a scanning electron microscope (SEM; FEI Quanta 
200 FEG, Hillsboro, VS). Prior to the SEM-measurements, the samples were coated with 
gold using a sputter coater (SCD 030, Balzers Union Ltd., Balzers, Liechtenstein). Image 
analysis software (SigmaScan Pro 5, SPSS Science, Chicago, US) was used to determine 
the average fiber and pore diameter, fifty diameter measurements were carried out on four 
samples from different fiber mats.  
2.2.2 Activation of the polyester surface  
Electrospun fiber mats were cut in pieces of 1 x 1 cm². In order to induce a hydrophilic 
surface samples were either dipped in 10 ml ethanol for 1 second (EtOH; VWR) or placed in 
an ultrasonic bath (Transsonic T700/H, Elma Ultrasonic, Ruiselede, Belgium). After EtOH 
dipping the PDLLA samples were washed extensively with demineralized water. For the 
ultrasonic activation, each sample was transferred in a plastic container filled with 40 ml 
demineralized water. The containers were subsequently placed in the ultrasonic bath for 3 
seconds. 
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 The effect of both procedures on the fiber morphology was analyzed by SEM. In order 
to evaluate and compare the efficiency of the different activation methods of the fiber 
surface, the activated samples were alternately immersed in Ca2+ and PO43- rich solutions 
using a standard nucleation procedure. In this procedure samples were first dipped in 20 
ml/cm² 1000 mM CaCl2.2H2O solution (JT Baker, Deventer, The Netherlands) for 1 min, 
washed with demineralized water for 30 seconds, dipped in 20 ml/cm² 600 mM Na2HPO4 
solutions (Merck) for 1 min and washed again for 30 seconds with demineralized water. This 
cycle of four steps was repeated five times. Samples were subsequently stained with Alizarin 
Red S (ARS; Sigma-Aldrich) solution prepared by dissolving ARS powder in demineralized 
water to a final concentration of 40 mM and adjusting the pH to 4.1 using 1 M NaOH. 
Scaffolds were stained on a glass cover plate with an excess of ARS solution for 10 minutes 
after which the scaffolds were rinsed repeatedly in demineralized water till all unbound dye 
was washed off. At a pH of 4.1 ARS stains the surface of the CP coated fibers red by binding 
to the precipitated calcium-ions. The color intensity is linearly correlated with the local 
calcium concentration.215 The morphology of the samples after treatment with the standard 
nucleation procedure was analyzed using SEM. All experiments were carried out at room 
temperature in triplicate in order to evaluate the reproducibility of the procedure. 
 
2.2.3 Optimization calcium phosphate coating 
 Coating of the fibers with a thin and homogenous CP layer was achieved by an 
alternate dipping process in CaCl2.2H2O and Na2HPO4 solutions. Important parameters of 
this coating procedure are the concentration of and incubation time in both the Ca2+ (CCa and 
TCa) and the PO43- rich (CP and TP) solutions as well as the number of cylces. In order to 
efficiently optimize these five parameters at the same time, a variable size simplex algorithm 
was used.216 As a base for the generation of the simplex, the parameters of the standard 
nucleation procedure were used. Experimental conditions generated by the simplex were 
carried out until a homogenous, thin and reproducible coating of the fibers was obtained. 
 Activated samples were immersed for a specific time in 20 ml/cm² of CaCl2.2H2O and 
Na2HPO4 solutions, each with a given concentration. The samples were washed in 40 ml 
demineralized water for 30 seconds after each immersion. This procedure was repeated for a 
specific number of cycles. A minimum of three samples was prepared in order to evaluate 
the reproducibility of the procedure. The morphology of the CP coating on the fibers was 
analyzed by SEM. The homogeneity of the CP coating and the reproducibility of the 
procedures was evaluated by ARS calcium staining. Based on the intensity of the red color 
after ARS staining, samples were assigned a mineralization score from 0 to 4. The higher the 
mineralization score, the more intense the red staining color. Samples that remain white after 
ARS staining were scored 0. 
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 The type of calcium phosphate deposited on the samples was identified by infrared 
(IR) spectrometry. Samples were immersed in a mixture of 1 ml/cm² acetone and 50 µl/cm² 
chloroform (Merck) for 10 minutes at room temperature to dissolve the polymer. After 
centrifugation (2 min; 7000 rpm)  the supernatant solution was removed. The remaining 
pellet was washed with 1ml/cm² acetone followed by centrifugation (2 minutes, 7000 rpm) 
and removal of the supernatant. This washing-step was repeated twice and the remaining 
powder was dried overnight at room temperature in order to remove residual acetone. IR 
spectra of the obtained CP powder dispersed in KBr (Merck) tablets were recorded using a 
Fourier-transform IR (FT-IR) spectrophotometer (Perkin Elmer Instruments, Waltham, US).  
 
2.2.4 Cell culture and seeding 
 Monolayers of MC3T3-E1 pre-osteoblasts were routinely cultivated in α-minimum 
essential medium (α-MEM) (glutaMAX-1 TM Gibco BRL, Belgium) supplemented with 10% 
fetal bovine serum (FBS) (heat inactivated, EC approved) and 1 mM sodium pyruvate 
(Invitrogen, Belgium) at 37°C and in 95% air/5% CO2 . The medium was changed twice a 
week.  
 For the cell viability study samples were selected that were coated with a different 
type of CP and/or a different degree of surface mineralization of the polymer fibers. 
Untreated electrospun PDLLA was used as control. CP coated and untreated PDLLA 
samples were transferred into a 24-well polystyrene standard tissue culture plate (Greiner 
Bio-one, Frickenhausen, Wemmel, Belgium) and sterilized under UV-light for 30 minutes. 
Forty thousand MC3T3-E1 cells diluted in 500 µl culture medium were added  to each well 
containing a sample or to a 24-well standard tissue culture plate (positive control). The tissue 
culture plates were incubated for 7 days.  
2.2.5 Cell viability 
 Cell viability on the CP coated and untreated samples was analyzed after 1 and 7 
days of culture with a PrestoBlueTM viability reagent assay (Invitrogen, Carlsbad, US). The 
samples were rinsed with culture medium after which 450 µl culture medium and 50µl 
PrestoBlueTM reagent was added to each well. After 2 h incubation at 37°C in a dark room, 
the medium was transferred to a new plate. The fluorescence was measured with a 
multilabel plate reader (Victor³, Perkin-Elmer). The quantity of viable cells is linearly 
correlated with the signal, and the viability was calculated as a percentage of the positive 
control after 7 days. Each material was tested in triplicate. 
 The morphology of the attached cells visualized after 1 and 7 days of culture using a 
calcein acetoxymethyl (AM) ester (Tebu-Bio, Belgium)/propidium iodide (PI) (Sigma-Aldrich) 
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live/dead staining. PI freely enters dead cells with compromised cell membranes where it 
intercalates into double-stranded DNA and emits red fluorescence (excitation: 535 nm, 
emmision: 617 nm). Calcein AM is a non-fluorescent, membrane-permeable dye. Under 
intracellular esterase activity the dye converts to a membrane-impermeable, green 
fluorescent compound (excitation: 490 nm, emission: 515 nm). The samples were rinsed with 
500 µl phosphate buffered saline (PBS) after which 500 µl PBS, 1 µl PI and 1 µl calcein AM 
was added to each well. After 10 minutes incubation in a dark room, samples were evaluated 
with a fluorescence microscope (Type U-RFL-T, Olympus, Belgium). 
2.2.6 Statistical analysis 
 Viability was evaluated using 2-factor ANOVA with the composition of the sample 
surface and the incubation time as independent variables. Significant differences between 
means were calculated using a Holm-Sidak multiple-comparison test at the 0.05 confidence 
level. 
2.3 Results 
2.3.1 PDLLA electrospun fibers 
 Electrospinning for 40 minutes results in fiber mats with an average thickness of 
0.060 mm with a standard deviation (SD) of 0.009 mm. The fibers have an average diameter 
of 1.55 µm with a SD of 0.24 µm. The distribution of the fiber diameters (n=200) is shown in 
figure 1 (right). The SEM image of the electrospun fiber mat in figure 1 (left) shows that the 
fibers are randomly oriented with irregularly shaped pores. The average pore diameter is 
9.97 µm with a SD of 4.90 µm. 
 
Figure 1. Left: SEM image 
of an PDLLA fiber mat 
after 40 minutes of 
electrospinning. Right: 
Frequency distribution for 
fiber diameters measured 
on the electrospun PDLLA 
samples (n=200). 
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2.3.2 Surface activation  
 Digital images of ARS stained samples treated with EtOH and subsequently treated 
according to the parameters of the standard nucleation procedure are shown in figure 2A 
(top). Samples show a heterogeneous staining, as some parts of the samples remain white 
and some parts color pale pink to dark red. This indicates that calcium was locally present on 
the fiber surface but in different concentrations. In addition, SEM images of EtOH dipped 
samples (figure 2A bottom) reveal that the microstructure of the samples is affected as 
numerous fibers are broken. Therefore no further experiments were carried out with this type 
of activation. 
Samples immersed in an ultrasonic bath for 3 seconds prior to the treatment 
according to the standard nucleation procedure, are uniform dark red after ARS staining, 
indicating that the calcium deposits are evenly distributed across the surface. Figure 2B (top) 
shows that similar results are obtained when repeated, demonstrating the reproducibility of 
the procedure. The SEM image of these samples in figure 2B (bottom) shows that all fibers 
are intact. The fiber surfaces are completely covered with a CP layer and even in-between 
the fibers CP deposits are present. Since ultrasonic immersion in demineralized water for 3 
seconds followed by treatment with the standard nucleation procedure results in a 
reproducible and homogenous CP coating without affecting the fiber integrity, ultrasonication 
was chosen as the activation method for the next experimental phase in which the nucleation 
step is optimized. 
 
Figure 2. A) top: Digital image of ARS stained sample after EtOH dipping and subsequent treatment 
with the standard nucleation procedure (SNP), bottom: SEM image of EtOH dipped samples, B) top: 
digital image of ARS stained samples after ultrasonication and subsequent treatment with the SNP, 
bottom: SEM image of samples after ultrasonic activation and subsequent treatment with the SNP. 
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2.3.2 Optimization nucleation step 
The conditions of the experiments generated by the simplex are given in table 1 
together with the mineralization score of the resulting samples. Based on the mineralization 
score and the morphology of the coated fibers, the samples obtained from the different 
experiments can be divided into three categories. 
 
a Samples with poor coating (score 0) 
The digital image of the samples treated with the parameters of experiment P-c 
shown in figure 3A is representative for all samples with a mineralization score of 0 (table 1). 
These samples remain mostly white after ARS staining. SEM images of the corresponding 
samples show that the fiber surface is not covered with a CP layer, only some local CP 
accumulations in-between the fibers are present.  
b  Samples with adequate mineralization (score 1)  
 Two experimental conditions result in an adequate coating of the PDLLA fibers (Ad-a 
and Ad-b; table 1). ARS stained samples prior treated with the experimental conditions of Ad-
a and Ad-b are pink (figure 3B and 3C top respectively). Although the intensity of staining is 
darker and more homogenous for the samples treated with the experimental conditions of 
Ad-b compared to Ad-a, on SEM images the difference is less pronounced (figure 3C and 3B 
bottom respectively). Both treatments result in a thin and homogenous CP coating of the 
fibers, without any excess of CP clogging the pores. 
c Samples with an excess of mineralization (scores 2 – 4) 
 Figure 3 shows the digital images of samples treated with the experimental conditions 
of experiment Exp-g (figure 3D), Exp-k (figure 3E) and Exp-s (figure 3F). These samples are 
scored 2, 3 and 4 respectively and are each representative for all samples with the same 
score. SEM images of samples rated with a mineralization score of 2 in figure 3D show CP 
accumulations in-between and on the fibers. Although locally some CP deposits obstruct the 
pores, the fibrous structure is still distinguishable. The latter is more difficult for samples 
rated with a mineralization score 3, where the pores are mainly obstructed with CP 
accumulations as the fibers are excessively covered with CP (figure 3E). In samples with a 
mineralization score of 4, the surface is completely covered with CP, pores and fibers are 
almost completely indistinguishable. The porous structure is completely compromised by the 
deposited CP (figure 3F).  
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Table 1. Conditions of the experiments used for the optimization of the calcium phosphate nucleation 
step. Based on the ARS staining and morphology of coating, experiments are assigned a 
mineralization score. The type of calcium phosphate deposited on the samples was identified using 
infrared (IR) spectrometry. 
 
  
                    
  
CaCl2.H2O Na2HPO4 
  
Exp No. Of Cycles 
Concentration 
(mM) 
Immersion 
Time (s) 
Concentration 
(mM) 
Immersion 
Time (s) Score IR 
    
SNP 6 1000 60 600 60 
 
4 CDAp 
P-a 8 412 50 632 175 0 - 
P-b 6 41 70 148 120 0 - 
P-c 2 1000 120 750 120 0 - 
Ad-a 6 82 35 295 120 1 CDAp/DCPD 
Ad-b 4 750 120 100 60 1 CDAp 
Exp-a 9 118 15 574 250 2 CDAp 
Exp-b 6 1000 120 250 120 2 CDAp 
Exp-c 4 479 60 646 185 2 CDAp 
Exp-d 7 439 40 189 90 2 CDAp 
Exp-e 4 456 55 677 255 2 CDAp 
Exp-f 6 146 60 347 215 2 CDAp 
Exp-g 6 164 70 590 240 2 CDAp 
Exp-h 6 288 25 642 280 3 CDAp 
Exp-i 8 207 60 663 185 3 CDAp 
Exp-j 6 82 70 295 240 3 CDAp 
Exp-k 6 743 90 639 135 3 CDAp 
Exp-l 6 705 50 704 155 3 CDAp 
Exp-m 8 575 60 603 160 4 CDAp 
Exp-n 6 164 35 590 120 4 CDAp 
Exp-o 7 461 20 947 150 4 CDAp 
Exp-p 6 250 120 750 120 4 CDAp 
Exp-q 6 1000 30 750 120 4 CDAp 
Exp-r 10 700 85 690 85 4 CDAp 
Exp-s 8 580 70 666 70 4 CDAp 
Exp-t 6 375 85 699 160 3 CDAp/DCPD 
Exp-u 6 312 30 610 215 3 CDAp/DCPD 
Exp-v 6 1000 120   750 30   4 CDAp/DCPD 
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Figure 3. Digital image of ARS stained samples (top) and SEM images (bottom) of samples after 
treatment with the parameters of experiment A) P-c (mineralization score 0) B) Ad-a and C) Ad-b 
(mineralization score 1), D) Exp-g (mineralization score 2), E) Exp-k (mineralization score 3) and F) 
Exp-s (mineralization score 4). 
2.3.3 FTIR analysis  
 The type of CP deposited on all samples with a mineralization score from 1 to 4 is 
identified by FTIR (table 1 and figure 4). Based on the band profiles of the IR spectra, two 
types of CP are detected; slightly carbonated calcium-deficient apatite (CDAp; Ca10-x-y(PO4)6-
x-y(HPO4)y(CO3)x(OH)2-x-y) and a combination of CDAp and dicalcium phosphate dihydrate 
(DCPD; CaHPO4.2H2O). 
 The IR spectrum of the CP deposition on the samples after alternate dipping in Ca2+ 
and PO43- rich solutions according to the experimental conditions of SNP shows peaks due to 
the ν4-PO43- bending at 500 to 700 cm-1 and the ν1 and ν3 stretching of PO43- groups around 
970, 1045 and 1100 cm-1. These are typical peaks of an apatite phase. In addition, three 
weak peaks in the IR spectra at 870, 1425 and 1470 cm-1 indicate the presence of CO32- 
substituting for PO43- in the apatite lattice (so-called B-type CO32-) resulting in a slightly 
carbonated apatite phase. The CO32- is probably native from atmospheric CO2. 
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Figure 4. Infrared spectra 
of the CP coating on the 
samples treated with the 
experimental conditions of 
experiment SNP, Exp-l, 
Exp-v and Exp-t. For 
comparison the IR spectra 
of apatite (Ap) and DCPD 
are shown. CO32- 
absorptions are marked by 
*, HPO42- absorptions are 
marked by + and the 
typical peaks of DCPD are 
marked by #.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The FTIR spectrum of the CP coating on the sample treated with experimental 
conditions of Exp-l is representative for the spectra of the CP present on the samples treated 
with the experimental conditions of Ad-b and Exp-a – Exp-s (figure 4). In these spectra the 
typical peaks of a slightly carbonated apatite are also found. However, the low intensity of the 
CO32- signal at 1425 and 1470 cm-1 compared to that of the signal at 870 cm-1 suggests that 
the peak at 870 cm-1 is not caused solely by the ν2 – vibration of CO32-. The peak at 870 cm-1 
can be mainly ascribed to the ν5-P-O(H) deformation in HPO42-. The presence of HPO42- 
substituting for PO43- in the apatite lattice is supported by the shoulder of the peak around 
530 cm-1. Apparently, the deposited CP is a slightly carbonated calcium-deficient apatite with 
a stoichiometry Ca10-x-y(PO4)6-x-y(HPO4)y(CO3)x(OH)2-x-y. The competition between HPO42- and 
CO32- for the substitution of PO43- then results in a CDAp with x>>y for the experimental 
conditions of SNP and in a CDAp with x<<y for the experiments Exp-l, Ad-b and Exp-a – 
Exp-s. 
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 Besides the typical peaks of CDAp, bands typical of DCPD are present in the FTIR 
spectrum of the CP depositions on samples treated with the experimental conditions of Exp-
v, (figure 4). The peaks at 530 and 580 cm-1 arise from O-P-O bending vibrations and those 
at 785, 860 and 1215 cm-1 indicate P-O(H) deformations of HPO42 in DCPD. The peaks 
around 984, 1060 and 1133 cm-1 can be assigned to PO43- stretching vibrations. At 665 cm-1 
the water peak arising from γOH vibrations in H2O is visible. The peak at 1645 cm-1 arises from 
the H – O – H deformations in water. The series of peaks at 3155, 3280, 3485 and 3540 cm-1 
arise from OH - stretching modes in H2O. These results suggest the deposited CP is a 
combination of CDAp and DCPD. 
 The combination of peaks typical for CDAp and DCPD can also be found in the 
spectra recorded for samples treated with the experimental conditions of Ad-a and Exp-t and 
u. The spectrum associated with Exp-t is shown in figure 4, and is representative for the 
spectra associated with experiments Ad-a and Exp-u. The intensity of the peaks typical for 
DCPD are lower than in the spectrum associated with Exp-v. Around 785, 860 and 1215 cm-
1
, the peaks arising from P-O(H) deformations in HPO42- - groups are slightly visible. The 
shoulders arising from the OH - stretching in H2O can be seen around 3155 and 3280 cm-1. It 
is clear that the CP coating on these samples is not a pure apatite but apatite in combination 
with a small amount of DCPD, the latter however to a lesser extent than on samples treated 
with the conditions of Exp-v. 
 
2.3.4 Cell viability on electrospun PDLLA fiber mats 
For the cell viability study samples are selected that are treated with the experimental 
conditions of Ad-b, Exp-q and Exp-v. These samples are coated with either an adequate 
amount of CDAp (Ad-b), an excess of CDAp (Exp-q) or an excess of a combination of Ap 
and DCPD (Exp-v). The corresponding SEM images are shown in figure 5A, 5B and 5C 
respectively. 
Figure 5. SEM images of the samples coated with  A) an adequate amount of CDAp, B) an excess of 
CDAp and C)an excess of a combination of CDAp and DCPD. These samples were used to assess 
the MC3T3-E1 cell viability. 
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The quantity of viable and attached MC3T3-E1 cells on the CP coated and untreated 
samples after 1 and 7 days, as reflected by the Presto BlueTM assay and expressed as a 
percentage of the positive control, is illustrated in figure 6. At day 1 and day 7, the amount of 
attached cells on the untreated PDLLA samples is less than 5% of the positive control. After 
1 day of incubation there is no significant difference between the untreated samples and the 
samples coated with an excess of CP. The number of attached cells on the samples coated 
with an adequate amount of CDAp, however, is significantly higher than on the untreated 
samples (p = 0.037). At day 7, the number of viable cells on all CP coated samples is 
significantly higher than on the untreated PDLLA (p ≤ 0.034). From day 1 to day 7 there is 
only a significant proliferation on the samples coated with an adequate amount of CDAp (p < 
0.001). The number of attached cells on these samples reaches 105% of the positive control, 
which is significantly higher than on the samples treated with an excess of CP (p < 0.001). 
Between the two samples coated with an excess of CP, there is no significant difference in 
the amount of viable cells (p = 0.262).  
Figure 6. Cell viability on 
untreated PDLLA and 
samples coated with an 
excess of CDAp and 
DCDP, an excess of 
CDAp and an adequate 
amount of CDAp after 1 
and 7 days of incubation. 
The cell viability was 
calculated as a 
percentage of the 
positive control at day 7 
of culture. 
 
 
After 24h of incubation, on the untreated samples (figure 7A) more dead cells are 
observed than on the CP coated samples (figure 7C-G). The cells are round and small on the 
untreated PDLLA samples, but show elongated morphologies on all CP coated samples.  
 After 7 days of incubation, the morphology of viable cells on the untreated samples 
(figure 7B) and on the samples treated with an excess of CP (figure 7D and 7F) remains 
more or less the same. On the untreated PDLLA samples, fewer dead cells are observed, 
but the majority of cells is still small and round (figure 7B). Cell attachment and spreading 
increases on samples coated with an adequate amount of CP (figure 7H). The morphology of 
the cells is similar to the morphology observed for cells in the confluent positive culture. 
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Figure 7. Morphology of MC3T3-E1 pre-osteoblast 
cells attached to untreated PDLLA fiber mats (A 
and B), samples coated with an excess of Ap and 
DCPD (C and D), samples coated with an excess 
of CDAp (E and F) and samples coated with an 
adequate amount of CDAp (G and H) after 1 day 
(A , C, E and G) and 7 days (B, D, F and H) of 
culture. Live cells are stained green and dead cells 
are stained red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4 Discussion 
In this study a porous 3D electrospun polyester structure coated with a thin and 
homogenous layer of apatite is made that can be a good substrate for cell adhesion and 
growth and has great potential as bone tissue engineering scaffold. Amorphous PDLLA is 
chosen due to its degradation time of 12 to 16 months in the human body which is adequate 
to ensure support during tissue regeneration without compromising the formation of new 
bone tissue.42,96,103 
Using the present electrospinning parameters, beadles and randomly oriented PDLLA 
microfibers with a narrow fiber diameter distribution were obtained with high reproducibility. 
The resulting irregular shaped pores had a rather large diameter of about 10 µm which could 
improve the transport of nutrients and metabolites through the scaffold and enables the 
infiltration of cells.124 
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In literature, the coating of PLA fibers is generally described as a two-step procedure 
of surface activation followed by mineralization in SBF. During initial surface activation, the 
fiber surface undergoes a hydrolysis which is known to result in enhanced hydrophilicity, as 
the result of an increase in the amount of carboxyl and hydroxyl groups on the surface.214 
Previous studies showed that in particular a high density of carboxyl groups on the fiber 
surface promotes the formation of a CP coating.211,214 Upon incubation in SBF, during the 
initial stages of nucleation, the interaction between calcium ions and carboxyl groups on the 
activated PDLLA surface might lead to the formation of a –[COO-Ca2+]+ or –(COO-)2Ca2+ 
through ion exchange. During subsequent soaking in sodium phosphate solution, it is 
expected that phosphate ions will interact with the calcium ions on the fiber surface.214 
For PDLLA, activation of the fiber surface is required as direct incubation of samples 
in 1.5xSBF did not result in a CP deposition after 6 days.207 Pre-immersion of the samples in 
EtOH resulted in a CP coating of the fibers upon incubation in 2xSBF for 7 days. However, 
an incubation period of 7 days in order to ensure adequate coating is quite long. Hence, the 
overall coating procedure needs optimization in order to reduce the time required to deposit 
an adequate amount of CP. One approach to accelerate the mineralization process is to 
perform a nucleation step using the alternate dipping technique instead of using SBF 
solutions. With this technique solutions can be used that contain much higher concentrations  
of calcium and phosphate ions than is possible in SBF solutions. 
2.4.1 Activation 
In literature described activation methods are the immersion in EtOH and/or NaOH, 
with or without ultrasonication. As reported previously for electrospun PDLLA, the immersion 
in NaOH resulted in severe degradation of the fibrous scaffold.195 According to Cui et al., 
immersion of PDLLA nanofibers (700 nm – 1 µm) in EtOH till soaked followed by an 
incubation in SBF for 6 days resulted in intact fibers with a homogenous CP coating.211 Even 
though the fibers in the present study are in the micrometer range (1.55 µm with a SD of 0.24 
µm), the present results showed that the PDLLA fibers were broken after 1 second dipping in 
EtOH (figure 2A). Destruction of the fibrous microstructure could affect the mechanical and 
degradation properties of the material which is not favorable for the bone tissue engineering 
scaffold potential of the material.214 Luickx et al. activated PCL electrospun samples using a 
combination of NaOH immersion under ultrasonication.217 As NaOH is unsuitable for PLA, 
the procedure was adjusted and samples were immersed in ultrapure water under 
ultrasonication. Upon treatment of the samples in an ultrasonic bath for 3 seconds followed 
by treatment with the standard nucleation procedure and ARS staining, samples stained 
uniform red (figure 2B top). SEM images confirmed that the fibers were completely covered 
with a layer of CP with accumulations on and in-between the fibers (figure 2B bottom). 
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Moreover, the fiber structure remained completely intact. The activation effects of ultrasound 
are mainly due to acoustic cavitation as bubble collapses near the material surface result in 
jets of liquid impinging at high velocity onto the surface. The acoustic cavitation apparently is 
able to cleave the ester bonds of the polyester and create carboxyl groups on the fiber 
surface. The micro-jets hitting the surface of the material also result in roughening of the 
surface which facilitates the rapid growth of CP compared to smooth surfaces.214,218,219 
Ultrasonic activation was selected for further experiments since this activation method results 
in a homogenous activation of the fiber surface without affecting the fiber morphology.  
2.4.2 Nucleation 
The current procedure of activation under ultrasonication followed by a nucleation 
step using an alternate soaking technique takes about 30 minutes which is a quite faster than 
the 6 days of incubation in the experiments of Cui et al.211 However, as treatment with the 
standard nucleation procedure also results in the deposition of CP particles in-between the 
fibers (figure 2B bottom), the nucleation procedure was further optimized in order to obtain a 
thin and homogenous layer of CP with preservation of the porous structure. 
The nucleation procedure was optimized using a variable simplex algorithm216 with 
specific emphasis on the reproducibility of the procedure and the thickness and uniformity of 
the deposited layer. The present study optimized the five parameters of the alternate dipping 
process simultaneously: the number of cycles, concentration of and immersion time in both 
the Ca2+ and the PO43- rich solutions (table 1).  
Based on the high number of experimental conditions resulting in samples with a high 
degree of mineralization (SNP and Exp-a – Exp-v), it can be assumed that once the samples 
were successfully activated a CP coating was easily deposited on the fiber surface. The 
challenge however was to limit the CP deposition in order to obtain a thin and homogenous 
CP layer on the fibers. ARS staining and SEM images show that only one specific 
combination of the five parameters result in the ideal conditions for the deposition of a 
homogenous, thin and reproducible CP coating on the PDLLA fibers (Ad-b). FTIR 
spectrophotometry reveals that the deposited CP coating obtained by treatment of the 
activated samples with the parameters of experiment Ad-b is CDAp (figure 4). SEM images 
of the corresponding samples show that the CP deposit results in a slight roughening of the 
fiber surface, which could indicate the nanocrystallinitiy of the CDAp crystals (figure 3C). 
CDAp nanocrystals are known to exhibit physicochemical characteristics similar to those of 
bone nanocrystals. Coating of PDLLA microfibers with nanoscaled CDAp crystals is thus 
expected to improve the cellular response as compared to untreated PDLLA. In addition, due 
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to their calcium deficiency, CDAp nanocrystals are more soluble and have an increased 
bioresorption rate in vivo compared to stoichiometric HAp.220,221  
The majority of the experimental conditions result in the deposition of CDAp (SNP, 
Ad-b and Exp-a – Exp-s) with the general formula Ca10-x-y(PO4)6-x-y(HPO4)y(CO3)x(OH)2-x-y. 
During the formation of CDAp there is a competition between CO32- and HPO42- for the 
substitution of PO43- in the apatite lattice. Substitution by HPO42- results in a more stable 
structure, which could explain the observation that only one experimental condition results in 
the deposition of a CDAp with x>>y (SNP; table 1). Beside CDAp some samples are coated 
with a combination of apatite and DCPD (Ad-a and Exp-t – Exp-v). 
Cui et al.211 found a linear relationship between the surface concentration of carboxyl 
groups and the amount of CP deposits. However,  all samples in the present study were 
subjected to the same activation treatment so that it can be assumed that they have an equal 
number of surface carboxyl groups. Variations in mineralization degree and the type of CP 
can then only be caused by variations in the parameters of the alternate dipping procedure. 
However, due to the interdependence of the five parameters in each nucleation experiment, 
no correlation can be found between the individual parameters and the resulting degree of 
mineralization nor the type of CP coating. Neither was there a correlation between the 
degree of mineralization and the type of CP deposited. Supposedly small variations in the 
Ca2+ – and PO43- concentrations and ratio will affect the pH of the solution surrounding the 
samples. This is in line with the observation that the precipitated calcium phosphate phase 
depends on the pH and the Ca/P ratio of the mineralization solution.7,222  
2.4.3 Cell viability study 
The cellular response to an implant is associated with a complex biological system 
that involves protein adsorption, protein-cell interactions and cell signaling pathways. The 
surface morphology and chemistry of the material influence the amount of protein adsorption 
which in turn controls cell attachment. Hence, the pore structure of the surface as well as the 
morphology and chemical composition of the CP coating will affect the cell viability of the 
substrate.156,223,224  
In the present study the influence of a CDAp coating on PDLLA electrospun samples 
on the cell viability of MC3T3-E1 cells was investigated. Samples with an open 
interconnected pore system were included in the study as well as samples with their surface 
completely covered with CDAp. To this end samples were treated with the experimental 
conditions of Ad-b and Exp-q respectively. In addition, in order to evaluate the influence of 
different types of CP coatings, samples treated with the experimental conditions of Exp-v 
resulting in an Ap/DCDP coating were also included in the study.  
Electrospun PDLLA scaffold 
112 
 
The amount of cells attached on the untreated PDLLA samples is low throughout the 
experiment. The cells are not well attached to the surface even after 7 days of culture (figure 
6, 7A and 7B). The observed cellular behavior could be expected due to the hydrophobic 
nature of the untreated PDLLA samples. The hydrophobicity hinders the initial biological 
responses, such as protein adsorption, impeding cell attachment.156 The activation and 
subsequent CP coating of the PDLLA nanofibers significantly enhances the MC3T3-E1 cell 
response after 7 days of culture (figure 6). After one week of culture, samples coated with an 
adequate amount of CDAp showed a significant higher number of viable cells compared to 
the two samples coated with an excess of CP. This could be expected due to the critical role 
of scaffold porosity in cell seeding and proliferation.50,104  
DCPD was expected to show a poor cell response as it is known to increase the Ca2+ 
and PO43- concentration of the culture medium upon incubation due to its high solubility.156 
However, no significant difference in cell viability could be seen between the samples coated 
with an excess of CDAp and an excess of CDAp/DCDP. During incubation in the culture 
medium, the small fraction of DCDP in the coating most probably is converted rapidly to the 
more stable apatite, which could explain the similar results for both samples coated with an 
excess of CP.225 
Based on the excellent results of the osteoblast viability study, CP coating of PDLLA 
microfibers with CDAp is a promising strategy for the improvement of the bone tissue 
engineering scaffold potential of electrospun PDLLA. Compared to other reports involving the 
mineralization of PDLLA by incubation of the samples in SBF for prolonged periods of time, 
the optimized procedure described in the present study results in a rapid, reproducible and 
uniform coating of the PDLLA microfibers. 
2.5 Conclusion 
 In the present study, the coating of an electrospun PDLLA microfibrous scaffold with a 
thin homogenous layer of CP was optimized. In a simple two-step procedure an adequate 
coating was achieved after 20 minutes. In the first step, the polymer surface was uniformly 
activated without any obvious change in the fiber structure. In the second step, the fibers 
were coated with a homogeneous, thin and reproducible CDAp layer, with preservation of the 
porous structure. Such CDAp coating on the surface of the PDLLA nanofibers drastically 
improved the osteogenic response and enhanced the cell affinity when compared to the 
uncoated PDLLA samples.  
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3 Calcium phosphate coating of a 3D plotted PCL scaffold 
 
Part of the research is based on the article: 
3D plotted poly(ε-caprolactone) scaffolds coated with hydroxyapatite with high 
carbonate content for bone tissue engineering applications.  
Nathalie Luickx, Natasja Van den Vreken, Felke Steijns, Nicolas Van Damme, Kim Ragaert, 
Heidi Declercq, Maria Cornelissen, Ronald Verbeeck. 
Article submitted to Biomedical Materials 
 
Abstract: There is a strong need for bone scaffolds to serve as  temporary constructs to 
restore the function of critical sized bone defects. In this study, 3D plotting was used for the 
production of porous poly(ε-caprolactone) (PCL) scaffolds.  In order to enhance the 
bioactivity, the present study aimed to coat the scaffolds with an apatite layer with high 
carbonate content using experimental simulated body fluid (SBF) solutions. In a preliminary 
study the pH and the hydrogencarbonate (HCO3-) and magnesium (Mg2+) contents of 
experimental SBF solutions were studied in relation to the type of calcium phosphate and the 
carbonate content of the precipitates formed in these solutions. SBF solutions in which 
hydroxyapatite precipitates with a high carbonate content (≤ 10.5 wt%) formed were selected 
for the coating of the PCL scaffolds. On one hand, the apatite coating was thicker and more 
homogenous when formed in SBF solutions with a low pH compared to SBF solutions with a 
higher pH. On the other hand, the carbonate content of the coating increased with increasing 
HCO3- concentration of the SBF solution, and was the highest when the solutions were 
deprived of Mg2+. Analysis of the cell viability, adhesion and proliferation of MC3T3-E1 cells 
on 3D plotted PCL scaffolds coated with hydroxyapatite with different carbonate contents 
showed that a carbonate content of at least 10 wt% carbonate improved the osteogenic cell 
response when compared to uncoated PCL scaffolds and scaffolds coated with a 
hydroxyapatite with a low carbonate content. 
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3.1 Introduction 
 Despite the high regenerative capacity of bone, the body is incapable of self-healing 
in case of a critical sized bone defect caused by severe trauma or after a bone tumor 
resection. In such a case a surgical intervention is needed. One approach to restore and 
maintain tissue function is the insertion of a porous three-dimensional (3D) biodegradable 
scaffold that serves as a temporary 3D replacement of the extracellular matrix, providing a 
mechanical platform to support adhesion, proliferation and differentiation of cells. While new 
bone tissue is generated, the scaffold slowly degrades in non-toxic components and 
eventually only new, functional and healthy tissue remains.15,24,41  
Material choice, design and fabrication of tissue scaffolds are still challenging topics 
in regenerative medicine, particularly for load bearing scaffolds in bone tissue engineering. 
Multiple biological properties must be met, such as biocompatibility, bioactivity and 
osteoconductivity.20,27 The mechanical strength of the scaffolds should be similar to that of 
the surrounding tissue so that the scaffold can provide a dimensional stability in the body.41 A 
non-negligible aspect in the fabrication of a bone scaffold is the internal geometry; 
interconnecting pores with a size ranging from 100 to 400 µm are necessary to assure cell 
and tissue infiltration and nutrient and metabolite diffusion.226,227  
Preferentially the shape of the scaffold should perfectly fit into the tissue defect of the 
individual patient. The first step to design such a patient-specific scaffold is creating a 3D 
digital image of the defect by means of computed tomography (CT) scanning. Computer 
aided design/computer aided manufacturing (CAD/CAM) software converts this obtained 
virtual object into a sequence of slices and this digital information can then be transferred to 
a rapid prototyping (RP) machine.127,228 During the last decade, tissue engineering has 
benefited from the development of RP techniques, which resulted in the production of free-
form porous scaffolds with custom-tailored architectures. A solid model corresponding to the 
real 3D object is built layer-by-layer.127,229 Various RP techniques are available. They differ in 
the materials that can be used and in the way the materials are deposited to form a 3D 
object.46,70,230  
 The Food and Drug Administration (FDA) approved family of aliphatic poly(α-esters) 
such as poly-(lactic acid) (PLA), poly-(glycolic acid) (PGA), poly-(ε-caprolactone) (PCL) and 
their copolymers are widely used as scaffolding material. These polymers are biocompatible 
as they do not elicit an inflammatory response and their non-toxic degradation products are 
excreted from the human body along natural pathways. Degradation kinetics, mechanical 
properties and crystallinity can be tailored by varying the molecular weight and 
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copolymerization.89,231 Due to their thermoplasticity, they can be processed by melting and 
subsequent shaping, after or during which the polymer solidifies.  
 One way to process thermoplastic polyesters is 3D plotting, a micro-extrusion type RP 
technique. 3D plotting allows the fabrication of scaffolds with customized shape, filament 
diameters (typically between 100-500 µm), and controllable porosity, in both geometry and 
interconnectivity.66,232,233 For 3D plotting, processing of the polyester starts from the base 
granulate material which has the advantage of working without a solvent, excluding the use 
of difficult to remove and/or cytotoxic solvents.234 Moreover, scaffolds created by 3D plotting 
commonly show superior control over mechanical properties and structural integrity when 
compared to the solution-based counterparts of the same polymer.134 
 Several authors have reported the application of the 3D plotting technique in the 
production of PCL 67,227,235 and PLA 66 scaffolds. However, due to the thermal vulnerability of 
PLA, the use of this polyester with the 3D plotting technique is limited. When heated for an 
extended time above the melting temperature, chain scissions may occur, effectively 
degrading the material.236 Therefore, in the current study PCL is selected because of its 
favorable properties for thermoplastic processing due to its high thermal stability.96 The 
melting point of 60°C and high decomposition temperature of 350°C of PCL allow a wide 
range of extrusion temperatures.237 In addition, PCL has a long degradation time in the 
human body (> 24 months), which is needed to maintain the desired mechanical properties 
for larger constructs. However, the large pore sizes and highly symmetrical geometrical 
designs of 3D plotted scaffolds often lead to a low seeding efficiency. So, Declerq et al. 205 
showed that the scaffold design, the pore size and geometry in particular, had an impact on 
the seeding efficiency, colonization and differentiation of MC3T3-E1 pre-osteoblastic cells. In 
scaffolds with a 0°/90° design, the open channels and relatively large pore sizes resulted in 
low seeding efficiency due to significant cell loss. More compact scaffold architectures, with a 
0°/45°/90°/-45° design and a pore size of 100-150 µm, positively influenced the seeding 
efficiency and differentiation. 
Another disadvantage of especially PCL scaffolds, is their hydrophobic nature, which 
hinders the initial biological responses, such as protein adsorption, making it difficult for the 
cells to adhere to the polyester surface.60,150,238,239 In order to improve the bioactive properties 
of PCL scaffolds, coating of the PCL surface with a bone-like apatite mineral has been 
reported.85,146,147,150,182,183,240 In general, the mineralization of PCL scaffold is achieved in three 
consecutive steps: activation, nucleation and maturation. During the activation step, reactive 
hydroxyl and carboxyl groups are created on the polyester surface by cleavage of the ester 
bonds. This step reduces the hydrophobicity and improves bioactivity of the scaffold.69,157 
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Oyane et al.183 showed that activation of the PCL surface is imperative for subsequent 
calcium phosphate coating. In the second step, scaffolds are alternately dipped in calcium – 
and phosphate rich solutions. During this step, calcium phosphate nuclei are deposited onto 
the PCL surface.69,157,183 In a final step, the scaffolds are incubated in a simulated body fluid 
(SBF) solution with a similar inorganic content as human blood plasma (Table 1). SBF, 
introduced by Kokubo et al.170, is a metastable and  slightly oversaturated solution with 
respect to apatite. Incubation of the pre-treated PCL scaffolds in SBF results in the 
deposition of a calcium phosphate layer on the scaffold.167 The coating is initiated by a 
process of heterogeneous nucleation of calcium phosphate clusters that aggregate, grow 
and mature at the PCL surface.167,241 PCL scaffolds fabricated with various techniques 
including electrospinning 177,210, fused deposition modeling 157,242, film blowing 151 and solvent 
casting 243 were successfully coated with a surface mineral layer. The coated scaffolds 
showed improved cell attachment and proliferation when compared to pure PCL 
scaffolds.119,151,157 However, a limited number of studies on the calcium phosphate coating of 
3D plotted PCL scaffolds have been reported.85 
 Because the mineral phase of bone tissue is a low crystalline carbonate substituted 
apatite with a carbonate content of 3.2 – 13 wt%, the PCL scaffold should ideally be coated 
with a bonelike carbonated apatite. In addition, carbonate incorporation in apatites enhances 
the solubility near physiological pH and hence the bioresorbability. Several studies showed 
that the cell adhesion, proliferation and metabolic activity of osteoblasts was increased on 
apatites with a high carbonate content (> 11 wt%), compared to hydroxyapatite.152,244 
However, in standard SBF, the concentration of hydrogencarbonate ions (4.2 mM) is much 
lower when compared with that of plasma (27 mM). As a result, precipitates and coatings 
formed in such SBF solutions have a low carbonate content (~ 2.5 wt%) and hence a slow 
bioresorption rate.245,246  Hence, increasing the carbonate content of the precipitated calcium 
phosphate by SBF maturation has become a topic of interest. Experiments with SBF 
containing higher concentrations of hydrogencarbonate ions were performed and the 
precipitates obtained from such solutions appeared to be more similar to the calcified 
tissues.243,244,246 However, coating of 3D plotted PCL scaffolds with a calcium phosphate 
coating with high carbonate content has not been studied.  
The present paper reports on the surface mineralization of 3D plotted PCL scaffolds 
with a homogenous calcium phosphate layer with a high carbonate content. In a preliminairy 
study, various experimental SBF solutions with varying carbonate and magnesium ion 
concentrations and pH were prepared. The influence of the carbonate and magnesium 
content and the initial pH of the SBF-like solution on the composition of the precipitates was 
analyzed. Actual coating was obtained by maturation of the PCL scaffolds in SBF-like 
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aqueous solutions, in which apatites with a high carbonate content were found to precipitate. 
The influence of the carbonate and magnesium content and the initial pH of the SBF-like 
solution on the coating formation and composition was analyzed. In an in vitro study, the 
adhesion and proliferation of pre-osteoblastic cells (MC3T3-E1) on PCL scaffolds coated with 
calcium phopshate with a low, medium and high carbonate content were compared. 
3.2 Materials and Methods 
 Freshly prepared demineralized water (Milli-Q system, Millipore, Billerica, USA) was 
used for the preparation of the solutions. PCL pellets were provided by Perstorp (Perstorp, 
Sweden). Ethanol (technical grade 95 vol.%), sodium hydroxide solution (NaOH; 1 M), 
sodium chloride (NaCl), tris(hydroxymethyl)aminomethane (TRIS) and acetone were 
obtained from VWR BDH Prolabo (Leuven, Belgium). Sodium bicarbonate (NaHCO3), 
disodium phosphate (Na2HPO4), potassium phosphate dibasic (K2HPO4), magnesium 
chloride (MgCl2.6H2O), hydrochloride (HCl; 37 vol.%), sodium sulfate (Na2SO4) and 
chloroform were purchased from Merck (Darmstadt, Germany) and potassium chloride (KCl) 
and calcium chloride (CaCl2.2H2O) from J.T. Baker (Deventer, The Netherlands). 
3.2.1 Scaffold production 
Samples were produced by 3D plotting using the BioScaffolder device (SysEng, 
Salzgitter-Bad, Germany). Optimization of the processing parameters was carried out by 
Ragaert et al.66. In short, PCL pellets are molten at 100°C after which the melt is transported 
forward by a rotating extrusion screw (15 rpm) and pressed through a 27 gauge needle (200 
µm). Regular filaments are deposited at a constant plotting feed (F) of 115 mm/min on a 
plotting table at room temperature. For this study, samples of 1 x 1 cm² were plotted in four 
consecutive layers each with a relative orientation of 45°, resulting in scaffolds with a 
0°/45°/90°/-45° overlay pattern. Digital images of the fabricated scaffolds were obtained with 
a Keyence 3D microscope (VHX-500F; Elmwood Park, US). Image analysis software 
(SigmaScan Pro 5, SPSS Science, Chicago, US) was used to determine the average 
filament diameter (FD) and strand distance (SD). For each parameter, measurements of five 
random locations on the scaffold were averaged.  
3.2.2 SBF  precipitation study 
3.2.2.1 Preparation of the experimental SBF solutions 
Based on the composition of 2xSBF, with ion concentrations adjusted to twice those 
of normal SBF, various SBF solution were prepared by changing the ion concentrations of 
Mg2+ and HCO3- ions as summarized in Table 1. The Mg2+ and HCO3- concentration were 
varied between 3 mM – 0mM, and 21 mM – 84 mM, respectively. In order to maintain all 
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other ion concentrations equal to those in 2xSBF, it was necessary to adjust the Cl- 
concentration (Table 1). 
Table 1: Ion concentration of human blood plasma (HBP), normal SBF, two times concentrated SBF 
(2xSBF) and the experimental 2xSBF solutions (xCyM) with varying concentrations of carbonate- (xC), 
magnesium- (yM) and chlorine-ions.  
 Ion concentration (mM) 
SBF solution     	
 
 
 
 
HBP 142.0 5.0 1.5 2.5 103.0 27.0 1.0 0.5 
SBF 142.0 5.0 1.5 2.5 147.8 4.2 1.0 0.5 
2xSBF 284.0 10.0 3.0 5.0 206.0 8.4 2.0 1.0 
21C3M 284.0 10.0 3.0 5.0 283.0 21.0 2.0 1.0 
21C2M 284.0 10.0 2.0 5.0 281.0 21.0 2.0 1.0 
21C1M 284.0 10.0 1.0 5.0 279.0 21.0 2.0 1.0 
21C0M 284.0 10.0 0.0 5.0 277.0 21.0 2.0 1.0 
42C3M 284.0 10.0 3.0 5.0 262.0 42.0 2.0 1.0 
42C2M 284.0 10.0 2.0 5.0 260.0 42.0 2.0 1.0 
42C1M 284.0 10.0 1.0 5.0 258.0 42.0 2.0 1.0 
42C0M 284.0 10.0 0.0 5.0 256.0 42.0 2.0 1.0 
63C3M 284.0 10.0 3.0 5.0 241.0 63.0 2.0 1.0 
63C2M 284.0 10.0 2.0 5.0 239.0 63.0 2.0 1.0 
63C1M 284.0 10.0 1.0 5.0 237.0 63.0 2.0 1.0 
63C0M 284.0 10.0 0.0 5.0 235.0 63.0 2.0 1.0 
84C3M 284.0 10.0 3.0 5.0 220.0 84.0 2.0 1.0 
84C2M 284.0 10.0 2.0 5.0 218.0 84.0 2.0 1.0 
84C1M 284.0 10.0 1.0 5.0 216.0 84.0 2.0 1.0 
84C0M 284.0 10.0 0.0 5.0 214.0 84.0 2.0 1.0 
 
Each experimental 2xSBF solution was prepared by mixing calculated volumes of 
concentrated solutions of NaCl, KCl, Na2HPO4, MgCl2.6H2O, CaCl2.2H2O and Na2SO4, in that 
order.  During stirring the pH was adjusted to 5±0.1 for the experimental 2xSBF solutions at 
low pH and to 7.75±0.05  for the solutions at high pH by adding 1 M HCl and/or 1 M NaOH 
solution. Next, a calculated amount of NaHCO3 was dissolved in order to obtain a 2xSBF 
solution with a carbonate concentration of 21 mM, 42mM, 63mM or 84mM (21C, 42C, 63C 
and 84C respectively). 
3.2.2.2 Incubation of the solutions 
Twenty ml of each solution was placed in a container thermostated at 37°C under 
dynamic conditions (50 rpm) for seven days. The precipitates formed during incubation were 
filtered through a Millipore filter (22 µm), washed three times with demineralized water, dried 
at 37°C and weighted. All experiments were conducted in duplo.  
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3.2.2.3 Analysis of the precipitates 
The morphology of the precipitates was analyzed using SEM (FEI Quanta 200 F, 
Hillsboro USA). Prior to the SEM measurements, the samples were coated with gold using a 
sputter coater (Balzer Union Highland Scientific SCD 030, Bedford, UK). The dimensions of 
the crystal aggregates were measured using digital imaging software (SigmaScan Pro 5.0, 
SPSS Science, Chicago, USA).  
The phase composition of the precipitates was identified with Fourier transform infra-
red spectroscopy (FT-IR, Spectrum One, Perkin Elmer Instruments, Waltham, USA). IR 
spectra of the precipitates dispersed in KBr tablets were recorded between 400 and 4000 cm-
1
. The carbonate content of the precipitates was determined by gas chromatography (Model 
8500, Perkin Elmer Instruments) based on the method of Godinot et al. 247. As such, a 
calculated amount of precipitate was dissolved by adding 10% H3PO4 (Merck) in a closed 
vial. The incorporated carbonate in the specimens is released as CO2 which is injected in the 
gas chromatograph. Florida Rock with 3.81 wt% carbonate was used as standard to obtain 
the calibration curve. 
3.2.3 Influence of ionic composition of the SBF solution on the calcium phosphate 
coating  
3.2.3.1 Pre-mineralisation treatment 
In order to induce a hydrophilic surface, each sample was immersed in 20 ml ethanol 
for 1 minute after which the PCL samples were washed with 40 ml demineralized water for 5 
minutes. Next, each sample was transferred into a plastic container filled with 20 ml 1 M 
NaOH solution, which was placed in an ultrasonic bath (Transsonic T700/H, Elma Ultrasonic, 
Ruiselede, Belgium) at 37°C for 15 minutes. After this activation treatment the samples were 
transferred into a plastic container filled with 40 ml demineralized water and placed in the 
ultrasonic bath at 37°C for 5 minutes.  
To enable the deposition of small calcium phosphate nucleates, the activated 
samples were alternately immersed in Ca2+ and PO43- rich solutions using a standard 
nucleation procedure. During this procedure, each sample was first dipped in 50 ml of 200 
mM CaCl2.2H2O solution for 1 minute, washed with 50 ml demineralized water for 30 
seconds, dipped in 50 ml 200 mM Na2HPO4 solution for 1 minute and washed again for 30 
seconds with 50 ml demineralized water. The alternate dipping process was conducted at 
room temperature and automated using a dipcoater (RDC30 Multidip, Bungard, Windeck, 
Germany). The treatment cycle of four steps was repeated five times and all solutions were 
stirred regularly at 250 rpm during the procedure. 
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3.2.3.2 SBF maturation 
Experimental 2xSBF solutions in which apatite with a high carbonate content (> 10 
wt%) was found to precipitate, were selected for a maturation study. After treatment of the 
samples with the pre-mineralization procedure, each sample was incubated in 20 ml 
experimental 2xSBF solution at 37°C under dynamic conditions (50 rpm). The solution was 
refreshed after 4 days of incubation. After 7 days of incubation, the PCL samples were 
washed extensively with demineralized water and dried overnight at room temperature. All 
experiments were conducted in triplicate. 
The amount, homogeneity and morphology of the calcium phosphate coating was 
analyzed by measuring the weight of the samples, Alizarin Red S staining (ARS; Sigma-
Aldrich) and SEM imaging, respectively. ARS powder was dissolved in demineralized water 
to a final concentration of 40 mM and the pH was adjusted to 4.1 using 1 M NaOH solution. 
The scaffolds were stained an a glass cover plate with an excess of ARS solution for 10 
minutes after which the scaffolds were rinsed repeatedly with demineralized water to wash 
off all unbound dye. At pH 4.1 ARS stains the surface of filaments coated with a calcium 
containing layer red. The color intensity is linearly correlated with the local calcium 
concentration.248  
For the identification of the coating with IR spectroscopy, the polymer scaffold was 
dissolved. Samples were immersed in 1 ml chloroform for 10 minutes and after centrifugation 
(2 minutes, 7000 rpm) the supernatant was removed. This step was repeated once. Next, 1 
ml acetone was added to the remaining calcium phosphate powder and after centrifugation 
(2 minutes, 7000 rpm) the supernatant was removed. After repeating this step once, the 
powder was dried overnight at room temperature and analyzed with IR spectroscopy (see 
3.2.2.3). 
3.2.4 Cell culture tests 
3.2.4.1 Cell culture and seeding 
Monolayers of MC3T3-E1 pre-osteoblasts (mouse calvaria pre-osteoblast cells, 
ATCC) were cultured in α-minimum essential medium (α-MEM) (glutaMAX-1TM, Gibco 
Invitrogen, Ghent, Belgium) supplemented with 10% fetal bovine serum (FBS) (heat 
inactivated, EC approved, Gibco Invitrogen) and 1 mM sodium pyruvate (Gibco Invitrogen) at 
37°C in 95% air/5% CO2 . The medium was changed twice a week.  
 Three sets of calcium phosphate coated 3D plotted PCL samples were selected for 
the cell viability study; samples coated with a homogenous apatite layer with a low, 
intermediate and high carbonate content. Untreated 3D plotted PCL samples were used as 
control. Calcium phosphate coated and untreated samples were sterilized under UV-light for 
30 minutes. After sterilization the samples were placed in 48-well tissue culture dishes 
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(suspension culture plates, Greiner Bio-One, Frickenhausen, Wemmel, Belgium). To each 
sample either 300,000 or 40,000 MC3T3-E1 cells, diluted in 500 µl culture medium, were 
added, for the live/dead staining and PrestoBlueTM-assay (Invitrogen), respectively. For both 
techniques, either 300,000 or 40,000 MC3T3-E1 cells, diluted in 500µl culture medium, were 
added to an adhesion plate (Nunc, Life Technologies, Merelbeke, Belgium) as positive 
control. The cell/scaffold constructs and the positive controls were cultured for 28 days 
(5%CO2/95% air, 37°C) with the medium changed twice a week. 
3.2.4.2 Cell viability and morphology 
The PrestoBlueTM-assay was applied to quantify the number of viable cells that 
attached on the calcium phosphate coated and untreated samples after 1, 7, 15, 21 and 28 
days of culture. The PrestoBlueTM-reagent is a blue resazurin-based non-fluorescent solution. 
Resazurin enters the cells where it is transformed to the red and fluorescent resorufin by the 
reducing power of the mitochondria.  
 The samples and the control were rinsed with culture medium after which 450 µl 
culture medium and 50 µL PrestoBlueTM-reagent was added to each well. After 2 h 
incubation at 37 °C in a dark room, 400 µl medium was transferred to 24-well dish (Greiner 
Bio-One). The fluorescence of the medium was measured in a multilabel plate reader 
(Victor³, Perkin-Elmer) (excitation: 560 nm, emission: 590 nm). The number of viable and 
attached cells is linearly correlated with the signal, and viability was calculated as a 
percentage of the positive control of the respective day. 
Cell viability and morphology after 1, 7, 15, 21 and 28 days on the calcium phosphate 
coated and untreated samples was visualized using fluorescence microscopy after 
performing live/dead staining with calcein acetoxymethyl (AM) ester (Tebu-Bio, Boechout, 
Belgium) and propidium iodide (PI) (Sigma-Aldrich). PI cannot pass through intact cell 
membranes, but may freely enter dead cells with compromised cell membranes where PI 
intercalates into double-stranded DNA and emits red fluorescence (excitation: 488 nm, 
emission: 617 nm). Calcein AM is a non-fluorescent, membrane-permeable dye. Under 
intracellular esterase activity the dye converts to a membrane-impermeable, green 
fluorescent compound (excitation: 490 nm, emission: 520 nm). After 1, 7, 15, 21 and 28 days 
the samples and positive controls were rinsed with 500 µl phosphate buffered saline (PBS) 
after which 500 µl PBS containing 1 µl PI and 1 µl calcein AM was added to each well. After 
10 minutes incubation in a dark room at room temperature, samples were evaluated with a 
fluorescence microscope (Olympus Type U-RFL-T, Aartselaar, Belgium).  
Each material and the controls were tested in triplicate. 
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3.2.5 Statistical analysis 
 A 1-factor analysis of variance (ANOVA) in conjunction with Bonferonni’s post hoc 
test was used to compare the differences between the mean mass and the carbonate 
content of the precipitates. Cell viability was evaluated using 2-factor ANOVA with the 
substrate and the incubation time as independent variables. Significant differences between 
means were calculated using a Holm-Sidak multiple-comparison test. Differences among 
groups were considered as statistically significant at p < 0.05. 
3.3 Results 
3.3.1 Scaffold structural characterization 
The 0°/45°/90°/-45° overlay pattern of the produced scaffolds is shown in figure 1. 
The scaffolds of 1x1 cm² have an average weight of 36.04 mg (standard deviation (SD) = 
6.78 mg) and an average thickness of 614.23 µm (SD = 27.76 µm). The filament diameter 
(FD) is 191.67 µm (SD = 6.60 µm) with a strand distance (SD’) of 322.18 µm (SD = 35.99 
µm) (Figure 2C). The resulting pore diameter is 119.88 µm (SD = 31.25 µm). 
 
Figure 1: Microscopic (A, B) and SEM (C) images of the 3D plotted PCL scaffold: (A) Microscopic 
image of top view, (B) Microscopic image of side view, (C) SEM image with an indication of the 
filament diameter (FD) and the strand distance (SD’). 
3.3.2 SBF precipitation study 
All experimental 2xSBF solutions summarized in table 1 are prepared at low and high 
pH, indicated by the suffix L and H in the notation, respectively.  
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3.3.2.1 Influence of Mg2+ and HCO3- concentration on precipitate formation 
The mass of the precipitates formed in the experimental 2xSBF solutions at high and 
at low pH after 7 days of incubation is shown in figure 2. 
 
Figure 2: The amount of precipitate (mg/20 mL 2xSBF) formed after 7 days incubation in experimental 
2xSBF solutions with varying magnesium – and carbonate concentrations at low and at high pH. Error 
bars represent standard deviations. 
 
The amount of precipitate formed in the experimental 2xSBF solutions is not 
significantly influenced by the HCO3--concentration or the Mg2+- concentration. Incubation of 
the solutions at a high pH results in a higher amount of precipitates compared to incubation 
at low pH.  
Moreover, the morphology of the precipitates differs depending on the pH of the 
solution, as is demonstrated by the SEM images in figure 3, different precipitate structures 
were formed. Representatively, figure 4 shows the SEM images of the precipitates formed 
after 7 days in 42C3ML (Figure 4A) and 42C3MH (Figure 4B). The average diameter of the 
crystal aggregates is 0.48 µm (SD = 0.13 µm) and 48.21 µm (SD = 17.37 µm), respectively. 
Precipitates formed in experimental 2xSBF solutions at high pH consisted of significantly 
larger crystal aggregates compared to precipitates formed in the same 2xSBF solution 
incubated at low pH. 
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Figure 3: SEM micrographs of the precipitates formed after 7 days in 42C3M solutions at A) low pH 
and B) high pH. 
The carbonate content of the precipitates formed in the experimental 2xSBF solutions 
is summarized in table 2. The carbonate content tends to increase with increasing HCO3--
concentration in the solution at a given pH and Mg2+-concentration. This trend is less 
pronounced in solutions with a low pH and high Mg2+-concentration. The carbonate content 
decreases with increasing Mg2+-concentration in the solution at a given HCO3--concentration 
and pH. This trend is more pronounced at high pH and at higher HCO3--concentration in the 
solution. 
 
Table 2: Carbonate content of the precipitates formed after 7 days incubation in experimental 2xSBF 
solutions with varying magnesium and carbonate concentrations at low and at high pH. Standard 
deviation in brackets.  
 
 
 
  21 mM HCO3- 42 mM HCO3- 63 mM HCO3- 84 mM HCO3- 
  High pH Low pH High pH Low pH High pH Low pH High pH Low pH 
3 mM Mg2+ 7.39 (0.04) n.d. 8.06 (0.23) n.d. 8.48 (0.06) 8.22 (0.52) 10.54 (0.11) 11.79 (0.06) 
2 mM Mg2+ 8.37 (0.35) n.d. 10.24 (0.24) 7.74 (0.27) 10.55 (0.37) 7.53 (0.18) 10.71 (1.15) 12.04 (0.56) 
1 mM Mg2+ 7.74 (0.26) 7.56 (n.d.) 10.58 (0.12) 8.97 (0.40) 14.47 (0.03) 11.29 (0.23) 17.82 (1.13) 11.82 (0.06) 
0 mM Mg2+ 9.04 (0.09) 6.99 (0.337) 10.93 (0.28) 11.03 (0.19) 16.8 (1.91) 12.84 (0.65) 21.6 (0.78) 14.72 (0.62) 
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3.3.2.2 Identification of the precipitates 
Based on the band profiles of the IR spectra of the precipitates formed after seven 
days of incubation, four types of calcium phosphates are detected; carbonated amorphous 
calcium phosphate (ACP), B-type carbonated hydroxyapatite (B-type HAp), A-type and B-
type carbonated hydroxyapatite (A/B-type HAp) and a mixture of B-type hydroxyapatite and 
calcite (CaCO3) (B-type HAp/CaCO3). Figure 4 shows some IR-spectra representative for 
these precipitates. An overview of the experimental 2xSBF solutions and the resulting 
calcium phosphate phase is given in figure 5.  
 The IR spectrum in the precipitates formed in the 63COML and 42C2ML solutions are 
representative for the spectra of B-type HAp (Figure 4). These spectra show peaks due to 
the ν4-PO43- bending around 603 to 569 cm-1 and the ν3 stretching of PO43- groups around 
1045 and 1100 cm-1. These are typical peaks of a HAp phase. The peak around 1620 cm-1 
arises from the H – O – H deformations in water. Typical peaks in the IR spectra at 880, 
1420 and 1460 cm-1 indicate the presence of CO32- that substitutes for PO43- in the apatite 
lattice (B-type substitution). The intensity of these peaks increases with increasing carbonate 
content in the precipitates.152,179 The intensity of the peaks attributed to the presence of CO32- 
are higher in the spectrum of the precipitates formed in the 63C0ML solution compared to the 
ones found in the spectrum of the precipitates formed in the 42C2ML solution. This is in line 
with the carbonate content of these precipitates amounting to 12.84 wt% and 7.74 wt%, 
respectively (table 2).  
 The spectrum of A/B-type HAp is represented by the spectrum obtained from the 
precipitates formed in the 21C1ML solution (Figure 4). Besides the typical peaks of B-type 
HAp, additional bands around 1545 cm-1 and 1480 cm-1 are present. The latter indicates that 
some CO32- substitutes for OH- in the apatite lattice (A-type substitution).152,179  
 Besides the typical peaks of B-type HAp, a small but sharp CO32- peak at 720 cm-1 is 
present in the IR spectrum of the precipitate formed in the 84C0MH solution (Figure 4). This 
peak indicates the presence of CaCO3 as a separate phase.249 
 In the IR spectrum of the precipitates formed in the 63C3MH solution, the PO43- peak 
in the region 603 to 569 cm-1 are not resolved which is typical for the presence of an 
amorphous mineral phase. The peaks around 1460 cm-1 and 1420 cm-1 show the presence of 
CO32-, substituting for PO43-, in the amorphous calcium phosphate (Figure 4).  
 Figure 5 shows that experimental 2xSBF solutions with both a high Mg2+ and HCO3- 
concentration result in the precipitation of ACP. On the other hand, low Mg2+ and HCO3- 
concentrations result in the precipitation of HAp. A-type carbonate substitution in the HAp 
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lattice takes place when the HCO3- concentration in the SBF solutions is ≤ 42 mM, preferably 
when the Mg2+ concentration is low (≤ 1 mM). At higher HCO3- concentrations, only B-type 
carbonate substitution occurs. Apart from the B-type carbonated HAp, an additional calcite 
phase precipitates in SBF solutions with a high HCO3- concentration in combination with a 
low Mg2+ concentration. 
Figure 4: Infrared spectra of the precipitates formed in 42C2ML, 63C0ML, 21C1ML, 63C3MH and 
84C0ML experimental 2xSBF solutions after 7 days of incubation. For comparison, the IR spectra of 
hydroxyapatite (HAp) with a low carbonate content, amorphous calcium phosphate (ACP) and calcite 
are shown. Typical peaks of B-type substitution (CO32- for PO43- ) and calcite are marked by * and +, 
respectively. 
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Figure 5: An overview of the calcium phosphate phases precipitates in the experimental 2xSBF 
solutions after 7 days of incubation. A/B type HAp: A-type and B-type hydroxyapatite; B-type HAp: B-
type hydroxyapatite; B-type HAp/CaCO3: a combination of B-type hydroxyapatite and calcite; ACP: 
carbonated amorphous calcium phosphate. 
 
In general, the ratio R of the intensity of the IR peak of CO32- (Ac) at 1460 – 1420 cm-1 
and that of PO43- (Ap) at 1090 – 1050 cm-1 increases with increasing carbonate content (wt%) 
of the precipitate as shown in figure 6. A regression analysis demonstrates that the 
relationship between the ratio R=Ac/Ap and the carbonate content is represented at the 95% 
confidence level by the equation (with coefficient of determination R² = 0.924) 
.%  0.44	  1.18		 	27.9	  3.7	#                              (1) 
   
 
Figure 6: Linear relationship between average carbonate content (wt%) y of the precipitates formed in 
the experimental 2xSBF solutions and  the intensity ratio R of the CO32- and PO43- peaks in the 
associated IR spectra at 1460-1420 cm-1 and 1090-1050 cm-1, respectively. 
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3.3.3 Maturation study 
For the actual coating of the PCL scaffolds, only experimental 2xSBF solutions 
resulting in calcium phosphate precipitates were formed carbonate content of at least 10.5 
wt%, were selected. SBF solutions in which calcite co-precipitated were excluded from the 
maturation study. In order to investigate the effect of the HCO3- concentration of the 
experimental 2xSBF solution on the coating of PCL samples, 21C0ML was included in the 
maturation study. For comparison, a set of samples were coated by maturation in standard 
2xSBF.  
The results of the maturation study are summarized in Table 3. Based on the IR 
spectra used for the identification of the mineral coatings of the scaffolds, the carbonate 
content of the calcium phosphate deposited on the samples was determined using equation 
1. The precipitated calcium phosphate phases and their carbonate content analyzed in the 
precipitation study are also presented in Table 3 to allow comparison of the precipitate and 
the coating formed in the same experimental 2xSBF solution. 
Table 3 shows that maturation of the samples in SBF solutions with a lower pH result 
in a higher weight increase and a darker, more homogenous coloring of the samples after 
ARS staining compared to samples matured in SBF solutions with a high pH. 
The type of calcium phosphate deposited on the samples apparently depends on the 
HCO3- and Mg2+ concentration of the SBF solution. On the samples incubated in 2xSBF 
solutions with a high HCO3- and Mg2+ concentration, predominantly an ACP coating is 
deposited. However, compared to the results of the precipitation study, ACP is deposited on 
the samples at lower  HCO3- and Mg2+ concentration . Incubation of the samples in 2xSBF 
solutions with no Mg2+  ions in combination with a low HCO3- concentration, results in the 
deposition of  A/B-type or B-type HAp. The CO32-  content  of the coating is higher when 
incubation is carried out in SBF solutions with high HCO3-  concentrations. This trend is 
clearly seen for the experimental SBF solutions without Mg2+ and containing 21 mM, 42 mM 
or 63 mM HCO3-  (21C0ML, 42C0ML and 63C0ML, respectively) which result in a calcium 
phosphate coating with respectively 10.76, 12.71 and 15.50 wt% CO32-.  In general, the 
incorporation of  CO32- in the apatite lattice, seems to be easier during the coating process 
compared to precipitation.  
 
 
 
3D plotted PCL scaffold 
134 
 
Table 3: The experimental 2xSBF solutions used for the maturation study, ranked according to 
increasing weight increase (with standard deviation (SD)) of the samples after 7 days of incubation 
and digital images of the corresponding samples after ARS staining. For comparison, the type and the 
carbonate content of the precipitates formed in the SBF solutions are also given. 
n.d.: not determined 
a: determined by IR spectroscopy using equation 1 
 
 
 
Coating 
 
Precipitate 
 
Weight increase 
after 7 days (%) 
(SD) 
ARS CP phase wt% 
a
 
CO32- 
 
CP phase wt% CO32- 
84C3MH No weight increase 
 
n.d. 
 
ACP 10.54 
84C2MH No weight increase 
 
ACP 16.62 
 
ACP 10.72 
63C2MH No weight increase 
 
ACP 10.20 
 
B-type HAp 10.55 
42C1MH No weight increase 
 
B-type HAp 12.71 
 
A/B-type HAp 10.58 
42C0MH 0.6 (0.3) 
 
B-type 
HAp/CaCO3 n.d. 
 
A/B-type HAp 10.94 
84C2ML 1.5 (0.5) 
 
ACP 13.83 
 
ACP 12.05 
84C1ML 1.7 (0.6) 
 
ACP 11.87 
 
ACP 11.83 
63C1ML 2.2 (0.6) 
 
ACP 10.48 
 
B-type HAp 11.29 
2xSBF 10.2 (2.9) 
 
A/B-type HAp 4.62 
 
n.d. n.d. 
21C0ML 13.1 (1.3) 
 
A/B-type HAp 10.76 
 
A/B-type HAp 6.99 
63C0ML 15.2 (3.5) 
 
B-type HAp 15.50 
 
B-type HAp 12.84 
42C0ML 16.9 (1.1) 
 
B-type HAp 12.71 
 
A/B-type HAp 11.03 
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3.3.4 Cell culture tests 
For the cell viability study, samples were selected that are coated upon maturation in 
2xSBF, 21C0ML and 63C0ML. These samples are coated with HAp with a carbonate content 
of respectively 4.62, 10.76 and 15.50 wt%. The corresponding SEM images are shown in 
figure 7. The selected coatings represent an adequate weight increase (Table 3) and cover 
the filaments of the scaffolds homogenously, without compromising the porous structure. 
Figure 7: SEM images of the samples coated with HAp with (A) a high carbonate content of 15.50 
wt%, (B) a medium carbonate content of 10.76 wt% and (C) a low carbonate content of 4.62 wt%. 
The quantity of viable and attached MC3T3-E1 cells on the calcium phosphate coated 
and untreated PCL samples after 1, 7, 15, 21 and 28 days of culture, as reflected by the 
Presto BlueTM-assay, is illustrated in figure 8. 
  After 1 day of incubation, the number of viable cells on all calcium phosphate coated 
samples is significantly higher than on the untreated PCL samples (p < 0.001). For the 
calcium phosphate coated samples, the cell viability is significantly higher on the samples 
coated with HAp with a medium carbonate content (p ≤ 0.05). At day 7 the cell viability is still 
the highest on the samples coated with a calcium phosphate with a medium carbonate 
content, but it differs only significantly from the cell viability on the samples coated with HAp 
with a low carbonate content (p < 0.001). After 15, 21 and 28 days of culture, there is no 
significant difference in cell viability between the samples (p ≥ 0.115). At day 28, however, 
the cell viability on all calcium phosphate coated samples is clearly higher compared to the 
untreated PCL samples, but the difference is not significant. 
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 From day 1 to 15, there is a significant increase in the number of cells on the 
untreated PCL samples (p ≤ 0.001). The cell viability on the coated samples significantly 
starts to increase after 7 days of incubation for the samples coated with HAp with a low and 
medium carbonate content (p ≤ 0.004), and after 15 days of incubation for the samples 
coated with HAp with a high carbonate content (p < 0.001). The cell viability stagnates after 
21 days of culture, as there is no more significant increase in cell viability from day 21 to 28 
on any sample (p = 1). 
 
Figure 8: Cell viability of MC3T3-E1 cells on untreated PCL and samples coated with HAp with a low, 
medium and high carbonate content after 1, 7, 15, 21 and 28 days of incubation. The cell viability was 
calculated as a percentage of the positive control of the respective day. Statistical differences (p<0.05) 
in the cell viability are annotated with lines and as follows: *, statistically difference between samples 
at the same day of incubation; #, statistically difference between samples on consecutive incubation 
days. Error bars represent standard deviations. 
Figure 10 shows the morphology of the MC3T3-E1 pre-osteoblast cells after 15 days 
of culture on the positive control. Although the amount of viable cells differs only significantly 
after 1 day of culture among the calcium phosphate coatings, large differences in cell 
morphology can be observed when evaluating the PCL samples by fluorescence microscopy 
after live/dead staining (Figure 10).  
The number of cells on the untreated PCL samples is low throughout the experiment, 
with predominantly round and dead cells (Figure 10A-10E).  
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After 1 and 7 days of incubation, a rather small number of cells are visible on the 
calcium phosphate coated samples (Figure 10F, G, K, L, P and Q). The cells on these 
samples are small and round, with some cells forming cellular extensions. After 7 days the 
largest number of viable cells is present on the samples coated with HAp with a high 
carbonate content (Figure 10Q). 
At day 15, the cells present on the samples coated with a calcium phosphate with 
medium carbonate content are large with a star shaped morphology and form cellular 
extensions (Figure 10M). The samples coated with a low and high carbonate content show a 
similar image; the filaments in the top layer of the scaffolds are homogenously covered with 
viable cells, whereas on the filaments below, mostly dead cells are visible (Figure 10H and 
R, respectively). The cell number and cell morphology on the samples coated with a low 
carbonate content remains more of less the same after 21 days and 28 days of culture 
compared to 15 days of culture (Figure 10I and J, respectively). There is however a small 
increase in the live/dead cell ratio. 
For the samples coated with HAp with a medium and high carbonate content,  the 
number of viable cells increases after 21 days of culture (Figure 10N and S, respectively). 
The filaments are fully covered with viable cells, and some pores are even bridged by them. 
The morphology of the viable cells is similar to the morphology observed for the cells in the 
confluent positive culture (Figure 9), which indicates a good adhesion of the cells. 
After 28 days of culture, the filaments of the samples coated with HAp with a medium 
carbonate content are fully covered with well-attached cells (Figure 10O). On the samples 
coated with a HAp with a high carbonate content, the number of viable cells is stable 
compared to 21 days of culture. A large number of dead cells are however visible on the 
underlying layer (Figure 10T). 
Figure 9: Fluorescence micrographs after live/dead staining of MC3T3-E1 cell on the positive control 
after 15 days of culture. 
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Figure 10: Fluorescence micrographs after live/dead staining of MC3T3-E1 cells cultured on untreated 
3D plotted PCL scaffolds (A-E) and samples coated with HAp with a low carbonate content (F-J), a 
medium carbonate content (K-O) and a high carbonate content (P-T) for 1 day (A, F, K and P), 7 days 
(B, G, L and Q), 15 days (C, H, M and R), 21 days (D, I, N and S) and 28 days (E, J, O and T). 
Annotations: bridging of pores. 
3.4 Discussion 
A 3D plotted PCL scaffold with a 0°/45°/90°/-45° architecture and a pore diameter of 
120 µm is interesting as BTE scaffold to support cell adhesion and in-growth due to its 
adequate 3D and interconnected pore structure.205,226 Moreover, PCL is a biodegradable and 
biocompatible material that has been extensively studied as material for the fabrication of 
BTE scaffolds.239 However, due to its hydrophobic nature, PCL lacks bioactivity.250,251 In order 
to enhance the bioactivity and osteoconductivity of PCL scaffolds, coating of the surface with 
a homogenous layer of calcium phosphate is recommended.69,151,183  
To enable the deposition of a calcium phosphate layer, the PCL surface first needs to 
be activated. The activation procedure used in the present study was adopted from Luickx et 
al. 69 and included pre-wetting with ethanol and ultrasonic activation with a NaOH solution. 
During this two-step activation, the hydrophobicity of the scaffold is sufficiently reduced and 
functional groups are created onto the PCL surface, respectively. Following activation the 
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scaffolds are alternately dipped in calcium – and phosphate-ion rich solutions in order to 
deposit calcium phosphate nuclei on the surface. Finally, the scaffolds are incubated in an 
experimental SBF solution during which the calcium phosphate nuclei grow further in situ 
(maturation) to form a continuous layer on the PCL surface without compromising the porous 
structure of the scaffold. Ideally, the composition and structure of the calcium phosphate 
coating should be identical to bone apatite, which is a HAp with a high carbonate content. 
As it is well known that the composition of the calcium phosphate deposited in an 
aqueous solution is largely dependent on the solution composition, the effect of varying the 
magnesium and carbonate concentration, two inhibitors of apatite crystal growth, and the 
initial pH, on the coating formation and carbonate incorporation was investigated.   
3.4.1 Precipitation study 
In analogy with Barrere et al.186, a preliminary study was conducted to analyze the 
precipitates formed in the experimental SBF solutions, prior to the actual coating of the PCL 
samples. In this study, the composition of the experimental SBF solutions was based on the 
2xSBF solution of Kokubo et al. 167, in which the Mg2+-, HCO3-- and the Cl-- concentrations 
were adjusted. A double concentrated SBF solution (2xSBF) was preferred as in normal SBF 
nucleation and precipitation of calcium phosphates are rather slow 146,167,183,252, whereas in 
condensed SBF solutions (e.g. 5xSBF or 10xSBF) the chemical composition of the 
precipitates was found to be less similar to that of bone with increasing ion concentration 
252,253
. Compared to the recipe of Kokubo et al.167, TRIS buffer was not used in the 
experimental 2xSBF solutions. TRIS is not present in the human body and it has the 
tendency to affect the extent of mineralization significantly by forming complexes with various 
cations, including Ca2+ and Mg2+.174,253 In addition, NaHCO3 was added in powder form as a 
final step in the preparation of the experimental 2xSBF solutions. In this way, the loss of 
carbonate in the form of CO2 release, otherwise occurring upon the pH reducing step during 
preparation, was avoided.249,253   
The present study clearly shows that the initial pH of the solution strongly affects the 
calcium phosphate precipitate formation and structure. During preparation of the 
experimental 2xSBF solutions at high pH, precipitation occurred in the solution when the pH 
was augmented to the final pH of 7.75±0.05. A higher pH is associated with a significant 
decrease of the solubility of the calcium phosphate thus resulting in an advanced and 
accelerated nucleation and crystal growth in the solution.179,254,255 Accordingly, after 7 days of 
incubation, compared to the low pH, the high initial pH conditions resulted in more 
pronounced precipitation (Figure 2 and 3).  
3D plotted PCL scaffold 
140 
 
In some studies the HCO3- concentration of SBF solutions was increased in order to 
increase the carbonate content of the precipitated calcium phosphate.179,244 The highest 
HCO3- concentration used in literature, however, is 27 mM, as found in human blood plasma. 
The resulting calcium phosphate precipitates had a higher carbonate content compared to 
the precipitates formed in standard SBF, but with  a maximum of 9 wt%. In the present study, 
2xSBF solutions with HCO3- concentrations ranging from 21 mM up to 84 mM were used 
(Table 1), resulting in the formation of precipitates with a carbonate content of 7.39 wt% to 
21.6 wt% (Table 2). As might be expected, the carbonate content of the precipitates 
increased with increasing HCO3- concentration of the SBF solutions, corroborating with 
previous experiments.256-258 
In literature, little information is found on the combined effect of Mg2+ and HCO3- on 
the formation of calcium phosphate precipitates in SBF, neither on the effect of Mg2+ on the 
incorporation of CO32- in the lattice of the calcium phosphates. 
The Mg2+ and HCO3- concentration in the SBF solution also affected the type of the 
precipitated calcium phosphate (Figure 5). A high HCO3- concentration (≥ 42 mM) and the 
presence of Mg2+ (≥ 1 mM) resulted in the formation of ACP. The formation of ACP precursor 
clusters is always present during the precipitation of calcium phosphates from 
supersaturated solutions. Such clusters are the transient solution precursors for the 
formation of apatitic calcium phosphates.253 It has been reported that Mg2+ and HCO3- have a 
strong inhibitory effect on crystal growth and phase transition to apatite in favor of the 
amorphous phase.254  The inhibitory effect of Mg2+ has been attributed to its adsorption at 
active growth sites in competition with the chemically similar but larger Ca2+. Carbonate ions 
are known to inhibit apatite crystal growth as they enter the apatite lattice, substituting the 
anionic phosphate (B-type substitution) or hydroxyl groups (A-type substitution).7,249,259,260  
The order in which Mg2+ and HCO3-, individually or in combination inhibit crystal 
growth and hence decrease crystallinity and promote the formation of ACP is 
$%&  '()
&
 ≫ 	$%& ≫ '()
&

 
7,249
 
The synergistic effect of Mg2+ and CO32- on the formation of ACP probably results 
from the incorporation of both ions into the calcium phosphate structure.  
Low concentrations of the crystal growth inhibitors facilitate the phase transformation 
of the ACP precursor into the more stable and crystalline HAp (Figure 5). The present study 
showed that a decrease of the Mg2+ concentration in the SBF solution results in the formation 
of a calcium phosphate with a higher carbonate content (Table 2). This can be explained by 
the synergistic effect of Mg2+ and HCO3- on the crystallinity of the precipitated calcium 
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phosphate; higher Mg2+ - and HCO3- concentrations are known to inhibit the crystal growth of 
the formed calcium phosphate phase thus decreasing also the incorporation of CO32-. Hence, 
calcium phosphate precipitates with a high carbonate content are obtained by increasing the 
HCO3- concentration and decreasing the Mg2+ concentration of the SBF solution.           
The dominant form of carbonate incorporation in the apatite lattice is B-type 
substitution. A-type carbonated apatite in combination with B-type carbonated apatite 
precipitated in SBF solutions with 21 mM HCO3- and 42 mM HCO3- if the Mg2+ concentration 
is low (≤ 1 mM). These results corroborate the findings of Barralet et al.258 that carbonate 
was substituted into A and B-sites of the HAp lattice if the carbonate contents were low. At 
higher carbonate contents, the carbonate was located predominantly in the B-site. 
In the 2xSBF solution with high carbonate and low magnesium concentration, the pH 
of the solution clearly affects the phase composition of the precipitates. So, in 63C2M at low 
pH, ACP precipitates formed, whereas B-type carbonated HAp is formed at high pH. This is 
caused by the higher rate of phase transformation of ACP to HAp, as HAp is more stable at a 
higher pH.249,254  
Apart from B-type carbonated HAp, calcite co-precipitated as separate phase in the 
63C1M, 63C0M and 84C1M solutions, at high pH and the 84C0M at low and high pH. At 
higher carbonate concentration and higher pH, more CO32- species are available, which 
easily bind with Ca2+ to form calcite.7,175,249 In addition, augmentation of the carbonate 
concentration results in an increase of the pH of the solution due to the buffering effect of 
HCO3-/CO32-, which could explain why calcite is also formed in 84C0ML at low initial pH.175,186 
Calcite also only formed at low magnesium concentrations (≤ 1 mM), which could be 
attributed to the ability of Mg2+ to inhibit calcite precipitation by associating with CO32- to form 
a stable aqueous MgCO3.249 The presence of MgCO3 could however not be demonstrated 
with IR spectroscopy. Evidently, the carbonate content as determined by gas 
chromatography of these precipitates is high (from 14.47 to 21.6 wt%) (Figure 4). However, 
these results give no information about the amount of carbonate substitution in the HAp 
lattice. 
3.4.2 Maturation study 
Maturation of the PCL samples in the selected 2xSBF solutions showed that more 
coating formed on the samples upon incubation at a low initial pH compared to high initial pH 
(Table 3). Additionally, within the SBF solutions with a low initial pH, the degree of coating 
increased with decreasing magnesium concentration. The observed enhanced coating in 
solutions with low pH and magnesium concentration could be explained by the delayed 
precipitation at these conditions. Indeed, magnesium is known to disturb calcium phosphate 
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surfaces by hindering crystal growth, and a lower pH results in a lower degree of 
oversaturation and increased calcium phosphate solubility, which is in favor of the deposition 
of calcium phosphate on the substrate surface. A higher pH is associated with a higher 
degree of oversaturation and decreased solubility of calcium phosphates which result in a 
fast precipitation of calcium phosphate in the SBF solution.179 Thus less ionic species are 
available in the solution for the deposition of calcium phosphate on the PCL samples. 
Furthermore, there is a competition between early formed calcium phosphate salts acting as 
seeds, and the heterogeneous nucleation on the PCL surface. When calcium phosphate 
globules form too fast in the solutions, the competition is detrimental to the coating 
formation.175,186 In addition, the precipitates formed in the SBF solutions with high pH were 
significantly larger than the ones formed in the solutions at low pH. When calcium phosphate 
globules are small, they remain well adhered onto the substrate, whereas larger globules 
easily detached from the substrate.186,254,255  
Table 3 shows that the type of calcium phosphate deposited onto the samples was 
not always the same as the precipitates formed in the same SBF solution. Barrere et al.186 
previously also combined a preliminary precipitation study prior to the actual coating of 
samples, but unfortunately only identified the precipitates formed in the experimental SBF 
solutions (5xSBF) and not the concurrent coating formed on the substrates (Ti6Al4V plates). 
Probably they assumed that the precipitates and the coating deposited from the same SBF 
solution were identical. No other studies were found in literature that identified both the 
precipitates and the coating formed in SBF solutions. The difference between the precipitates 
and the coating formed in the same SBF solutions could be due to an interaction between 
the functional groups on the PCL samples and the ions in the solution. There is evidence that 
the character of the deposited mineral phase is not only dependent on the composition of the 
mineralization solution but also on the inducing charged groups.178  
The ratio of the peaks at 1460-1420 cm-1 (Ac) and  1090-1050 cm-1 (Ap) can be used 
to calculate the carbonate content of the calcium phosphate layer (Equation (1)). The 
carbonate content in the deposited coating calculated from Ac/ Ap was systematically higher 
in the deposited coating compared to the precipitates formed in the same experimental 
2xSBF solution. This could possibly also be explained by the interaction between the 
functional groups on the PCL surface and the ions in the solution. The risk of a systematic 
overestimation of the carbonate content using Equation (1) should however also be taken 
into consideration.  
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3.4.3 Cell viability and morphology 
Osteoblast behavior is sensitive to biochemical and topographical features of their 
substrate. In the present study the effect of a calcium phosphate coating with low, medium 
and high carbonate content on 3D plotted PCL samples on the cell viabilitity of MC3T3-E1 
cells was examined. Although the PrestoBlueTM-assay only showed a significant higher 
amount of viable, adherent cells on the calcium phosphate coated samples after 1 day of 
culture (Figure 9), large differences were observed when evaluating the PCL samples by 
fluorescent microscopy after live/dead staining (Figure 11). Throughout the 28 days of the 
experiment, low cell viability was observed on the untreated PCL samples and cells show a 
round morphology (Figure 11A – E). The observed cellular behavior could be expected due 
to the hydrophobic nature of PCL, which is known to hinder the initial biological responses 
and cell attachment. PCL however is biocompatible, and cells are indeed able to adhere to 
PCL scaffolds. The latter could explain the observed increase in cell viability with increasing 
incubation time (Figure 9). After 15 days of culture, all of the struts of the calcium phosphate 
coating scaffold were covered with cells, independent of the carbonate content of the 
coating. Nevertheless, bridging of the pores was only achieved for the samples coated with a 
calcium phosphate with a carbonate content of at least 10.76 wt% (Figure 11N and S). On 
these samples the cells have a spread morphology and form a confluent layer. A decrease in 
charge density and crystallinity at the HAp surface, as well as changes in the crystal 
morphology of the apatite coating, might attribute to changes in composition and 3D structure 
of the protein adsorption layer and hence to the observed cell behavior. It was indeed 
recently reported that apatites with high carbonate content and consequently low crystallinity 
were the most performant in terms of cell adhesion and proliferation.152  
The present study clearly demonstrates that the coating of 3D plotted PCL with a HAp 
layer with a carbonate content of 10 wt% or more is a promising strategy for the improvement 
of its bone tissue engineering scaffold potential. 
3.5 Conclusion 
In this paper, a 3D plotted PCL porous scaffold was coated with a calcium phosphate 
layer in three consecutive steps; activation, nucleation and maturation. During the activation 
step, functional groups are created on the PCL surface. Subsequent treatment of the 
samples with a standard nucleation procedure enables the nucleation of calcium phosphate 
particles on the surface. In a final step, the samples are incubated in an SBF solution which 
enables the maturation of the calcium phosphate layer. By varying the pH and the 
composition of the SBF solution, the type and the composition of the calcium phosphate 
layer can be varied. The present study showed that incubation of the samples in SBF 
solutions with a low pH resulted in a thicker and more homogenous coating, whereas higher 
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carbonate contents were obtained when the carbonate concentration was augmented and 
the magnesium concentration of the mineralization solution reduced. Such calcium 
phosphate coating, with at least 10 wt% carbonate improved the osteogenic response and 
enhanced the cell affinity when compared with the uncoated PCL samples and samples 
coated with a calcium phosphate with a low carbonate content. 
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4 Calcium phosphate coating of a multiscale PCL scaffold 
 
Part of the research is based on the article:  
Calcium phosphate coating of a microfibrous/nanofibrous multiscale scaffold. 
Nathalie Luickx, Natasja Van den Vreken, Nicolas Van Damme, Kim Ragaert, Maria 
Cornelissen, Heidi Declercq 
 
Article in preparation 
 
Abstract: In recent year, the fabrication of multiscale fibrous scaffolds containing both micro- 
and nanofibers has attracted a lot of attention in tissue engineering. The combination of 
nanofibers and microfibers is a promising approach in which the microfibrous structure 
provides the porous 3D structural environment with mechanical integrity while the nanofibers 
provide the favorable surface topography with nanoscale features for cell attachment. In this 
study, 3D plotting was used for the production of microfibrous poly(ε-caprolactone) (PCL) 
scaffolds. The 3D plotted scaffolds were coated with a thin layer of PCL nanofibers by means 
of electrospinning. In order to enhance the bioactivity, the present study aimed to coat the 
multiscale PCL scaffolds with an apatite layer with high carbonate content using a 
mineralization solution with ions concentrations based on simulated body fluid (SBF). 
Analysis of the cell viability, adhesion and proliferation of MC3T3-E1 cells showed that the 
cells attached well to the multiscale scaffold. An enhanced cell response was obtained when 
the multiscale scaffolds were coated with a carbonated hydroxyapatite layer. The developed 
structures are believed to have great potential for the 3D organization and guidance of cells 
that are important for engineering 3D bone tissue. 
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4.1 Introduction 
Scaffold-based bone tissue engineering is popular due to the potential of current scaffold 
fabrication technologies to mimic the architecture of the natural extracellular matrix (ECM). 
The ideal scaffold is biocompatible, biodegradable, bioactive and osteoconductive. In 
addition, the scaffold should exhibit a high and interconnected porosity as well as a high 
surface to volume ratio and possess mechanical properties comparable with the tissue being 
engineered.21,41 The diameter of the interconnected pores must be between 100-300 µm. 
These pores are necessary to allow the infiltration of cells, vascularization and efficient 
transport of oxygen, nutrients and metabolites.9,261  Such a scaffold promotes cell adhesion, 
proliferation and differentiation.60  
Various polymers and fabrication techniques have been investigated to produce such an 
ideal bone tissue engineering scaffold.21,41,50,261 Synthetic biodegradable aliphatic polyesters 
such as the Food and Drug Administration (FDA) approved polylactic acid (PLA), polyglycolic 
acid (PGA), polycaprolactone (PCL) and their copolymers are interesting scaffold 
materials.21,41,89 These polyesters are biocompatible and the mechanical properties and 
degradation kinetics can be tailored by varying the monomer composition and molecular 
weight. Due to their thermoplasticity these polymers are processable by 3D plotting46,66,84. 
This technique is widely studied for the fabrication of bone tissue engineering scaffolds 
thanks to its ability to produce polymeric matrices with reproducible interconnected pore 
systems.60 
3D plotting is a layer-by-layer additive manufacturing technique, based on computer 
aided design (CAD) and manufacturing (CAM). A single layer of the scaffold is obtained by 
depositing an extruded filament of a thermoplastic polymer melt according to the pattern 
described by the positioning system. This is repeated for all subsequent layers of the scaffold 
until the 3D geometry is completed. Because 3D plotting can produce scaffolds with complex 
structures, this system is particularly interesting for bone tissue engineering as the scaffold 
can be fabricated to perfectly fit the bone defect.67 
3D scaffolds are composed of filaments of which the diameter can be between 100-500 
µm and possess a porous structure large enough for the migration of cells through the 
construct, enabling in vitro cell adhesion and proliferation throughout the whole scaffold.  
However, it is reported that cells attached to different filaments are hardly able to interact due 
to the large interfilament distance of a couple of hundred micrometers, causing limited 
bridging between cells.68  
Bridge forming between the filaments may be improved by laying down a fine network of 
randomly orientated nanofibers on the filaments, creating a hybrid scaffold. Such a fine 
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nanofiber network can be fabricated by means of the electrospinning process where 
electrostatic forces are used to produce fine fibers from polymer solutions or melts. 
Electrospun fibers have a diameter ranging from less than 100 nm to 10 µm and resulting 
fiber meshes have a high and interconnected porosity with a large surface-to-volume ratio. 
Due to their large surface area electrospun nanofiber meshes contain a high amount of 
binding sites for proteins that modulate cell adhesion. Hence, the nanofeatures of the 
scaffold enhance cell adhesion, viability, proliferation and differentiation.15 Their pore 
dimensions from nanometers up to a few micrometers, allows a cell to adhere on multiple 
fibers simultaneously. However, in vitro studies on nanofiber meshes demonstrated the 
formation of only a monolayer of cells and cell infiltration in the meshes was limited due to 
the small pore size. In order to enable cell infiltration, only a very thin network consisting of a 
few layers of nanofibers should be spun over the 3D scaffolds. Several studies demonstrated 
that such hybrid polyester scaffolds improved adhesion, proliferation and spreading of 
chondrocytes130,135,262, MSCs262 and pre-osteoblastic cells131 compared to scaffolds built up 
by either nanofibers or microfibers individually. The interaction between the cells and the 
hybrid scaffold were improved as the cells were able to colonize the interfilament gap due to 
the presence of a nanofibrous layer between the microfibers. The hybrid scaffolds also 
showed a higher amount of cells distributed throughout the scaffold. Hence, the combination 
of nanofibers and microfibers is a promising approach in which the microfibrous structure 
provides the porous 3D structural environment with mechanical integrity while the nanofibers 
provide the favorable surface topography with nanoscale features for cell 
attachment.90,130,131,133,135,262  
PCL is one of the most commonly used polyesters for the fabrication of bone tissue 
engineering scaffolds due to its lack of toxicity, low cost and slow degradation profile.239 Due 
to its melting point of 60°C and high decomposition temperature of 350°C, PCL is most 
suitable for thermoplastic processing.237 In addition, because of the excellent solubility in a 
number of organic solvents, PCL is easily processable by electrospinning.108 Consequently, 
the bone tissue engineering scaffold potential of nanofibrous263, microfibrous68 and nano-
/microfibrous PCL scaffolds135, fabricated by respectively electrospinning, 3D plotting and a 
combination of both, has been investigated.   
A disadvantage in the use of polyesters scaffolds is their poor mechanical strength and  
hydrophobic nature.178,240 The latter hinders the initial biological responses, such as protein 
adsorption, making it difficult for the cells to adhere to their surfaces.238 In order to improve 
surface properties of PCL scaffolds, some authors report the surface coating with a bone-like 
apatitic mineral. PCL scaffolds fabricated through electrospinning69,120 and 3D plotting85 were 
successfully coated with a surface calcium phosphate (CP) layer. The mineralized scaffolds 
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showed improved cell attachment and proliferation and augmented mechanical strength 
compared to pure PCL scaffolds.69,120,145,151,178 In this paper, a microfibrous/nanofibrous 
hybrid PCL scaffold is fabricated using 3D plotting and electrospinning. In order to improve 
the scaffold’s potential use in bone tissue engineering a mineralization procedure is applied. 
Because the mineral phase of bone tissue is a low crystalline carbonate substituted apatite 
with a carbonate content of 3.2 – 13 wt%, the PCL scaffold should ideally be coated with a 
bonelike carbonated apatite. Such a 3D scaffold with nanofibrous features and bioactive 
apatite coating provides a 3D environment to support cell ingrowth as well as functionality 
related to the surface affinity for enhanced cell attachment and growth. The pure microfiber 
3D plotted PCL scaffold, the hybrid PCL scaffold and the CP coated scaffolds were 
compared in terms of surface morphology, cell-attachment and cell in-growth. 
4.2 Materials and Methods 
4.2.1 Materials 
Freshly prepared demineralized water (Milli-Q system, Millipore, Billerica, US) was used 
for the preparation of the solutions. PCL pellets for the electrospinning scaffold were 
purchased from Sigma-Aldrich (St. Louis, US) and for the 3D plotting PCL was purchased 
from Perstorp (Malmö, Sweden). Sodium chloride (NaCl), ethanol (technical grade, 95 
vol.%), sodium hydroxide solution (NaOH; 1 M), tris-(hydroxymethyl) aminomethane (TRIS) 
and acetone were obtained from VWR BDH Prolabo (Leuven, Belgium). Sodium bicarbonate 
(NaHCO3), disodium phosphate (Na2HPO4), potassium phosphate dibasic (K2HPO4), 
magnesium chloride (MgCl2.6H2O), hydrochloride (HCl; 37 vol.%), sodium sulfate (Na2SO4) 
and chloroform were purchased from Merck (Darmstadt, Germany) and potassium chloride 
(KCl) and calcium chloride (CaCl2.2H2O) from J.T. Baker (Deventer, The Netherlands). 
4.2.2 Fabrication of a hybrid nano-/microscale scaffold  
4.2.2.1 Production of 3D microfibrous scaffolds by 3D plotting 
 The 3D PCL scaffolds were manufactured by 3D plotting on a BioScaffolder machine 
(SysEng, Singapore) as described by Ragaert et al..237 The BioScaffolder is composed of a 
screw extrusion head equipped with a micronozzle (gauge 27, inner diameter 200 µm) to 
produce a polymer melt filament. The polymer was molten at 100°C and deposited on a 
plotting table at room temperature. Spindle speed of the extrusion screw was constant at 15 
rpm. The consecutive layers were deposited with a relative layer orientation of 45°. For the 
present study four layered scaffolds of 1x1cm2 were produced, thus with an overall pattern of 
0°/45°/90°/-45°.  
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4.2.2.2 Deposition of electrospun fibers onto 3D plotted scaffolds 
The electrospinning of PCL is described in detail by Van der Schueren et al..21 Briefly, a 
14 wt% PCL solution was made by dissolving PCL pellets in the binary solvent system 90 % 
formic acid/10 % acetic acid (both Sigma-Aldrich). The polymer solution was then loaded into 
a syringe (Becton Dickinson, Franklin Lakes, US) and a high voltage electric field of 18 kV 
(Glassman High Voltage Series EH Source, High Bridge, US) was applied to draw the fibers 
from the spinneret (gauge 17 needle) onto the collector plate. A constant feed rate of 1 ml/h 
was applied using a syringe pump (KD Scientific, Syringe Pump Series 100, Holliston, US) 
and a distance of 12 cm was maintained between the tip of the spinneret and the collector 
plate. The 3D plotted PCL scaffolds were placed on the collector plate. Fibers were 
deposited for 1 second on each site of the scaffold in order to coat the complete scaffold 
surface with a thin layer of electrospun fibers.  
4.2.3 Coating of the scaffolds 
4.2.3.1 Activation step 
For the activation of the hybrid scaffolds the optimized activation procedure of Luickx et 
al.69 was slightly adjusted. Samples were immersed at room temperature in 10 mL/cm² 
ethanol for 1 minute and washed for 5 minutes in demineralized water. Next, samples are 
immersed in a 1 M NaOH solution for 40 minutes under ultrasonic conditions and washed for 
5 minutes in demineralized water.  
4.2.3.2 Nucleation step 
Deposition of a thin primer layer of CP nucleates was achieved by an alternate dipping 
process in CaCl2.2H2O and Na2HPO4 solutions in which the parameters of the previously 
optimized nucleation procedure were used.69 Samples were first immersed in 100 mL of 
32.30 mM CaCl2.2H2O for 70 seconds, washed for 30 seconds with demineralized water, 
next the samples were immersed in 100 ml of 35.98 mM Na2HPO4 solution for 45 seconds 
and washed for 30 seconds in demineralized water. During sample immersion the solutions 
were stirred at 250 rpm. This cycle of four steps was repeated seven times.  
4.2.3.3 Maturation step 
In order to coat the samples with an apatite layer with varying carbonate content, the 
samples were further subjected to an incubation in 20 ml of two different SBF-based 
solutions for up to 24h at 37°C under dynamic conditions (50 rpm). For coating with an 
apatite with low carbonate content the samples were incubated for 24h in a two times 
concentrated SBF solution (2xSBF). For coating with an apatite layer with higher carbonate 
content the samples were incubated for 15h in an experimental SBF solution with a high 
carbonate ion concentration and without magnesium ions (63C0Mg). The ion concentrations 
Multiscale PCL scaffold 
155 
 
of the 2xSBF solution and the experimental SBF solution are shown in table 1.  The 2xSBF 
and the 63C0Mg solution were prepared by mixing concentrated ion solutions. The recipes 
for preparation are shown in table 2. After incubation in the SBF solutions, the samples were 
dried at room temperature. 
 
Table 1. Ion concentrations and pH of human blood plasma (HBP), original SBF, 2xSBF and 63C0Mg. 
 
Table 2. Concentrations, order and volume of concentrated ion solutions for preparing 1000 ml of 
2xSBF. 
Ion solution Concentration 
(mM) 
Order Volume (ml) 
2xSBF 
Volume (ml) 
63C0Mg 
NaCl 1000 1 274 215 
KCl 100 2 100 100 
Na2HPO4 20 3 100 100 
MgCl2.6H2O 30 4 100 - 
NaHCO3 84 5 100 - 
HCl 1000 6 40 Adjust to pH 5±0.1 
CaCl2.2H2O 50 7 100 100 
Na2SO4 10 8 100 100 
TRIS-buffer 500 9 100 - 
HCl 1000 10 Adjust to pH 7.75 ± 0.05 - 
   
 Add 5.275 g NaHCO3 powder 
 
4.2.4 Characterization of the scaffolds 
The morphology of the scaffolds, before and after mineralization, was characterized using 
a Keyence 3D microscope (VHX-500F; Elmwood Park, US) and a scanning electron 
microscope (SEM; FEI Quanta 200 F, Hillsboro, US). Prior to SEM measurements, the 
samples were coated with gold using a sputter coater (Balzers Union Highland Scientific 
SCD 030, Bedford, UK). Image analysis software (SigmaScan Pro 5, SPSS Science, 
Chicago, US) was used to determine the average filament diameter (FD) and strand distance 
(SD). For each parameter, measurements of five random locations on the scaffold were 
averaged.  
The homogeneity of the CP coating and the reproducibility of the procedure was 
evaluated using ARS calcium staining. Following the removal of most of the polymer by 
dissolution, the type of calcium phosphate deposited was identified by infrared (IR) 
 Ion concentration (mM)  
 
Na+ K+ Mg2+ Ca2+ Cl- HCO3- HPO42- SO42- pH 
HBP 142 5 1.5 2.5 103 27 1 0.5 7.4 
Original SBF 142 5 1.5 2.5 147.8 4.2 1 0.5 7.4 
2xSBF 282 10 3 5 295 8.3 2 1 7.75 
63C0Mg 284 10 0 5 235 63 2 1 7.65 
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spectrometry. Samples were immersed in 1 ml chloroform for 10 minutes. After centrifugation 
(2 minutes; 7000 rpm) the supernatant solution was removed. This step was repeated once. 
The remaining pellet was washed with 1ml acetone followed by centrifugation (2 minutes; 
7000 rpm) and removal of the supernatant. This washing-step was repeated once, the 
remaining powder was dried overnight. IR spectra of the CP powder dispersed in KBr tablets 
were recorded using a Fourier-transform IR (FT-IR) spectrophotometer (Perkin Elmer 
Instruments, Waltham, US). The carbonate content of the precipitates was determined by 
gas chromatography (Model 8500, Perkin Elmer Instruments) based on the method of 
Godinot et al..247 As such, a calculated amount of precipitate was dissolved by adding 10% 
H3PO4 (Merck) in a closed vial. The incorporated carbonate in the specimens is released as 
CO2 which is injected in the gas chromatograph. Florida Rock with 3.81 wt% carbonate was 
used as standard to obtain the calibration curve. 
4.2.5 Cell culture and seeding 
Monolayers of MC3T3-E1 pre-osteoblasts (mouse calvaria pre-osteoblast cells, 
ATCC) were cultured in α-minimum essential medium (α-MEM) (glutaMAX-1TM, Gibco 
Invitrogen, Ghent, Belgium) supplemented with 10% fetal bovine serum (FBS) (heat 
inactivated, EC approved, Gibco Invitrogen) and 1 mM sodium pyruvate (Gibco Invitrogen) at 
37°C in 95% air/5% CO2 . The medium was changed twice a week.  
 Untreated 3D plotted PCL samples and hybrid PCL samples were used as control. 
Calcium phosphate coated and untreated samples were sterilized under UV-light for 30 
minutes. After sterilization the samples were placed in 48-well tissue culture dishes 
(suspension culture plates, Greiner Bio-One, Frickenhausen, Wemmel, Belgium). To each 
sample 40,000 MC3T3-E1 cells, in droplet, were added, for the PrestoBlueTM-assay 
(Invitrogen). For the live/dead staining and the histology, 300,000 cells, diluted in 500 µl 
culture medium, were added to each sample. For the PrestoBlueTM-assay and the live/dead 
staining, either 40,000 or 300,000 MC3T3-E1 cells, in droplet or diluted in 500 µl culture 
medium, respectively, were added to an adhesion plate (Nunc, Life Technologies, 
Merelbeke, Belgium) as positive control. The cell/scaffold constructs and the positive controls 
were cultured for 14 days (5%CO2/95% air, 37°C) with the medium changed twice a week. 
4.2.6 Characterization of cell/scaffold constructs 
4.2.6.1 Cell viability and morphology 
The PrestoBlueTM-assay was applied to quantify the number of viable cells that 
attached on the calcium phosphate coated and untreated samples after 1, 7 and 14 days of 
culture. The PrestoBlueTM-reagent is a blue resazurin-based non-fluorescent solution. 
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Resazurin enters the cells where it is transformed to the red and fluorescent resorufin by the 
reducing power of the mitochondria.  
 The samples and the control were rinsed with culture medium after which 450 µl 
culture medium and 50 µl PrestoBlueTM-reagent was added to each well. After 2 h incubation 
at 37 °C in a dark room, 400 µl medium was transferred to a 24-well dish (Greiner Bio-One). 
The fluorescence of the medium was measured in a multilabel plate reader (Victor³, Perkin-
Elmer) (excitation: 560 nm, emission: 590 nm). The number of viable and attached cells is 
linearly correlated with the signal, and viability was calculated as a percentage of the positive 
control of the respective day. 
Cell viability and morphology after 1, 7 and 14 days on the calcium phosphate coated 
and untreated samples was visualized using fluorescence microscopy after performing 
live/dead staining with calcein acetoxymethyl (AM) ester (Tebu-Bio, Boechout, Belgium) and 
propidium iodide (PI) (Sigma-Aldrich). PI cannot pass through intact cell membranes, but 
may freely enter dead cells with compromised cell membranes where PI intercalates into 
double-stranded DNA and emits red fluorescence (excitation: 488 nm, emission: 617 nm). 
Calcein AM is a non-fluorescent, membrane-permeable dye. Under intracellular esterase 
activity the dye converts to a membrane-impermeable, green fluorescent compound 
(excitation: 490 nm, emission: 520 nm). After 1, 7 and 14 days the samples and positive 
controls were rinsed with 500 µl phosphate buffered saline (PBS) after which 500 µl PBS 
containing 1 µl PI and 1 µl calcein AM was added to each well. After 10 minutes incubation in 
a dark room at room temperature, samples were evaluated with a fluorescence microscope 
(Olympus Type U-RFL-T, Aartselaar, Belgium).  
Each material and the controls were tested in triplicate. 
4.2.6.2 Histology 
Cell/scaffold constructs were rinsed with Ringer solution, fixed with 4% phosphate-
buffered (10 mM) formaldehyde (pH 6.9; 4°C; 24h), dehydrated in a graded alcohol series 
and embedded in paraffin. 5-7 µm sections were cut and stained with hematoxylin and eosin 
(H&E). 
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4.3 Results 
4.3.1 Fabrication of the scaffolds 
The 1x1cm² 3D plotted PCL scaffolds had a thickness of 626 µm with a standard 
deviation (SD) of 11 µm. Digital and SEM images of the samples are shown in figure 1A and 
1B, respectively. The average filament diameter was 191.67 µm with a SD of 6.60 µm, the 
average strand distance was 322.18 µm with a SD of 35.99 µm. The resulting pore diameter 
was 119.88 µm with a SD of 31.25 µm.  
Figure 1: Digital and SEM images of the (A, B) 3D plotted and (C, D) hybrid PCL scaffolds. 
 Figure 1C and 1D shows the digital image and the SEM image of the hybrid scaffold 
with the PCL nanofibers collected onto the 3D plotted PCL scaffold. The scaffolds with 
dimensions of 1x1 cm² had an average thickness is 627 µm with a SD of 8 µm. The 
deposited PCL nanofibers had an average fiber diameter of 331.37 nm with a SD of 76.39 
nm.  
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4.3.2 Coating of the hybrid scaffolds 
4.3.2.1 Pre-mineralization treatment 
SEM images of the hybrid PCL scaffold after treatment with the activation and nucleation 
procedure are shown in figure 2A and 2B, respectively.  The samples showed no changes in 
the micro- and nanostructure, nor in the overall scaffold morphology after immersion in 
ethanol and NaOH solutions. After subsequent alternate dipping in Ca2+ and PO43-- rich 
solutions, mineral crystals could be observed on the fiber surface of the nanofibers situated 
on top of the microfiber strands. No deposits were visible on  the nanofibers bridging over 
neighboring microfibers in the hybrid scaffold, nor on the microfibers in the 3D PCL scaffold 
(figure 2A).  The presence of CP deposits on the hybrid scaffolds was confirmed by the red 
color of the samples after ARS staining (figure 2D).  
Figure 2: SEM images of (A) 3D plotted PCL samples after treatment with the activation and 
nucleation procedure, (B) hybrid PCL samples after treatment with the activation procedure and (C) 
after subsequent treatment with the nucleation procedure. (D) Digital image of ARS stained samples 
after treatment with the activation and nucleation procedure. 
4.3.2.2 Maturation 
SEM images of the hybrid scaffolds after subsequent incubation for 24h in 2xSBF and 
for 15h in the 63C0Mg solution at 37°C are shown in figure 3A-B and 3C-D, respectively. The 
SEM images showed that a calcium phosphate coating covered the surface of the 
electrospun fibers. After 24h of incubation in 2xSBF the calcium phosphate deposition was 
more massive, but still the porous structure of the scaffold was more or less preserved.  
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Figure 3: SEM images of hybrid scaffolds after (A,B) 24h incubation in 2xSBF and (C,D) 15h 
incubation in 63C0Mg, at 37°C.  
 
4.3.2.3 Analysis of the  coating 
The FTIR spectrum of the calcium phosphate coating deposited on the samples after 24h 
incubation in 2xSBF and 15h in 63C0Mg is shown in Figure 4.  
Incubation of the samples in these solutions resulted in the deposition of a carbonated 
apatite. The spectrum of the coating formed during incubation in 63C0Mg shows peaks due 
to the ν4-PO43- bending around 603 to 569 cm-1 and the ν3 stretching of PO43- groups around 
1045 and 1100 cm-1. These are typical peaks of a hydroxyapatite phase. The peak around 
1620 cm-1 arises from the H – O – H deformations in water. Typical peaks in the IR spectra at 
880, 1420 and 1460 cm-1 indicate the presence of CO32- that substitutes for PO43- in the 
apatite lattice (B-type substitution). The spectrum of the sample after incubation in 2xSBF 
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shows, besides the typical peaks of B-type hydroxyapatite, additional bands around 1545 cm-
1 and 1480 cm-1. The latter indicates that some CO32- substitutes for OH- in the apatite lattice 
(A-type substitution).  
Evidently, the intensity of the peaks arising from CO32- increase with increasing carbonate 
content in the calcium phosphates. The intensity of the peaks attributed to the presence of 
CO32- are higher in the spectrum of the precipitates formed in the 63C0Mg solution compared 
to the ones found in the spectrum of the precipitates formed in the 2xSBF solution. This is in 
line with the carbonate content of these precipitates that amounts to 8.2 wt% and 4.6 wt%, 
respectively.  
Figure 4: Infrared spectra of the calcium coating formed on the samples after 24h incubation in 2xSBF 
and 15h in 63C0Mg. Annotations mark CO32- absorptions. The dotted lines mark some typical peaks of 
hydroxyapatite. 
4.3.3 Cell culture tests 
The quantity of viable and attached MC3T3-E1 cells on the untreated and the calcium 
phosphate coated PCL samples was determined after 1, 7 and 14 days of incubation, as 
presented in figure 5. 
In comparison to that of the positive control, the attachment of the cells on the scaffolds 
was low. Although no statistical significant difference could be found, the amount of cells was 
lower on the untreated 3D plotted scaffolds than on the multiscale scaffolds at any given time 
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point. The amount of viable cells was also systematically higher on the calcium phosphate 
coated scaffolds compared to the untreated samples. The best results in terms of cell viability 
and proliferation were obtained for the hybrid scaffolds coated with a high carbonate content. 
Only for these scaffolds the amount of viable cells significantly increased after 14 days, 
compared to 1 and 7 days (p ≤ 0.037). 
 
Figure 5: Cell viability of MC3T3-E1 cells on untreated 3D plotted PCL scaffolds, untreated hybrid 
PCL scaffolds and hybrid PCL scaffolds coated with HAp with a low and high carbonate content after 
1, 7 and 14 days of incubation. The amount of attached cells was quantified by a PrestoBlue assay. 
The cell viability was calculated as percentage of the positive control after 14 days. Statistical 
differences (p ≤ 0.05) in the cell viability are annotated with *. Error bars represent standard 
deviations.  
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Figure 6: Fluorescence micrographs after live/dead staining of MC3T3-E1 cells cultured on untreated 
3D plotted PCL scaffolds, untreated hybrid PCL scaffolds, hybrid PCL scaffolds coated with a calcium 
phosphate with low carbonate content and hybrid PCL scaffolds coated with a calcium phosphate with 
high carbonate content after 1, 7 and 14 days of culture.  
 
The MC3T3 cell viability and morphology on the four scaffolds after 1, 7 and 14 days is 
shown in figure 6. For the untreated 3D plotted scaffolds, only some of the filaments were 
covered with cells after 1 day of culture, whereas after 7 days of culture all filaments were 
fully covered with cells. After 14 days of culture, a lot of dead cells were visible on the 
filaments. For the untreated multiscale scaffold the cells preferred to colonize the surface 
covering the microfilaments. After 7 days of culture the cells formed a monolayer covering 
the complete surface of the scaffold. Whereas on the calcium phosphate coated scaffolds, a 
monolayer of cells formed as of 1 day of culture. The majority of the cells continued to remain 
viable after 2 weeks. 
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Cross-sections of the cell/scaffold constructs after H&E staining showed a similar cell 
infiltration into the scaffolds after an incubation period of 14 days (Figure 7). All scaffolds 
showed colonization in the center of the scaffold. This indicates that even for the calcium 
phosphate coated multiscale scaffolds, the cells were able to infiltrate the electrospun mesh 
that covered the 3D plotted scaffolds. On these calcium phosphate coated scaffolds a high 
concentration of cells was also present on both sides of the electrospun mesh. 
Figure 7: Colonization of the scaffolds after 14 days of incubation. Cross-sections were stained with 
hematoxylin and eosin (H&E). 
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4.4 Discussion 
4.4.1 Fabrication of a hybrid nano-/microscale scaffold 
Multiscale PCL scaffolds were successfully fabricated by combining 3D plotting and 
electrospinning. The fabrication of the constituting single scale micro – and nanofibrous PCL 
scaffolds was previously optimized by Ragaert et al.237 and Van der Schueren et al.114, 
respectively. For the present research, 3D plotted scaffolds with a 0°/45°/90°/-45° 
architecture, a pore diameter of 120 µm and a filament diameter of approximately 190 µm 
were fabricated. Scaffolds with such compact architectures showed an enhanced cell 
seeding efficiency and subsequent differentiation of pre-osteoblastic cells compared to 
scaffolds with larger pores.205 During 1 second, an electrospun nanofibrous mesh with fiber 
diameters of approximately 330 nm was deposited on top of the 3D plotted scaffolds, on both 
sides. Thickness and coverage of the nanofibrous layer could be controlled by modulating 
the electrospinnning time. Hence, in the present study the electrospinning time was kept as 
short as possible in order to deposit a thin nanofibrous mesh without closing off the pores of 
the 3D plotted scaffolds too much.  
The limitation of the current fabrication procedure is that the electrospinning apparatus 
and the BioScaffolder are two individual devices. An interesting possibility is the integration 
of the two techniques in a single device. With such a device it would be possible to fabricate 
scaffold with alternating layers of nanofibers and microfibers. Moreover, the architecture of 
the scaffold could be more easily tuned during fabrication to obtain a construct of desired 
morphology and characteristics. 
4.4.2 Coating of the scaffolds 
For the activation of the multiscale scaffolds the optimized protocol for the activation of 
electrospun PCL samples was slightly adopted; in order to ensure sufficient wetting the 
samples were immersed for 1 minute in ethanol. This longer treatment did not affect the 
morphology of the electrospun fibers (figure 1B). Upon subsequent treatment with the 
optimized nucleation procedure for electrospun PCL, calcium phosphate nucleates were 
successfully deposited on the multiscale scaffold. SEM imaging revealed that the calcium 
phosphate deposited was only present on the nanofibers situated on top of the microfibers. 
Incubation of the samples for 24h in 2xSBF and for 15h in 63C0Mg enabled the 
deposition of hydroxyapatite with a carbonate content of 4.6 and 8.2 wt% respectively. 
Although the porous structure of the scaffolds was still visible, the coating clearly caused a 
decrease of the pore diameters.  
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The carbonate content of the coating obtained by incubation in 63C0Mg was not as high 
as was expected based on the high carbonate concentration of the SBF-based solution and 
previous experiments with 3D plotted PCL scaffolds. It can be expected that during 
prolonged incubation in 63C0Mg, more carbonate would incorporate in the hydroxyapatite 
lattice. As during longer incubation the calcium phosphate layer also grows further, the 
incubation period of the current multiscale scaffolds was limited and could not be extended 
without causing obstruction of the pores.  
4.4.3 Cell response 
It is well known that micro-or nanotopographical features on the surface of biomaterials 
can control cellular behaviors such as adhesion, spreading, migration, proliferation and 
differentiation to a large extent.135 
As shown in figure 6, for the single scale untreated 3D plotted scaffold the initial cell 
adhesion was low, which could be expected due to hydrophobic nature of PCL that hinders 
the adsorption of proteins. After 7 days of culture a higher amount of cells were adhered to 
the filaments. The cells are however confined to a single filament due to the absence of 
bridging across microfibers that are too far apart (Figure 6).  
Compared to the untreated single scale scaffold, more cells were able to adhere to the 
untreated multiscale scaffold after 1 day of culture. It was indeed expected that the presence 
of randomly oriented fibers with nanoscale features would enhance initial cell adhesion and 
response.90 After 7 days of culture the cells were directed to bridge between the microfibers 
which resulted in the formation of a confluent monolayer of cells after 14 days of culture. So 
even without a calcium phosphate coating, multiscale scaffolds showed an enhanced cell 
response compared to single scale 3D plotted PCL scaffolds. The positive effect of the 
addition of nanofibers was confirmed in other studies.90,136,264  
For the multiscale PCL scaffolds coated with a hydroxyapatite layer with low and high 
carbonate a further enhancement of cell response was observed, with the highest amount of 
cell adhesion on the scaffolds coated with the high amount of carbonate. (Figure 5 and 6). 
Although a monolayer of cells was formed on the exterior electrospun mesh, figure 7 
shows that the cells were able to infiltrate into the interior of the scaffolds. This suggests that 
as the electrospun mesh was very thin, the attached cells have the ability to push against the 
nanofibers and migrate into the matrix. 
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4.5 Conclusion 
In order to combine the properties of both microfibers (pores large enough for cell 
migration) and nanofibers (physical mimicry of native ECM), multiscale scaffolds were 
fabricated. MCT3T3-E1 cells attached well on the multiscale scaffold, and an enhanced cell 
response was obtained when the multiscale scaffolds were coated with a carbonated 
hydroxyapatite layer. The developed structures are believed to have great potential for the 
3D organization and guidance of cells that are important for engineering 3D bone tissue. The 
multiscale scaffolds promote cellular adhesion and growth.  
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Bone tissue has a high regenerative capacity and the normal physiologic reaction to 
fracture is the spontaneous sequence of events briefly summarized as initial inflammation, 
followed by soft callus formation, hard callus formation and ultimately bone remodeling. 
When this natural process does not occur, as in the case of large-scale bone injury caused 
by trauma, disease or surgical resection, surgical intervention is warranted. Different surgical 
strategies have been developed, of which BTE represents one promising strategy. 
Scaffold-based BTE is a rapidly emerging field that focuses on developing 
biologically-based substitutes that integrate with and are eventually replaced by host bone. It 
involves the implantation of ECM analogues that can support cell function and provide 
structural support. The scaffold must exhibit a porous, interconnected, and permeable 
structure to permit infiltration of cells and nutrients and should exhibit the appropriate surface 
structure and chemistry for cell colonization, migration, proliferation and differentiation. 
Ideally, the scaffold should be made of a biodegradable material, whose degradation rate is 
coupled to the tissue formation dynamics. In this way the mechanical support of the scaffold 
would be progressively overtaken by the newly formed tissue. To date, no suitable scaffold 
has been developed for the repair and regeneration of bone tissue due to its complex 
composition, structure, mechanical and biological properties.  
This thesis aimed to fabricate a biomimetic scaffold for BTE purposes. In order to 
mimic the natural composite structure of bone, the fabrication of biodegradable polyester 
coated with a thin layer of bone-like apatite was investigated.  
1 Scaffold development 
Material selection and processing method selection are two major and primary 
considerations in the development of an ideal BTE scaffold. The biocompatibility and the 
surface chemistry of the scaffold is determined by the scaffold material, whereas the 
(interconnected) porosity and the pore and overall scaffold architecture depend on the 
fabrication method. Both the scaffold architecture and scaffold chemistry can influence 
cellular response by means of osteoconductivity and osteoinductivity. The mechanical 
properties of the scaffold are determined by the type of biomaterial, but also by its structural 
properties (e.g. porosity, interconnectivity) when processed to create a scaffold.  
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1.1 Material selection 
Among the multitude of choices of biomaterials, in this thesis, two biocompatible and 
biodegradable materials were selected due to their tailorable properties; PCL and PDLLA. 
Both polyester have an established use in clinical practice and differ in their degradation rate 
and mechanical properties. The semi-crystalline PCL has a long degradation time in the 
human body (> 24 months), whereas the amorphous PDLLA has a medium long degradation 
time (12-16 months). Both polyesters are already FDA approved for some specific 
applications in the human body such as for drug-delivery devices and sutures, which could 
ensure a smooth introduction to the market.239 Other advantages of these polyesters are their 
good solubility, low economic cost, ease of shaping and processing to porous structures as 
those used in TE. 
It should however be noted that some concerns exist about the use of PCL and PDLLA 
as materials for the fabrication of bone scaffolds. First, the slow degradation of PCL 
scaffolds. It has been found that a PCL system with a high molecular weight (Mn of 50,000) 
requires 3 years for complete removal from the host body. In addition, PCL has a  
significantly low mechanical strength due to the fact that PCL is in the rubbery state at body 
temperature (high elasticity).96 As for PDLLA, the physical and some mechanical properties 
are often not good enough for end-use applications. Since polymers from lactic acids have 
glass transition temperature (Tg) above body temperature, these scaffolds are stiff with little 
elasticity in the body and are somewhat brittle at room temperature.96 The brittleness of 
PDLLA is an important limitation in its applications in BTE. Both PCL and PDLLA have a 
good blend-compatibility and blending techniques are an extremely promising approach 
which can improve the original properties of both polymers.265-267 Moreover, combining 
PDLLA and PCL in a certain ratio can result in composite scaffolds with appropriate 
degradation time.266 Additionally, mineralization of both polyester scaffolds was also shown 
to improve the mechanical strength of the scaffolds.106,157,240,268 
1.2 Processing method selection 
In recent years, multiscale fibrous scaffolds containing a combination of micro-and 
nanoscale fibers have attracted a lot of attention in the TE field. Such scaffolds can be 
manufactured by combining 3D plotting and electrospinning. However, to date research on 
the fabrication of such multiscale polyester scaffolds is limited. 
In order to investigate the mineralization of such multiscale scaffolds, it was first 
necessary to fabricate and optimize the mineralization procedure of the constituting 
elements, namely electrospun nanofibers and 3D plotted microfilaments. 
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Electrospinning is one of the most commonly employed techniques in TE for the 
generation of nanoscaled fibrous structures. The electrospun fibers are in the same scale as 
the ECM fibril network surrounding the cells in their natural environment, and, therefore, are 
considered to mimic the physical cues to which the cells are normally exposed. For the 
electrospun PCL and PDLLA scaffolds used in the present study, the electrospinning process 
was optimized in order to obtain beadles and randomly oriented nanofibers with small 
diameter distributions and high reproducibility (Chapter 3.1 Figure 1; Chapter 3.2 Figure 1). 
The average fiber diameter of the electrospun PCL scaffolds was 419 nm, whereas it was 
1.55 µm for the electrospun PDLLA scaffolds. The difference in fiber diameter can be 
attributed to a difference in conductivity of the solutions used for electrospinning. As a higher 
voltage is required for steady state electrospinning of the PCL solution than the PDLLA 
solution, it can be assumed a solution of 14 wt% PCL dissolved in a 90% formic acid/10% 
acetic acid solvent system has a higher conductivity than a solution of 17 wt% PDLLA 
dissolved in a DMF/acetone (2/1) solvent system. The application of a higher voltage 
encourages the reduction of the fibers diameter due to increased stretching of the solution jet 
as a result of higher levels of charges carried by the solution.64  
The microporous 3D scaffolds were produced with the 3D plotting technology, which 
provides an accurate control over internal scaffold micro-architecture and external shape. A 
serious limitation in the use of 3D plotting for the processing of biodegradable polyesters is 
the thermal vulnerability of some of the polyesters. When heated for an extended time above 
their melting temperature, chain scissions may occur, effectively degrading the material. 
Upon degradation the material flow changes, the scaffolds become more brittle and the 
geometrical characteristics differ for each scaffold. Thermal degradation of the scaffold 
material during the production process is also devastating to scaffold reproducibility with 
respect to mechanical properties. Polymers from lactic acid, such as PDLLA, are highly 
sensitive to this phenomena and in addition to their inherent brittleness, difficult to process by 
means of 3D plotting.236 Even though Ragaert et al.88,236 were able to fabricate 3D plotted 
PDLLA scaffolds, the structures were too brittle and difficult to handle as they broke easily 
into pieces. Consequently 3D plotted PDLLA scaffold could not be used for further 
experiments. Semi-crystalline polymers are more resilient against high temperatures than 
amorphous polymers, which explains the high thermal stability of PCL. In the present thesis 
3D plotted PCL scaffolds with compact architectures, a 0°/45°/90°/-45° design and a pore 
size of 120 µm were successfully fabricated (Chapter 3.3). Declercq et al.205 previously 
showed that scaffolds with such compact architecture showed higher seeding efficiency and 
differentiation compared to scaffolds with larger pores and open channel architectures. 
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The final objective of this study was set forth by completing an introductory study on the 
development of a multiscale scaffold. In chapter 3.4 the 3D plotting and electrospinning 
technique were integrated to create a PCL multiscale system in which the 3D plotted scaffold 
would give the stable support structure and pore organization for tissue development and the 
electrospun network would provide topological and physical cues for the cells.  
2 Mineralization 
As both PCL and PDLLA lack intrinsic bioactivity, much attention has been paid to the in 
vitro mineralization of these materials. For the coating of fibrous polyester scaffolds, in the 
present thesis a three-step mineralization procedure was applied (Figure 16). The first step 
involved the activation of the polyester surface, in the second step or nucleation step the 
samples were alternately dipped in calcium and phosphate rich solutions and finally the 
samples were incubated in a mineralization solution based on SBF (maturation step). 
Figure 16: Schematic overview of the three-step mineralization procedure used in the present thesis. 
 
2.1 Optimization surface activation 
Due to the hydrophobic nature of PCL and PDLLA it is necessary to create negatively 
charged functional groups on the scaffold surface in order to enable the deposition of a 
calcium phosphate layer.106 The activation method chosen in the present study was partial 
surface hydrolysis by the wet chemical method (Chapter 1 Figure 12). This was preferred 
above plasma treatment as the currently available plasma techniques cannot efficiently 
modify deeply located surfaces due to the limited penetration depth of plasma in the pores of 
the scaffold.213 Wet chemical methods can offer the flexibility for surface modification 
throughout fibrous scaffolds.  
However, when biodegradable polymeric fibrous scaffolds are surface-modified using 
partial hydrolysis, special care must be taken. The type and concentration of the hydrolyzing 
agent, but also the duration of the hydrolysis are important parameters to consider in order to 
produce surface functional groups without changing the bulk properties of the material. 
Furthermore, the activation of the scaffold surface should be homogenous.  
General discussion and conclusion 
177 
 
Various studies report on the use of an alkaline NaOH solution for the generation of a 
functionalized and hydrophilic polymer surface.120,150,157,183,184,195,201,213,269 However, for brittle 
polyesters such as PDLLA, treatment with NaOH severely degrades the polyester 
structure.195 Due to the absence of crystallinity and a higher amount of accessible ester 
groups in PDLLA, it is more vulnerable to degradation by ester hydrolysis compared to 
PCL.270,271 In order to reduce the risk of damaging the PDLLA fibers, the activation method 
should be as mild as possible. The current research showed that immersion of electrospun 
PDLLA samples for 3 seconds in ultrapure water under ultrasonication successfully 
homogenously activated the fiber surface without affecting the fibers. These results show 
that, from a solution as mild as water, the introduction of ultrasound has some physical and 
chemical effects that are useful in surface modification: 
• Physical: the erosive action of micro-jets hitting the material can roughen the 
surface, providing an ideal surface for subsequent coating 
• Chemical: acoustic cavitations generate localized high pressures that can break 
bonds on the surface.272,273 
Even though for the more stable PCL, a more aggressive activation treatment could be 
expected, the long incubation times120,147,157,183,184 in or high concentrations157,184 of the NaOH 
solutions suggested in literature should be avoided to reduce the risk of loss of mechanical 
properties or structural integrity of the scaffold. In order to reduce the incubation time and 
concentration of the NaOH solution, two innovative approaches were investigated in the 
present research: pre-wetting with ethanol and activation under ultrasonication. Ethanol, a 
well-known wetting medium of polyester,274,275 was applied by Yang et al.201 as co-treating 
medium to make PLLA macroporous scaffolds more hydrophilic and assist the nucleophilic 
attack by a NaOH solution on the ester bond. Their results showed that upon co-treatment 
with ethanol lower concentrations of NaOH and shorter treatment times could be applied to 
reduce the surface hydrophobicity, which resulted in an enhanced cell affinity for the PLLA 
scaffolds. However, the appliance of ethanol as pre-wetting medium of polyesters during 
activation-step in a mineralization procedure was a rather new approach, although its ability 
to reduce the pre-treatment time during calcium phosphate film formation was already 
investigated by Choi et al.276 for poly(methyl methacrylate) (PMMA) substrates. Based on 
these findings better results in terms of degree of NaOH solution infiltration were expected by 
the ethanol pre-treatment procedure because of the reduced hydrophobicity of the 
polyesters. The present study showed that electrospun PCL scaffolds were indeed 
successfully activated by ethanol dipping followed by a 40 minutes immersion in NaOH under 
ultrasonication.  
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So, with the implementation of ethanol pre-wetting and/or ultrasonication a reproducible, 
milder and less time-consuming protocol than others reported in literature was achieved for 
the activation of electrospun PCL and PDLLA scaffolds.  
In analogy with the electrospun PCL scaffolds, the activation procedure of the 3D plotted 
samples was optimized. With the parameters of the optimized two-step activation procedure 
of electrospun PCL as base, the immersion time in NaOH was reduced from 40 minutes to 
15 minutes. A reduction of the activation time could be expected as the pores of the 3D 
plotted samples are larger, which results in a more sufficient infiltration of the aqueous NaOH 
solution into the pores of the scaffold.  
For the multiscale scaffolds, the activation protocols for electrospun and 3D plotted PCL 
were combined to a new protocol. Successful activation was demonstrated upon immersion 
of the samples for 1 minute in ethanol to allow for complete soaking of the scaffold and 
subsequent immersion in NaOH under ultrasonication for 40 minutes to assure sufficient 
infiltration of the alkaline solution into the pores of the exterior electrospun PCL layer. 
2.2 Nucleation 
During activation, carboxylate moieties are created on the polyester surface; those are 
known to be involved in the deposition of calcium phosphate in SBF. Nevertheless, activation 
alone is not decisive, and only slightly accelerates calcium phosphate deposition on the 
polyester surface.243 Alternate dipping in calcium and phosphate rich solutions after 
activation of the surface, as proposed first by Taguchi et al.189 and later by Oyane et al.182, 
has been shown to be effective in inducing apatite deposition. The mechanism of calcium 
phosphate deposition upon being alternately dipped in calcium and phosphate rich solutions 
can be explained as follows; when the activated samples are first dipped in the calcium rich 
solution, the carboxylate groups on the surface attract Ca2+ ions from the solution by a 
chelating ion-exchange reaction. When the samples are subsequently dipped in phosphate 
rich solution, the Ca2+ ions attract the negatively charged PO43- ions from the solution. As a 
result, calcium phosphate nuclei are deposited on the polyester surface with an anchoring 
effect of the carboxylate groups.243 
For electrospun scaffolds, due to their nanofibrous structure and narrow pores, the major 
challenge when depositing a calcium phosphate layer on the fibers, is the preservation of the 
porous structure and the coating of fibers located in the inner layers of the scaffold. In order 
to control the deposition of a thin and homogenous calcium phosphate layer, the nucleation 
procedure for electrospun PCL and PDLLA scaffolds was optimized using a variable simplex 
algorithm. The use of a simplex facilitates the optimization of multi-parametric procedures.277-
279
 In chapter 3.1 and 3.2, the five parameters of the alternate dipping process were 
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simultaneously optimized: the number of cycles, concentration of and immersion time in both 
the calcium and phosphate rich solutions, for the electrospun PCL and PDLLA scaffold 
respectively. The obtained coating on both scaffolds was a slightly carbonated 
nanocrystalline calcium deficient apatite. As the alternate dipping process is mainly used as 
an intermediate step in the mineralization procedure, the calcium phosphate phase deposited 
after this step was rarely identified. Our results are however consistent with Furunzo et al.280, 
which demonstrated the deposition of a deficient apatite containing carbonate and HPO42- 
ions on silk fabric.  
Because of the difficulty of coating electrospun scaffolds without obstructing the pores, 
further maturation experiments, in which the calcium phosphate primer layer further grows, 
were not performed with the electrospun scaffolds.  
For the 3D plotted PCL scaffolds, the thickness of the calcium phosphate layer deposited 
during the nucleation process is less of a limiting factor as the pores are much larger 
compared to the electrospun scaffold. Therefore, a standard nucleation procedure, adopted 
from literature could be used.183,184 At this point we were able to automate the otherwise labor 
intensive method by introducing the use of a dip coater machine, the RDC30 Multidip from 
Bungard. The robotic arm of the machine was capable of raising and lowering up to six 
samples simultaneously and placing them into four separate beakers filled with (1) 
CaCl2.2H2O-solution, (2) demineralized water, (3) Na2HPO4-solution and (4) demineralized 
water. Although the deposited calcium phosphate seeds could not be visualized by SEM, nor 
identified by IR, the necessity of the nucleation step was demonstrated as its implementation 
was shown to accelerate the deposition of a more homogenous calcium phosphate layer 
upon subsequent incubation in SBF.281 
Because the exterior layer of the multiscale scaffold consists of electrospun fibers, the 
parameters of the nucleation procedure optimized for the electrospun PCL scaffolds were 
used for the nucleation of the multiscale scaffolds. Although not identified, it can be assumed 
that the deposited coating is also a nanocrystalline calcium deficient apatite, in analogy with 
the coating deposited on the electrospun samples after treatment with the same nucleation 
procedure. 
2.3 Maturation 
Following the activation and nucleation step, the 3D plotted PCL scaffolds and multiscale 
PCL scaffolds were further subjected to a maturation step in SBF-based solutions in order to 
deposit a carbonate rich apatite layer on the scaffold surface. 
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Bioactive materials form apatite nuclei on their surfaces prior to the spontaneous growth 
of apatite upon immersion in an SBF solution. In analogy, the surface of the activated and 
alternately dipped samples can at this stage be considered to be similar to that bioactive 
materials, having calcium phosphate nuclei on their surface. The nuclei are proposed to 
activate the growth of an apatite-like coating when immersed in a SBF solution by providing 
sites for heterogeneous nucleation. Consequently, the formation of a solid calcium 
phosphate phase, by consuming calcium and phosphate ions from the surrounding solution, 
is much easier.243,281  
In the 1990s developed mineralizing solution based on physiological fluids, SBF, can be 
used to deposit apatitic layers on various substrates at near-physiological temperature and 
pH.282,283 This biomimetic coating method offers several advantages, such as coating of 
temperature-sensitive polymers, formation of phases other than hydroxyapatite, such as 
carbonated apatite and deposition on porous and complex geometric shapes. In order to 
enable the formation of highly carbonated apatite it is necessary to change the ionic 
composition of the original SBF solution. It is well known that the composition of the calcium 
phosphate layer deposited in aqueous solutions largely depends on the composition of the 
mineralization solution.186,257,259 
For the preparation of the experimental SBF solution, concentrated stock solutions were 
used. SBF preparation from stock solutions was previously proven to be more efficient, user-
friendly and repetitive than direct preparation form salt weighing.243,284 After the synthesis of 
experimental SBF solutions with the ability to form carbonate rich deposits was established, 
3D plotted and multiscale PCL scaffolds were coated with a carbonate rich apatite layer (up 
to 16 wt% carbonate). Our results showed that in order to deposit an apatite with high 
carbonate content, the mineralization solution should preferentially be deprived of Mg2+ ions, 
and rich in CO32- ions (≥ 42 mM). As a matter of fact, CO32- as well as Mg2+ have been shown 
to act as crystal growth inhibitors, by slowing down apatite nucleation in favor of the 
formation of an amorphous state. Compared to CO32-, Mg2+ has a stronger inhibitory effect on 
crystal growth by adsorption onto the surface of the apatite.175,285 Moreover, there is a 
synergistic effect of Mg2+ and CO32- ions on the decrease of crystallinity.7,249 This may be due 
to the inactivation of crystal growth sites by adsorption of CO32- to the divalent Mg2+ cations 
instead of Ca2+.243 Although the reduction of the crystal size has been shown to allow for a 
better physical attachment of the coating on the substrate 175,186, the presence of Mg2+ ions in 
combination with a high concentration of CO32- ions clearly hindered the crystal growth too 
much so that no coating was deposited during incubation in these solutions.  
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The deposited apatite coating is predominantly a low crystalline B-type carbonated 
apatite, in which CO32- is substituted for PO43- in the apatite lattice. These results contradict 
the hypothesis of Müller et al.246, that assumed that at HCO3- concentrations higher than 20 
mM both A and B-type carbonated apatite forms. The highest  HCO3- concentration used in 
their experimental SBF is 27 mM, from which a carbonated apatite layer with a carbonate 
content of 9 wt% precipitated. To our opinion, there is no evidence that CO32- substituted for 
OH- as the characteristic bands associated with A-type substitution could not be observed in 
the associated IR spectrum, which is in fact in contradiction with their own hypothesis. 
Because of its great simplicity, the present surface mineralization protocol has 
advantages in cost and processing time over other methods. Furthermore, upon optimization 
of the parameters, the protocol has potential to be applicable to not only 3D plotted and 
multiscale PCL but also to scaffolds produced with other fabrication techniques and/or 
materials as well. 
To summarize, an overview of the optimized coating procedure of all four scaffold is 
shown in figure 17. 
Figure 17: Overview of the optimized step-wise mineralization procedures of the scaffolds 
investigated in the present thesis. 
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3 Cell response 
When cells approach an implant material, they do not make direct contact with its 
surface, but with a layer of adsorbed proteins from the culture medium, blood or serum. 
Hence, it is to these adsorbed proteins, rather than to the surface itself, cells initially respond. 
Diverse studies using a range of materials have demonstrated the pivotal role of extracellular 
adhesion proteins – fibronectin and vitronectin in partical – in cell adhesion, morphology and 
migration.286 Thus, the ability of materials to adsorb such proteins (in an active state) will 
determine their ability to support cell adhesion and spreading.287 
For the electrospun scaffolds the influence of a calcium deficient apatite coating on the 
cell viability and proliferation was evaluated. For the 3D plotted and multiscale PCL scaffolds, 
cell response was evaluated for the samples coated with apatite with different carbonate 
contents. Mouse calvaria-derived pre-osteoblastic cells, MC3T3-E1, were used for the 
evaluation of biological performance on all scaffolds. These cells are commonly used in 
similar approaches because of the cell culture reproducibility.288 
In general, the amount of cells attached to the untreated scaffolds was low throughout all 
experiments. In addition, the majority of cells showed a rounded morphology. The observed 
limited cell-biomaterial interactions could be expected due to the hydrophobic nature of the 
untreated polyesters. Moderately hydrophilic surfaces are known to induce more favorable 
cell responses than hydrophobic surfaces, by favoring adsorption of vitronectin and/or 
fibronectin and better preserving the bioactivity of adsorbed proteins.123,287 The observation 
that some cellular proliferation occurs during prolonged incubation illustrates a limited or 
unfavorable protein adsorption. Also, fluorescence micrographs of the untreated samples 
after calcium/propidium iodide staining generally shows the presence of predominantly green 
cells. The latter supports the non-toxicity of untreated PCL samples. Comparison of the 
observed cell viability on untreated electrospun and 3D plotted PCL samples (Chapter 3.1 
figure 11 and Chapter 3.2 figure 8, respectively) showed a very low number of attached cells 
after one day of culture on both scaffolds. After 7 and 14 days of culture, however still rather 
low, a larger number of cells was able to attach to the 3D plotted samples compared to the 
electrospun samples. Based on previous reports in literature118-120,220 the lower cell response 
on electrospun samples could be expected and can be ascribed to their smaller pore 
diameter. This results in a limited cell infiltration and cells are only able to adhere to surface 
of the electrospun samples. The larger pores of the 3D plotted scaffold enable the migration 
of cells through the samples. As a result, the cells can adhere to the surface of the filaments 
throughout the samples. The latter represents a larger surface compared to the surface of 
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the electrospun samples which is reflected in the higher number of attached cells on the 
untreated 3D plotted PCL samples compared to the untreated electrospun samples. 
Our results demonstrated generally higher amounts of viable cells and higher proliferation 
rates on the mineralized scaffolds compared to the untreated scaffolds. The increase in cell 
attachment can probably be accounted to an enhancement of proteins adsorption such as 
fibronectin and vitronectin on the mineralized scaffolds. Moreover, the carbonate content of 
the apatite layer clearly had an impact on cell attachment and proliferation. Bridging of the 
pores in the 3D plotted PCL scaffolds was only achieved for the samples coated with a 
calcium phosphate with a high carbonate content (≥10 wt%). It was indeed previously shown 
that carbonated apatite powders promote cell attachment and proliferation compared to 
carbonate-free apatites.152,289,290 The incorporation of CO32- in the apatite lattice results in a 
decrease of the charge density at the apatite surface and a change in available Ca2+ and 
PO43- surface groups which will probably influence the adsorption of proteins.291 Also, CO32- 
incorporation results in a change of the surface structure as it favors the formation of smaller 
crystals, with larger surface area. Moreover, the incorporation of carbonate increases the 
solubility of the apatite in physiological fluids, which may promote the bioresorption of these 
materials and could also have been a reason for the more pronounced osteoblast 
proliferation in coating with higher carbonate content.292 
4 Conclusion 
In the present study, electrospun PCL and PDLLA nanofibrous scaffolds were coated 
with a thin, homogenous primer layer of slightly carbonated calcium deficient hydroxyapatite, 
with preservation of the porous structure. The optimized protocol enabled a faster deposition 
of such a calcium phosphate coating at milder conditions than the coating procedures 
described in literature. 
Microfibrous PCL scaffolds, fabricated by the rapid prototyping technique 3D plotting, 
were successfully coated with highly carbonated hydroxyapatite. By adjustment of the 
carbonate and magnesium content of the mineralization solution, higher amounts of 
carbonate incorporation were obtained than previously reported in literature.  
Finally, a novel technique for fabricating multiscale polymer scaffolds was presented. 
3D plotting was combined with electrospinning to fabricate scaffolds with both nano – and 
microfibrous structures. Accordingly, the previously optimized coating procedure for the 
constituting single scale scaffolds were combined for the coating of the multiscale scaffolds 
with a highly carbonated hydroxyapatite. 
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Analysis of the cell viability, adhesion and proliferation of MC3T3-E1 cells showed 
improved osteogenic response and enhanced cell affinity on all calcium phosphate coated 
scaffolds compared to untreated samples. Moreover, the best results in term of cell adhesion 
and proliferation were obtained upon coating of the samples with a hydroxyapatite layer with 
high carbonate content.  
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Calcium phosphate coated electrospun scaffolds 
Although the final aim of the present study was the coating of electrospun fiber as part of 
a multiscale scaffold, mineralized electrospun fibers as such have also great potential in BTE 
and can either be used alone as 2D or 3D matrices or in combination with larger tissue 
engineered constructs. The following section summarizes some potential applications. 
 Electrospinning can also be used to produce and deposit polymeric nanofibers on 
metallic substrates. Surface coating with polymers provides better corrosion resistance, 
enhances biocompatibility and cell response and reduces the degradation in 
physiological environment.293 Soujanya et al.294 showed that the corrosion rate of 
electrospun PCL coated AZ31 magnesium alloys was five times lower compared to 
chemically treated samples. The addition of an apatite coating could increase the 
bioactivity of the composite structure. 
 In order to reduce implant-related infections following invasive orthopedic surgery, an 
implant can also be coated with antibiotic-loaded electrospun mats. In this way, the 
release of antibiotic is localized and targeted to the desired site and released at high 
concentrations over a prolonged period of time. For instance, Zhang et al.295 coated 
titanium implants with vancomycin loaded electrospun PLGA. The coated titanium 
implants exerted antibacterial properties in vitro and in vivo. Also in this application, 
coating of the electrospun fibers with an apatite layer could improve the bioactivity of the 
complete implant. As the coating will shield the antibiotic-loaded electrospun fibers from 
the surrounding body fluids, the release-profile of the antibiotic will likely be altered. 
 In 2011, Kolambkar et al.296 developed a scaffold that consisted of an electrospun PCL 
nanofiber tube. This scaffold was tested to repair critical sized, femoral segmental defects 
in rats. Nanofiber tubes were placed around the adjacent bone ends, such that the tube 
lumen contained the defect. The tube lumen was filled with alginate gel with recombinant 
bone morphogenetic protein-2 (rhBMP-2). The results indicated that this novel scaffold 
resulted in consistent bony bridging of the challenging bone defects within 12 weeks. 
Apatite coating of such nanofiber tubes could eliminate the disadvantageous 
hydrophobicity of the PCL material, enhance the bioactivity of the tube and possibly even 
slightly improve the mechanical properties of the construct.  
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Optimization fabrication technique multiscale scaffolds  
The limitation of the current fabrication procedure is that the electrospinning apparatus 
and the BioScaffolder are two individual devices. An interesting possibility is the integration 
of the two techniques in a single device. With such a device it would be possible to fabricate 
scaffolds with alternating layers of nanofibers and microfibers. 
Mechanical testing 
Analysis of the mechanical properties of the scaffold is an essential element that should 
still be investigated in vitro as well as at load bearing sites in vivo. Important in the latter is 
the degradation behavior of the scaffold; even if the scaffold has sufficient mechanical 
properties at the time of implantation, the way its mechanical properties change during 
degradation could also affect function within the tissue defect. 
In vitro tests 
In order to assess applicability of scaffolds technologies in tissue repair and 
regeneration, experiments with human cells are of importance prior to in vivo testing 
In vivo tests 
In vivo studies should be performed to determine the effect of the calcium phosphate 
coating on bone formation. The resorption of these coatings should also be evaluated. In 
vivo, optimal conditions can be different than in vitro, given the fact that in vivo, the 
degradation behavior of both polymer structures and the calcium phosphate coating will be 
different. Additional needs of nutrient supply, blood vessel ingrowth etc. need to be met as 
well. In a first approach the scaffolds can be implanted into the subcutaneous dorsal pockets 
of nude mice, a standard technique used for the evaluation of in vivo osteogenic potential of 
scaffolds. In a next phase osteogenesis can be further evaluated by implantation of the bone 
scaffolds into a bone defect (in a weight-bearing position) in an animal model.  
Eventually, the developed constructs should be investigated in clinical relevant 
orthopedic defects to test the hypothesis that the coating of biodegradable fibrous polyester 
scaffolds with a layer of bioactive carbonated apatite leads to improved synthetic graft 
substitutes.  
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Clinical translation 
While progress has been made to deliver bench to bedside solutions, the rate at which 
tissue engineering has seen innovations translated to the clinic is slow. The major challenge 
represents the translation of laboratory-based scaffold preparation processes into “clinically 
appropriate larger scale production techniques” that are “reproducible, safe, clinically 
effective and economically acceptable”.297 In this respect, for the present scaffold, the 
scaffold fabrication process should be automated and up-scaled. This includes the combined 
use of 3D plotting and electrospinning, as well as the complete mineralization procedure. An 
additional concern is obtaining regulary approval. 
Finally, upon commercialization, a custom-made patient specific scaffold can be 
fabricated on demand and on short notice in a GMP/GLP (good manufacturing/laboratory 
practice) facility and transported to the clinic where the bone reconstructive surgery is 
perfomed.  
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